Page last updated: 2024-08-23

piperacillin and tazobactam

piperacillin has been researched along with tazobactam in 718 studies

Research

Studies (718)

TimeframeStudies, this research(%)All Research%
pre-199013 (1.81)18.7374
1990's201 (27.99)18.2507
2000's212 (29.53)29.6817
2010's206 (28.69)24.3611
2020's86 (11.98)2.80

Authors

AuthorsStudies
Baum, EZ; Bush, K; Foleno, BD; Grant, EB; Guiadeen, D; Hlasta, DJ; Jin, H; Montenegro, DA; Nelson, EA1
Feigelson, GB; Petersen, PJ; Prashad, AS; Sandanayaka, VP; Yang, Y1
Lin, YI; Mansour, TS; Prashad, AS; Sandanayaka, VP; Williamson, RT; Yang, Y1
Abe, T; Ado, M; Agarwal, A; Dos Santos, O; Francisco, G; Gu, Y; Knox, JR; Kumagai, T; Li, Z; Lin, YI; Mansour, TS; Petersen, PJ; Shlaes, DM; Sum, FW; Tsuyoshi, T; Ushirogochi, H; Venkatesan, AM; Weiss, WJ; Yamamura, I; Yang, Y1
Bonnet, R; Chanal, C; Delmas, J; Lesens, O; Robin, F; Schweitzer, C; Tournilhac, O1
Aubert, D; Naas, T; Nordmann, P; Ozcan, A1
Arlet, G; Loli, A; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS1
Cattoir, V; Corvec, S; Drugeon, H; Faccone, D; Galas, M; Mugnier, P; Nordmann, P; Pasteran, F; Petroni, A; Poirel, L; Rapoport, M1
Ayala, JA; Casellas, JM; Di Conza, J; Ghiglione, B; Gutkind, G; Power, P; Radice, M; Rodríguez, MM1
Amicosante, G; Caporale, B; Celenza, G; Docquier, JD; Mezzatesta, M; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S1
Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS1
Bonnet, R; Brebion, A; Constantin, JM; Delmas, J; Dubois, D; Robin, F1
Girlich, D; Leclercq, R; Naas, T; Nordmann, P1
Correia, A; Domingues, MR; Domingues, P; Fonseca, F; Henriques, I; Saavedra, MJ; Samyn, B; Sarmento, AC; van Beeumen, J1
Bonnet, R; Neuwirth, C; Robin, F; Siebor, E1
Courvalin, P; Decré, D; Høiby, EA; Meziane-Cherif, D; Périchon, B1
Courvalin, P; Dupêchez, M; Galimand, M; Lambert, T; Meziane-Cherif, D1
Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ1
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR1
Andlovic, A; Jeverica, S; Karisik, E; Koren, S; Krizan-Hergouth, V; Livermore, DM; Mesko Meglic, K; Müller-Premru, M; Palepou, MF; Pike, R; Seme, K; Woodford, N1
Nordmann, P; Plésiat, P; Poirel, L; Rodriguez-Martinez, JM1
Bonnet, R; Brisabois, A; Cloeckaert, A; Doublet, B; Fabre, L; Granier, SA; Robin, F; Weill, FX1
Kirikae, T; Kitao, T; Miyoshi-Akiyama, T1
Chanteperdrix, V; Croizé, J; Nordmann, P; Poirel, L; Potron, A1
Kotsakis, SD; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS1
Ghori, S; Griggs, DJ; Johnson, MM; Mott, A; Peake, L; Piddock, LJ1
Bonnet, R; Casin, I; Doublet, B; Fabre, L; Le Fleche, A; Robin, F; Weill, FX1
De Luca, F; Docquier, JD; Ide, L; Nordmann, P; Poirel, L; Rossolini, GM; Verlinde, A1
Girlich, D; Nordmann, P; Poirel, L1
Bethel, CR; Bonomo, RA; Distler, AM; Kasuboski, C; Papp-Wallace, KM; Taracila, M1
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS1
Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH1
Bonomo, RA; Distler, AM; Endimiani, A; Hornick, JM; Hujer, AM; Hujer, KM; Papp-Wallace, KM; Taracila, M1
Chan, MC; Chang, TY; Chiueh, TS; Sun, JR; Wang, WY1
Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS1
Bethel, CR; Bonomo, RA; Caselli, E; Drawz, SM; Dwulit-Smith, JR; Papp-Wallace, KM; Prati, F; Rodkey, EA; Romagnoli, C; Smith, KM; Taracila, MA; van den Akker, F; Winkler, ML; Xu, Y1
Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT1
Colchón, E; González-Bello, C; Pernas, M; Rodríguez, Á; Rodríguez, D1
Dutta, A; Faulkner, R; Greene, DS; Halstenson, CE; Haynes, J; Johnson, CA; Kelloway, JS; Shapiro, BE; Tonelli, A; Zimmerman, SW1
Spencer, RC; Wilcox, MH; Winstanley, TG1
Brismar, B; Kasholm-Tengve, B; Nord, CE; Tunevall, G2
Bure, A; Carbon, C; Jehl, F; Mentec, H; Saleh-Mghir, A; Vallois, JM1
Brismar, B; Kinzig, M; Nord, CE; Sörgel, F1
Barry, AL; Fuchs, PC; Gerlach, EH; Hardy, DJ; McLaughlin, JC; Pfaller, MA1
Kelsey, SM; Newland, AC; Pocock, CE; Shaw, E; Weinhardt, B1
Bäckstrand, B; Bergman, L; Brismar, B; Kihlström, E; Malmborg, AS; Mentzing, LO; Nyström, PO; Skau, T; Tunevall, G; Wretlind, B1
Meyran, M; Thabaut, A1
Carret, G; Chanal, C; Derlot, E; Kitzis, MD; Soussy, CJ1
Cordin, X; Duex, JM; Kazmierczak, A; Péchinot, A; Siebor, E1
Dubreuil, L; Sedallian, A1
Baquero, F; Martínez, JL; Pérez-Díaz, JC; Reguera, JA1
Ansari, A; Douglas, JG; Gould, IM; Harvey, G; Reid, TM; Smith, CC1
Andrews, JM; Cooper, M; Logan, M; Wise, R1
Kunii, O; Miyashita, T; Ono, Y1
Cullmann, W1
Bauernfeind, A; Eberlein, E; Jungwirth, R; Schweighart, S1
Livermore, DM; Seetulsingh, P1
Chang, SC; Hsieh, WC; Hsu, LY; Luh, KT1
Castiglia, P; Maida, A; Mezzatesta, ML; Muresu, E; Nicoletti, G; Stefani, S1
Karp, WB1
Akova, M; Livermore, DM; Yang, Y1
Stobberingh, EE1
Crokaert, F; Lismont, MJ; Van der Linden, MP; Yourassowsky, E1
Higashitani, F; Hyodo, A; Inoue, M; Ishida, N; Mitsuhashi, S1
Gunderson, D; Kennedy, SL; Kern, W; Sachdeva, M; Sande, ER; Täuber, MG1
Blakemore, PH; Drabu, YJ; Mehtar, S1
Cullmann, W; Stieglitz, M1
Cherubin, CE; Eng, RH; Smith, SM1
Dornbusch, K; Göransson, E; Mörtsell, E1
Kempers, J; MacLaren, DM1
Echols, RM; Robbiano, EM; Venezia, RA; Yocum, DM1
Ràfols, M; Reig, R; Roy, C; Teruel, D; Tirado, M1
Diver, JM; Thornber, D; Wise, R1
Appelbaum, PC; Aronoff, SC; Jacobs, MR; Yamabe, S1
Kuck, NA; Petersen, PJ; Testa, RT; Weiss, WJ1
Fass, RJ; Prior, RB1
Acar, JF; Coutrot, A; Ferré, B; Gutmann, L; Kitzis, MD1
Carver, AH; Hoyt, KD; Ocampo, AP; Puglisi, CV; Wadgaonkar, N1
Jacobus, NV; Kuck, NA; Petersen, PJ; Testa, RT; Weiss, WJ1
Maniwa, M; Marunaka, T; Matsushima, E; Minami, Y1
Hyatt, JM; Nix, DE; Schentag, JJ; Stratton, CW1
Brogden, RN; Bryson, HM1
Betschel, S; Kreiswirth, B; Low, DE; Willey, BM1
Grimm, H1
Aldridge, KE1
Kinzig, M; Sörgel, F3
Lahnborg, G; Nord, CE1
File, TM; Tan, JS2
Grundel, E; Vestweber, KH1
Neu, HC1
Brewster, SF; Gingell, JC; MacGowan, AP1
Chin, A; Chung, KC; Gill, MA; Moon, YS; Ulrich, RW1
Duval, J; Leclercq, R1
Cony Makhoul, P; Darmaillac, V; Fourche, J; Maugein, J; Perrier, F1
Higashitani, F; Hyodo, A; Inoue, M; Nishida, K1
Dudley, MN1
Jones, RN1
Jones, R; Satishchandran, V; Shapiro, T; Suh, B; Truant, AL1
Amyes, SG; London, N; Stobberingh, E; Thomson, CJ1
Chin, A; Chung, KC; Gill, MA; Moon, YS1
Danziger, LH; Occhipinti, DJ; Rodvold, KA; Schoonover, LL1
Chamard-Neuwirth, C; Cordin, X; Duez, JM; Kazmierczak, A; Pechinot, A; Siebor, E2
Bergogne-Berezin, E; de Larminat, V; Jehl, F; Monteil, H; Muller-Serieys, C1
Blumer, JL; Goldfarb, J; Lemon, E; Reed, MD; Yamashita, TS1
Appelbaum, PC; Jacobs, MR; Pankuch, GA1
Bansal, S; Doepner, M; Halstenson, CE; Johnson, CA; Keane, WF; Onorato, JJ; Sia, L; Tantillo, K; Wong, MO; Zimmerman, SW1
Fujii, R; Fujita, K; Fukushima, N; Inyaku, F; Ishikawa, A; Okuno, A; Saijo, M; Takimoto, M; Wagatsuma, S; Yoshikawa, M1
Hirayama, T; Iwai, S; Mashita, K; Matsuno, S; Nakagawa, Y; Otsuka, K; Rikiyama, T; Shinagawa, N; Tanaka, T; Yura, J1
Blickle, JF; Brogard, JM; Caro-Sampara, F; Jehl, F; Westphal, JF1
Kawaguchi, S; Kawahara, M; Koike, T; Mitutake, Y; Ohno, T; Oizumi, K; Saisho, M; Saito, A; Takebe, K; Tomizawa, M1
Hiraga, Y; Inoue, H; Kawaguchi, S; Kawahara, M; Ohmichi, M; Oizumi, K; Saito, A; Sano, N; Sigematsu, H; Tanaka, F1
Burm, JP; Chin, A; Choi, JS; Gill, MA; Jhee, SS; Ulrich, RW1
Cantrell, HF; Lankford, RB; Murray, PR1
Hashimoto, M; Niidome, K; Nishida, K; Nishino, T; Otsuki, M1
Bonfiglio, G; Livermore, DM2
MacLaren, DM; Namavar, F; Severin, WP; Smeets, T; Stobberingh, E1
Anai, M; Anai, S; Hayashi, T; Kawazu, K; Kaziwara, T; Umano, T; Yada, H; Yamasaki, K1
Auletta, CS; Cockrell, BY; Daly, IW; Hayashi, T; Knezevich, AL; Yada, H1
Blair, M; Blanchard, GL; Geil, RG; Hayashi, T; Laughlin, KA; Tucek, PC; Yada, H1
Christian, MS; Hoberman, AM; Lochry, EA; Sato, T2
Christian, MS; Hoberman, AM; Sato, T1
Kouchi, Y; Matsuo, K; Oguro, M; Takemoto, M1
Kashihara, A; Kouchi, Y; Maeda, Y; Ohuchida, A; Omae, S; Taniguti, A1
Dudley, MN; Gilbert, DH; Medeiros, AA; Pivarnik, P; Strayer, AH; Zinner, SH1
Appelbaum, PC; Jacobs, MR; Spangler, SK3
Kakuo, H; Komuro, M; Maeda, T; Matsushita, H; Shimada, J1
Baughman, R; Boylen, CT; Chan, JC; Charan, NB; Cormier, YC; Erickson, A; Grossman, R; Kirmani, N; Shlaes, DM; Suh, B1
Carias, LL; Rice, LB; Shlaes, DM1
Cantrell, HF; Jones, RN; Lankford, RB; Sutton, LD1
Bethea, C; Das Gupta, V; Mathew, M1
Cony-Makhoul, P; Fière, D; Guy, H; Herbrecht, R; Marie, JP; Milpied, N; Pico, JL; Plantier, I; Vekhoff, A1
Sanders, CV1
Gorbach, SL1
Nord, CE2
Nowé, P1
Charbonneau, P1
Choi, JH; Incavo, SJ; Kinzig, M; Ronchetti, PJ; Sörgel, F; Wu, H1
Bradford, PA; Sanders, CC1
Murray, BE; Okhuysen, PC; Singh, KV1
Collins, LA; Eliopoulos, GM; Ferraro, MJ; Moellering, RC; Wennersten, CB1
Baquero, F; Reig, M1
Decazes, JM; Gutmann, L; Kitzis, MD; Leleu, G; Vallois, JM1
Edelstein, MA; Edelstein, PH1
Duncanson, FP; Norden, CW; Talan, DA; Tan, JS; Wishnow, RM1
Bywater, MJ; Holt, HA; MacGowan, AP; Reeves, DS1
Allen, M; Bonfiglio, G; Chen, HY; Edwardson, T; Livermore, DM; McVey, D; Piper, D1
Duchateau, V; Husson, M; Kinzig, M; Lambert, C; Sörgel, F; Van der Auwera, P1
Faro, S; O'Brien, WF; Roy, S; Sanfilippo, JS; Seidlin, M; Sweet, RL1
Alhava, E; Haapiainen, R; Havia, T; Kivilaakso, E; Laitinen, S; Matikainen, M; Miettinen, P; Niinikoski, J; Pääkkönen, M1
Cullmann, W; Elhardt, D; Tassler, H1
DeVries, VG; Kuye, O; Morrow, CA; Tally, FP; Teal, J1
Acar, JF; Goldstein, FW; Kitzis, MD1
Appelbaum, PC1
Eklund, AE; Nord, CE1
Ajana, F; Beuscart, C; Chidiac, C; Lecocq, P; Leroy, O; Mouton, Y; Senneville, E1
Wise, R1
Allen, SD; Barry, AL; Fuchs, PC; Hardy, DJ; Jorgensen, JH; McLaughlin, JC; Tenover, FC1
Gentile, G; Girmenia, C; Martino, P; Meloni, G; Micozzi, A; Nucci, M; Venditti, M1
Gupte, JM; Immermann, FW; Jacobus, NV; Testa, RT1
Barie, PS; Cheadle, WG; Fink, MP; Garber, GE; Hebert, JC; Laverdiere, M; Polk, HC; Wilson, SE1
Chung, KC; Gill, MA; Le-Bui, LP; Park, TW; Rho, JP1
Dhoore, P; Verbist, L1
Behbahani, R; Kostman, JR1
Atchison, K; Czajkowski, DP; Fiakpui, C; Hyodo, A; Kunugita, C; Maiti, SN; Micetich, RG; Phillips, OA; Setti, EL1
Arpi, M; Bruun, B; Gottschau, A; Mortensen, I; Victor, MA1
Gerber, L; Wing, EJ1
Vandenhoven, G; Verbist, L; Verhaegen, J; Wouters, C1
Daley, D; Dimech, W; Mulgrave, L; Munro, R; Neville, S; Smith, H1
Bourget, P; Carsin, H; Le Bever, H; Le Reveillé, R; Lesne-Hulin, A1
Sanders, CC; Sanders, WE1
Albert, G; Audran, M; Augey, V; Bressolle, F; Grosse, PY1
Alonso, JM; Fournier, JL; Jacolot, AC; Petitjean, OJ; Ramisse, F; Scavizzi, MR; Szatanik, M1
Bowker, KE; Hedges, AJ; Holt, HA; MacGowan, AP; Reeves, DS; Wootton, M1
Livermore, DM; Yuan, M1
Atwood, E; DiTore, V; Landman, D; Patel, K; Quale, J; Saurina, G1
Arredondo-Garcia, JL; Figueroa-Damian, R; San Martín-Herrasti, JM; Villagrana-Zesati, R1
Atchison, K; Atwal, H; Czajkowski, DP; Hyodo, A; Kunugita, C; Maiti, SN; Micetich, RG; Phillips, OA; Reddy, NA; Setti, EL1
Dalla Costa, T; Derendorf, H1
Knapp, CC; Ludwig, MD; Pohlman, JK; Washington, JA1
Aguirre, C; Barreiro, G; Ruiz-Irastorza, G1
Klepser, ME; Marangos, MN; Nicolau, DP; Nightingale, CH; Quintiliani, R; Zhu, Z1
Blumer, JL; Bonafede, ME1
Gould, IM; Milne, K1
Chimura, T; Hirayama, T1
Bonomo, RA; Rudin, SA; Shlaes, DM1
Lister, PD; Prevan, AM; Sanders, CC1
Klimonova, NV; Lobakov, AI; Nasonov, VN; Savitskaia, KI; Savov, AM1
Palmer, SM; Rybak, MJ1
Kinzig-Schippers, M; Kolenda, H; Müller, C; Nau, R; Prange, HW; Rössing, R; Schinschke, S; Sörgel, F1
Eliopoulos, GM; Moellering, RC; Thauvin-Eliopoulos, C; Tripodi, MF1
Higashitani, F; Hyodo, A; Kunugita, C; Nishida, K; Unemi, N1
Bayle, C; Bourhis, JH; Cartron, J; Gautier, E; Pico, JL; Tchernia, G1
Hanaki, H; Nagayama, A; Nomura, S1
Adloff, M; Blicklé, JF; Brogard, JM; Caro-Sampara, F; Jehl, F; Monteil, H; Westphal, JF1
Mulder, PO; Stegeman, CA; Uges, DR; van der Werf, TS; Zijlstra, JG1
Kadima, TA; Weiner, JH1
Chen, HY; Livermore, DM1
Douboyas, J; Tsakris, A; Tzouvelekis, LS1
Dalla Costa, T; Derendorf, H; Nolting, A; Rand, K1
Danziger, LH; Occhipinti, DJ; Pendland, SL; Rodvold, KA; Rypins, EB; Schoonover, LL1
Constantoulaki, S; Paniara, O; Platsouka, E; Zissis, NP1
Hitt, CM; Nicolau, DP; Nightingale, CH; Patel, KB; Zhu, Z1
Adhikari, M; Pillay, DG; Pillay, T; Sturm, AW1
Diepersloot, RJ; Hoekstra, JB; Hoynck van Papendrecht, AA; van Kraaij, MG; Veldkamp, KE; Zeillemaker, AM1
Bryce, E; Frighetto, L; Jewesson, P; MacDougall, C; Marra, F; Reynolds, R; Sleigh, K; Stiver, G1
Makandiramba, B; Moyo, SR; Nziramasanga, P; Obi, CL; Robertson, V; Tswana, SA1
Bianchi, C; Bonfiglio, G; Nicoletti, G; Stefani, S; Zollo, A1
Böhme, A; Hoelzer, D; Shah, PM; Stille, W1
Dudley, MN; Okereke, C1
Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A1
Böhme, C; Hess, U; Rey, K; Senn, HJ1
Babini, GS; Bates, J; Livermore, DM; Palepou, MF; Woodford, N1
Haruta, T; Kobayashi, Y; Nishio, T1
Pastor, JM; Pérez-Vázquez, A; Riancho, JA1
Alvarez-Bravo, J; Bouza, E; García Rodríguez, JA; Gobernado, M; Perea, E1
Ambrosetti, P; Aymon, D; Bille, J; Chiolero, R; Cometta, A; Glauser, MP; Harbarth, S; Huber, O; Jaccard, C; Lew, D; Praz, G; Ricou, B; Romand, J; Schneider, R; Troillet, N; Zanetti, G1
Forrest, A; Nix, DE; Schentag, JJ; Strenkoski-Nix, LC1
Birawska, I; Fuchs, J; Szulakowska, E1
Corrado, OJ; Fawley, WN; Hawkey, PM; Settle, CD; Wilcox, MH1
Lessing, MP; Stewart, BA1
Dalla Costa, T; Derendorf, H; Kovar, A; Nolting, A1
Bryce, EA; Frighetto, LO; Jewesson, PJ; Marra, CA; Marra, FO; Reynolds, RP; Sleigh, KM; Stiver, HG1
Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R1
Gardner, VM; Lister, PD; Sanders, CC1
Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P1
Ell, C; Gossner, L; Hahn, EG; Keymling, J1
Auclair, B; Ducharme, MP1
Markham, A; Perry, CM1
Betriu, C; Gómez, M; Palau, ML; Picazo, JJ; Sánchez, A1
Cederberg, A; Forssell, H; Ohlin, B; Solhaug, JH; Tveit, E1
Czymek, R; Düsel, W; Lenz, S1
Brogard, JM; Caro-Sampara, F; Jehl, F; Westphal, JF1
Kays, MB1
Babini, GS; Livermore, DM1
Bonafede, M; Bonomo, RA; Carias, LL; Hoyen, C; Hujer, AM; Hutton, R; Rice, LB1
Miranda, E; Sader, HS; Sejas, L; Tosin, I1
Carbon, C; Carlet, J; Dupont, H1
Aznar, E; Climent, MA; Máiquez, J; Palau, J; Picón, I1
Bradley, SJ1
Lister, PD1
Burgess, DS; Hastings, RW1
Cross, JM; May, AK; McGwin, G; Melton, SM; Moser, SA; Rue, LW1
Baddour, LM; Googe, PB; Prince, TL1
Mohammedi, I; Tigaud, S; Tournadre, JP1
Christou, N; Eiseman, I; Siami, G; Tack, KJ1
Coia, JE; Gillespie, TA; Hanson, MF; Johnson, PR; Notman, AW1
Anstead, G; Blaser, M; Craig, F; Jorgensen, J; Patterson, T1
Chen, Y; Gao, L; Hou, F; Li, J1
Gooding, WE; Grandis, JR; Johnson, JT; Myers, EN; Pou, AM; Simons, JP; Vickers, RM; Wagner, RL; Yu, VL1
O'Connell, M; Petros, AJ; Roberts, C; van Saene, HK; Wade, P1
Allen, MC; Bradley, SJ; Goldstone, AH; Scott, GM; Sher, HA; Wilson, AL1
Abi-Said, D; Bivins, C; Hachem, R; Hanna, H; Huaringa, A; Raad, I; Sukumaran, A; Thornby, J; Walsh, G; Whimbey, E1
Niki, Y1
Hidai, H1
Brown, A; Freeman, J; Wilcox, MH1
Bode, U; Fleischhack, G; Hasan, C; Havers, W; Marklein, G; Schmidt-Niemann, M; Wulff, B1
Akhan, S; Coskunkan, F; Tansel, O; Vahaboglu, H1
Amorusi, P; Dowell, JA; Korth-Bradley, J; Milisci, M; Tantillo, K; Tse, S1
Amato, R; Andò, F; Azzaro, R; Bellissima, P; Cicciarella, S; Covelli, I; Delia, S; Fogliani, V; Fraschini, F; Girbino, G; Jacoviello, C; Laganà, P; Magrì, M; Maierna, G; Maria, GD; Marone, P; Messina, G; Muscianisi, G; Napoletano, G; Pela, R; Pezza, A; Rizza, S; Rossi, A; Sabato, V; Sanguinetti, C; Tedeschi, D; Varotto, F; Viola, B; Vitale, S1
Dul, MJ; Hoyen, C; Salvator, A; Toltzis, H; Toltzis, P; Walsh, M; Zetts, L1
Bauduer, F; Boiron, JM; Boulat, O; Cousin, T; Fegueux, N; Jourdan, E; Molina, L; Reiffers, J; Rigal-Huguet, F1
Moland, ES; Thomson, KS1
Androulakakis, E; Dimitriou, L; Kafetzis, DA; Lebesii, E; Maltezou, HC; Nikolaidis, P1
Backman, JT; Neuvonen, PJ; Takkunen, O; Tiula, E; Valtonen, M1
Adinolfi, LE; Andreana, A; Casillo, R; Durante Mangoni, E; Farina, C; Gambardella, M; Sarnataro, G; Tripodi, MF; Utili, R1
Liu, Y; Wang, R; Yu, B1
Naber, KG; Salmen, HC; Savov, O1
Harris, AD; Johnson, JA; Kaye, KS; Morris, G; Perencevich, E; Roghmann, MC1
Cassone, M; Falcone, M; Paris, A; Pavoni, G; Pistella, E; Venditti, M1
Minami, S; Takahata, M; Yamada, H1
Capitano, B; Kim, MK; Mattoes, HM; Nicolau, DP; Nightingale, CH; Quintiliani, R; Xuan, D1
Ceesay, TP; Gesser, R; Graham, DR; Holtom, P; Lucasti, C; Malafaia, O; McAdams, A; Nichols, RL; Perez, NQ; Woods, GL1
Archontaki, HA; Marselos, SC1
Batlle, M; Benlloch, L; Capote, FJ; Gutiérrez, M; Jarque, I; Julià, A; Lahuerta, JJ; Larrea, L; López, J; Palau, J; Pérez, C; Ramos, F; Rovira, M; Sanz, MA; Vázquez, L1
Ehrlich, M; Galla, TJ; Horch, RE; Kümmerer, K; Trittler, R1
Jones, RN; Mutnick, AH; Turner, PJ1
Kaygusuz, A1
Citron, DM; Gesser, RM; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, Y1
Burgess, DS; Waldrep, T1
Ahmed, S; Gouda, HE; Najjar, M; Rodriguez, P1
Burgess, DS; Nathisuwan, S1
Kuti, JL; Nicolau, D; Nightingale, CH; Quintiliani, R1
Chang, LK; Tsai, WC1
Bassilios, N; Restoux, A; Rondeau, E; Sraer, JD; Vincent, F1
Berardi, B; Callea, A; Cormio, L; Fiorentino, N; Sblendorio, D; Traficante, A; Zizzi, V1
Bornhauser, M; Ehninger, G; Hanel, M; Kroschinsky, F; Ordemann, R; Schuler, U; Wichmann, G1
Choti, MA; Fishman, EK; Geschwind, JF; Kaushik, S; Kobeiter, H; Ramsey, DE1
Goldberg, RA; Li, TG1
Deng, S; Han, C; Li, X; Liao, Z; Wang, W; Xu, W1
Brañas-Fernández, F; Garcia-Porrua, C; Gonzalez-Gay, MA; Pego-Reigosa, R1
Faltýn, J; Lochmann, O; Vyhnánek, F1
Fixson, A; Glasmacher, A; Gorschlüter, M; Hahn, C; Horré, R; Marklein, G; Mey, U; Molitor, E; Sauerbruch, T; Schmidt-Wolf, IG; Ziske, C1
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL1
Zaĭtsev, AA1
Chapuis, F; Duperret, S; Mohammedi, I; Petit, P; Ploin, D1
Kotapati, S; Kuti, JL; Nicolau, DP; Nightingale, CH1
Dittrich, P; Maier, A; Matzi, V; Nuhsbaumer, S; Pinter, H; Pinter, J; Smolle, J; Smolle-Jüttner, FM; Tomaselli, F; Woltsche, M1
Adeyi, B; Angel-Muller, E; Hague, C; Higareda, I; Ismail, M; Roy, S; Teppler, H; Woods, GL1
Finsterer, J; Kotzailias, N1
Maier, A; Smolle-Jüttner, FM; Tomaselli, F1
Chin, NX; Della-Latta, P; Libre, PE1
Bantar, C; Bertolini, P; Blázquez, N; Borda, N; Casellas, JM; Couto, E; Cudmani, N; Guerrera, J; Juárez, MJ; Littvik, A; López, T; Méndez, E; Notario, R; Ponce, G; Quinteros, M; Salamone, F; Sparo, M; Sutich, E; Tomé, G; Vaylet, S; Wolff, L1
Castillo Caparrós, A; Montijano Cabrera, AM1
Alos, JI; Gomez-Garces, JL; Hernaiz, C; Picardo, A1
Gesser, RM; McCarroll, KA; Woods, GL1
Ribaud, P; Sulahian, A; Touratier, S1
Bark, B; Perlick, E; Stöver, B1
Glasmacher, A; Wade, JC1
Ahern, JW; Alston, WK1
Bethe, U; Breuer, K; Cornely, OA; Diehl, V; Fätkenheuer, G; Karthaus, M; Reichert, D; Salzberger, B; Schwonzen, M; Seifert, H; Ullmann, AJ; Wicke, T1
Choi, MK; Fish, DN; Husain, M; Jung, R1
Blosser-Middleton, RS; Ge, Y; Karlowsky, JA; Sahm, DF; Wikler, MA1
Häfner, H; Klik, S; Kümmerer, K; Lemmen, SW; Lütticken, R; Zolldann, D1
Kwan, TH; Siu, YP; Tong, MK; Yung, CY1
Goessens, WH; Gyssens, IC; Lemmens, N; Mouton, JW; Stearne, LE; van Boxtel, D1
Derendorf, H; Liu, Q; Rand, K1
Burgess, DS; Hall, RG1
Auvrignon, A; Le Guyader, N; Leverger, G; Portier, E; Tabone, MD; Vu-Thien, H1
Cassini, M; Corrocher, R; Gabrielli, GB; Stanzial, AM1
Aspinall, S; Husain, S; Mietzner, S; Obman, A; Singh, N; Stout, JE1
Aksoylar, S; Cetingül, N; Kansoy, S; Kantar, M; Karapinar, D; Kavakli, K1
Aron, DC; Donskey, CJ; Gordon, SM; Paterson, DL; Pultz, NJ; Stiefel, U1
Apfalter, P; Berger, A; Kretzer, V; Pollak, A; Rohrmeister, K; Zaknun, D1
Bonnefoy, A; Delachaume, C; Dupuis-Hamelin, C; Fairley, M; Guitton, M; Lampilas, M; Seys, C; Stachyra, T; Steier, V1
Bassotti, G; Chistolini, F; De-Roberto, G; Morelli, A; Sietchiping-Nzepa, F1
Extremina, C; Fonseca, AF; Fonseca, AP; Sousa, JC1
Li, C; Nicolau, DP; Nightingale, CH; Xuan, D; Ye, M1
Danziger, LH; Drusano, GL; Lodise, TP; Lomaestro, B; Rodvold, KA1
Crisostomo, AC; Erasmo, AA; Hong, YS; Lee, KU; Lo, CM; Yan, LN1
Arzuaga, A; Canut, A; Corral, E; Fonseca, F; Gascón, AR; Isla, A; Maynar, J; Pedraz, JL; Rello, J; Sánchez-Izquierdo, JA1
Akgün, H; Caner, F; Erkiliç, K; Eşel, D; Evereklioglu, C; Ozkiriş, A1
Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M1
Arzuaga, A; Gascón, AR; Isla, A; Martín, A; Maynar, J; Pedraz, JL; Solinís, MA; Toral, D1
Baines, SD; Freeman, J; Wilcox, MH1
Akgün, H; Erkiliç, K; Esel, D; Evereklioglu, C; Göktas, S; Ozkiris, A1
Hameed, S; Johnson, M; Lipman, M; Tariq, S; Tyrer, M1
Ashkenazi, S; Bishara, J; Lev, B; Levy, I; Livne, G; Ofir, O; Pitlik, S; Samra, Z1
Guymon, CH; McManus, AT; Peng, DZ; Xiao, GX1
Aigner, F; Bonatti, H; Hoeller, E; Kafka, R; Stelzmueller, I; Weiss, H; Wiesmayr, S1
Bermúdez, A; Besalduch, J; Nocea, G; Pascual, MJ; Rovira, M; Sanz, MA; Sanz-Rodríguez, C1
Dana, A; Kuti, JL; Li, C; Mansfield, DL; Nicolau, DP; Nightingale, CH1
Bellaire, T; Cornely, OA; Dörken, B; Einsele, H; Krause, S; Kubin, T; Maschmeyer, G; Reich, G; Sandherr, M; Thiel, E1
Jones, MF; Rigge, DC1
Dittrich, P; Hoffmann, C; Kerl, H; Krause, R; Legat, FJ; Salmhofer, W; Scholz, S; Tscherpel, J; Tscherpel, T; Zenahlik, P1
Marinella, MA1
Cheng, FW; Fok, TF; Hui, J; Lee, N; Leung, TF; Ng, PC; Yap, F1
Bonomo, RA; Donskey, CJ; Harmoinen, J; Helfand, MS; Kääriäinen, S; Koski, P; Lindevall, K; Pultz, NJ; Stiefel, U; Wickstrand, N1
Hanehara, C; Higashitani, F; Inoue, M; Ishida, N; Mitsuhashi, S; Uji, T1
Jacobus, NV; Kuck, NA; Petersen, PJ; Tally, FP; Testa, RT; Weiss, WJ1
Cheung, WK; Faulkner, RD; Greene, DS; Hibberd, M; Houston, A; Kuye, O; Shin, K; Silber, BM; Tonelli, AP1
Capparelli, FJ; Del Castillo, ME; Diaz, MF; Hlavnika, A; Leiguarda, R; Wainsztein, NA1
Bette, M; Menendez, S; Mutters, R; Nüsing, RM; Schulz, S; Zamora, ZB1
Benner, A; Egerer, G; Geiss, HK; Goldschmidt, H; Harter, C; Ho, AD; Hoppe-Tichy, T; Schulze, B1
Bock, R; Calandra, T; Cometta, A; Crokaert, F; Glauser, MP; Kern, WV; Paesmans, M; Viscoli, C1
Aydogdu, I; Ersoy, Y; Kaya, E; Kuku, I; Serefhanoglu, K; Serefhanoglu, S1
Cooper, A; Joshi, M; Kassira, W; McCarthy, M; Metzler, M; Olvey, S1
Banic, S1
Alireza, S; Gholamali, G; Javad, A; Kazem, G; Qulamreza, K; Vahid, P1
Alouf, B; Pitone, M1
Dana, A; DeRyke, CA; Kuti, JL; Mansfield, D; Nicolau, DP1
Bhattacharya, SK; Kumari, N; Mohapatra, TM; Rai, A1
Arzuaga, A; Corral, E; Gascón, AR; Isla, A; Maynar, J; Pedraz, JL1
Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T1
Rice, LB1
Bier, U; Callies, R; Regidor, PA; Schindler, AE; Wagner, KJ1
Cirioni, O; Ghiselli, R; Giacometti, A; Kamysz, E; Kamysz, W; Licci, A; Lukasiak, J; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C1
Leitner, E; Lode, H; Schmitt, DV; Welte, T1
Chang, HT; Chen, IS; Chou, MY; Hsueh, PR; Huang, WK; Hung, MN; Ko, WC; Lee, WS; Lin, CF; Liu, CY; Liu, YC; Luh, KT; Shyr, JM; Teng, LJ; Wang, JH; Wu, JJ1
Appavu, SK1
Burgess, DS; Frei, CR; Hampton, SL1
Carreras, E; Fernández-Avilés, F; Gallego, C; García, L; Gaya, A; González, M; Granell, M; Hernando, A; Martínez, C; Montserrat, E; Ramiro, L; Rovira, M; Segura, S; Urbano-Ispizua, A; Valverde, M1
Bernabeu-Wittel, M; de la Cruz-Vicente, F; García-Morillo, JS; López-Ruiz, T1
Kinzer, S; Maier, W; Ridder, GJ1
Avlamis, A; Daikos, GL; Markogiannakis, A; Papaparaskevas, J; Papapareskevas, J; Petrikkos, G; Stefanakos, G; Zissis, NP1
Antretter, H; Bonatti, H; Guggenbichler, JP; Ladurner, R; Laesser, R; Margreiter, R; Mark, W; Muehlmann, G; Stelzmueller, I; Tabarelli, D; Tabarelli, W; Wiesmayr, S; Zimmerhackl, LB1
Wang, GJ; Xia, CH; Xiong, YQ1
Harada, AS; Lau, W1
Khan, HM; Malik, A; Shahid, M; Shujatullah, F; Shukla, I; Singhai, M; Tahira, F1
Erba, P; Hintermann, B; Kalbermatten, DF; Laifer, G; Pierer, G; Rieger, UM; Uike, K1
Cross, SE; Dalley, AJ; Lipman, J; Roberts, MS; Rudd, M; Venkatesh, B1
Choudhri, S; Giordano, P; Lipsky, BA; Song, J1
Tucker, H; Wu, D1
Bennett, KM; Dodds-Ashley, E; Hayward, TZ; Kaye, KS; Scarborough, JE; Sharpe, M; Vaslef, SN1
Adeyemi, OA; Montevecchi, M; Newman, D; Nicolau, DP; Noskin, GA; Postelnick, MJ; Scheetz, MH1
Braga, AL; Burattini, MN; Jukemura, EM; Medeiros, EA; Pereira, CA1
Blau, IW; Graf, B; Penack, O; Rempf, P; Thiel, E1
Anuradha, K; Lakshmi, V; Sailaja, VV; Satheesh, T; Umabala, P1
Clapson, P; Debien, B; Leclerc, T; Lenoir, B; Perez, JP1
Black, J; Brasso, W; Moland, ES; Reuben, J; Thomson, KS; Wiles, T1
Cirioni, O; Di Matteo, F; Ghiselli, R; Giacometti, A; Kamysz, E; Kamysz, W; Mocchegiani, F; Orlando, F; Riva, A; Rocchi, M; Saba, V; Scalise, G; Silvestri, C1
Abbruzzetti, A; Cirioni, O; Di Matteo, F; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C1
Ikonomidis, A; Kantzanou, M; Maniatis, AN; Neou, E; Pournaras, S; Tsakris, A1
Chow, P; Godambe, S; Maulidi, H1
Arora, J; Dogra, A; Rao, P; Taneja, N1
Cholongitas, E; Dasenaki, M; Kaklamanis, L; Pipili, C1
Allaouchiche, B; Boselli, E; Bouvet, L; Breilh, D; Chassard, D; Guillaume, C; Rimmelé, T; Saux, MC; Xuereb, F1
Lipman, J; Paratz, JD; Roberts, JA1
Barnaud, G; Chevrel, G; Dreyfuss, D; Eveillard, M; Meybeck, A; Mounier, R; Ricard, JD1
Friedland, I; Kaniga, K; Ketter, N; Lee, M; Lobo, SM; Niederman, M; Prokocimer, P; Réa-Neto, A; Schroeder, E1
Abe, T; Anderson, VE; Bethel, CR; Bonomo, RA; Carey, MP; Carey, PR; Distler, AM; Helfand, MS; Hujer, AM; Hujer, KM; Kalp, M; Leonard, DA; Mansour, TS; Ruszczycky, MW; Taracila, M; Thomson, JM; Venkatesan, AM1
Glasmacher, A; Gorschlüter, M; Hahn-Ast, C; Marklein, G; Molitor, E; Orlopp, K; Purr, I; Reiffert, SM; von Lilienfeld-Toal, M; Welter, A1
Arndt, PA; Garratty, G; Leger, RM1
Church, DL; Gregson, DB; Laupland, KB; Le, P; Pitout, JD1
Aldeyab, MA; Bailie, R; Elshibly, SM; Hanley, J; Hughes, CM; Kearney, MP; McDowell, DA; McElnay, JC; McMahon, MA; Scott, MG1
Cho, YB; Choi, CH; Jang, CH; Park, H1
Al Hassan, M; Byrd, RP; Halawa, A; Roy, TM; Yacoub, G1
Di Giovamberardino, G; Federici, G; Ferrannini, M; Pastore, A; Testore, GP1
Burgess, DS; Frei, CR1
Batista, N; Fernández, MP; Gambra, ML; Rodríguez, L1
Bleeker-Rovers, CP; Koopman, M; Mannaerts, L; Punt, CJ; van Herpen, CM1
Cotter, M; Crowley, B; O Connell, N; Roche, C1
Kuo, HY; Lin, ML; Liu, CY; Wang, FD; Yen, YF1
Bonatti, H; Cejna, M; Hartmann, G; Stelzmueller, I; Tabarelli, W; Wenzl, E1
Barie, PS; Cayci, C; Eachempati, SR; Fusco, D; Goldstein, MJ; Huston, JM; Kapur, S; Mathew, M; Rodney, JR; Shou, J1
Hu, LD; Huang, XJ; Jia, JS; Li, J; Lu, KY; Wang, C; Wu, DP1
Enbawe, S; Lat, A; Lodise, TP; Manor, K; Patel, GW; Patel, N; Smith, R; Trombley, K1
Gospodarek, E; Jachna-Sawicka, K1
Fujimura, S; Nakano, Y; Takane, H; Watanabe, A1
Butt, MU; Zakaria, M1
Albertí, S; Juan, C; Mulet, X; Oliver, A; Pérez, JL; Zamorano, L1
Rotschafer, JC; Ullman, M1
Cheatham, SC; Kays, MB; Shea, KM; Smith, DW; Sowinski, KM; Wack, MF1
Jones, RN; Moet, GJ; Sader, HS; Watters, AA1
Drusano, GL; Lodise, TP; Patel, N; Scheetz, MH1
An, MM; Chen, ML; Jiang, YY; Liu, P; Shen, H; Wang, R; Zhang, JD; Zou, Z1
Dundar, D; Otkun, M1
Arias, MJ; de la Torre, A; Díaz, JA; Hernández, AP; Silva, E1
Blondiaux, N; Courcol, RJ; Durocher, A; Favory, R; Nseir, S; Onimus, T; Roussel-Delvallez, M; Wallet, F1
Apolônio, AC; de Andrade, HM; de Carvalho, MA; Diniz, CG; dos Santos, KV; Farias, Lde M; Giusta, Mda S; Pires, Sda F; Santos, AV; Veloso, Lde C1
Foley, RJ; Kannan, S; Kourelis, T1
Gast, C; Ketter, N; Kollef, MH; Merchant, S; Nathwani, D; Quintana, A1
Chang, WC; Chen, CP; Chen, TL; Cho, WL; Fung, CP; Kuo, SC; Lee, YT; Siu, LK1
Chin, K; Haruna, A; Ichiyama, S; Ito, I; Kadowaki, S; Kase, M; Matsumoto, H; Mishima, M; Nakai, A; Niimi, A; Tanabe, N; Tsukino, M; Yasutomo, Y1
De Backer, D; Delattre, I; Dugernier, T; Jacobs, F; Laterre, PF; Layeux, B; Spapen, H; Taccone, FS; Vincent, JL; Wallemacq, P; Wittebole, X1
Calcinari, A; Casteletti, S; Cirioni, O; Ghiselli, R; Giacometti, A; Guerrieri, M; Kamysz, E; Kamysz, W; Orlando, F; Rimini, M; Silvestri, C; Tocchini, M1
Subaalaxmi, MV1
Jahagirdar, R; Khadilkar, AV; Khadilkar, VV; Lalwani, S; Rustagi, VT1
Amancio Martins, W; Bahia, JL; Cara, DC; Coutinho, SC; DE Macedo Farias, L; Galuppo Diniz, C; Lopes DE Andrade, JP; Morais Apolonio, AC; Nicoli, JR; Roque DE Carvalho, MA; Valéria Dos Santos, K1
Buyle, F; Claus, B; Robays, H; Vogelaers, D1
Jeong, MS; Seon, JK; Song, EK1
Bauer, SR; Butler, R; Connor, MJ; Fissell, WH; Groszek, J; Hofmann, CL; Rehm, SJ; Salem, C1
Clarke, MJ; Edwards, SJ; Wordsworth, S1
Luetzke, A; Ruebben, H; Schenck, M; Schneider, T1
Choi, JS; Kee, WJ; Koh, YI; Park, HB; Park, SH1
Braun, L; Fairchok, M; Flanagan, R; Mahlen, S; Sainato, R1
Kılıç, SC; Sarper, N; Zengin, E1
Chao, CM; Chiu, YH; Hou, CC; Lai, CC; Liu, WL1
Baquero, F; Cantón, R; Galán, JC; Novais, A; Ripoll, A; Rodríguez-Domínguez, MJ; Turrientes, MC1
Blahut, L; Hricová, K; Kolár, M; Neiser, J; Urbánek, K; Uvízl, R; Vojtová, V1
Bulik, CC; Keel, RA; Nicolau, DP; Sutherland, CA; Tessier, PR1
Bernusset, S; Cattoen, C; Cuzon, G; Naas, T; Nordmann, P1
Chen, YM; Huang, CC; Kuo, CC; Tsai, CH; Yang, FJ1
Funke, M; Janssen, E; Rodloff, AC; Schaumann, R1
Bellomo, R; Cole, L; Lipman, J; Liu, X; Nair, P; Roberts, DM; Roberts, JA; Roberts, MS1
Hansson, J; Johnsson, E; Jönsson, C; Körner, U; Ludwigs, K; Lundholm, K1
Andres, CR; Benz-de Bretagne, I; Gendrot, C; Jonville-Bera, AP; Jourdain, A; Le Guellec, C; Tarfaoui, N1
Andersson, RE; Schein, M1
Chandorkar, G; Gotfried, MH; Huntington, JA; Rodvold, KA; Umeh, O1
Inan, D; Ogunc, D; Ongut, G; Ozen, NS; Seyman, D1
Bilker, WB; Edelstein, PH; Han, JH; Kasahara, K; Lautenbach, E1
Adams, CA; Cioffi, WG; Connolly, MD; Gregg, S; Heffernan, DS; Monaghan, SF; Stephen, A; Thakkar, RK1
Bulitta, JB; Drusano, GL; Holzgrabe, U; Kinzig, M; Kirkpatrick, CM; Landersdorfer, CB; Sörgel, F; Stephan, U1
Metan, G1
Clamp, PJ; Egala, A; Hajioff, D1
Costa, P; Gattuso, G; Scalzini, A; Tomasoni, D1
Chen, HC; Chuang, SH; Huang, JC; Lee, MH; Lin, SY; Shen, MC1
Falagas, ME; Ikawa, K; Tansarli, GS; Vardakas, KZ1
Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F1
Alder, J; Arvis, P; Dryden, M; Gyssens, IC; Kujath, P; Nathwani, D; Reimnitz, P; Schaper, NC1
Chai, LY; Chee, YL; Chng, WJ; Ding, Y; Hsu, LY; Jin, J; Lee, YM; Poon, LM; Tan, LK1
Argento, AC; Heavner, MS; Ruggero, MA; Topal, JE1
Celebi, S; Demirkaya, M; Hacımustafaoglu, M; Sevinir, B1
Hoppe, UC; Kochanek, M; Larbig, R; Lehman, C; Michels, G; Reda, S; Rottländer, D1
Choi, EH; Lee, HJ; Lee, J; Oh, CE1
Charoenpong, L; Thamlikitkul, V; Tongsai, S1
Gümüşderelioğlu, M; Kahraman, AS; Pulat, M; Tan, N1
López-Cerero, L; Muniain, MA; Pascual, Á; Retamar, P; Rodríguez-Baño, J1
Ambrose, PG; Bhavnani, SM; Castanheira, M; Forrest, A; Friedrich, LV; Jones, RN; McCauley, J; Mendes, RE; Okusanya, OO; Steenbergen, J; Vanscoy, B1
Althaus, K; Busemann, C; Friesecke, S; Greinacher, A; Hron, G; Knutson, F; Lubenow, N; Thiele, T1
Arakawa, S; Fujisawa, M; Miyake, H; Shigemura, K; Tanaka, K1
Creely, D; Dunne, WM; Gayral, JP; Shortridge, D; Shubert, C; Slaughter, J; van Belkum, A; Zambardi, G1
Fortier, LC; Garneau, JR; Valiquette, L1
Boots, RJ; Jarrett, P; Kirkpatrick, CM; Lipman, J; Roberts, JA; Varghese, JM1
Bruchmann, S; Cabot, G; Haussler, S; Juan, C; Moyà, B; Mulet, X; Oliver, A; Zamorano, L1
Aghazadeh, M; Hojabri, T; Hojabri, Z; Mahdian, R; Nahaei, MR; Pajand, O; Pirzadeh, T; Rahmati, M1
Akers, KS; Cannon, JW; Chung, KK; Cota, JM; Murray, CK; Niece, KL1
Michels, G; Pfister, R1
Bentley, AM; Felton, TW; Goodwin, J; Hope, WW; Isalska, B; Malagon, I; McCalman, K; Whalley, S1
Hong, SK; Kim, EC; Kim, JA1
Dietrich, KA; Herzinger, T; Ruzicka, T1
Bandettini, R; Barco, S; Cangemi, G; Castagnola, E; Maffia, A; Tripodi, G1
Frey, L; Maier, B; Suhr, A; Teupser, D; Vogeser, M; Zander, J; Zoller, M1
Conte, V; D'Inzeo, T; De Angelis, G; Di Florio, V; Fiori, B; Giani, T; Giaquinto, A; Palucci, I; Rossolini, GM; Sanguinetti, M; Santangelo, R; Scoppettuolo, G; Spanu, T1
Agudelo, M; Rodriguez, CA; Vesga, O; Zuluaga, AF1
Bandettini, R; Barco, S; Bruschettini, M; Cangemi, G; Castagnola, E; Ramenghi, LA; Risso, FM; Tripodi, G1
Carroll, F; Pai, MP; Truong, J; Zheng, H1
Chong, Y; Jeong, SH; Kim, M; Kim, WH; Lee, K; Lee, Y; Seo, YH; Yim, J; Yong, D1
Avidor, I; Gefen, A; Hakim, F; Kassis, I; Shachor-Meyouhas, Y; Weyl Ben-Arush, M; Zaidman, I1
Chen, L; Wang, Y; Yang, H; Zhang, C; Zhou, Q1
Ender, PT; Kazi, HA; Shaik, S1
Kok, J; Lam, VW; McMullan, B; Pollett, S; Qureshi, C1
Loureiro, M; Nogueira, C; Portugal, R; Santos, B1
Baek, JY; Sohn, KM1
Cheatham, SC; Chung, EK; Fleming, MR; Healy, DP; Kays, MB; Shea, KM1
Du, Y; Guo, W; He, J; He, Q; Wang, Z; Wei, M; Wu, C; Yang, Z1
Castanheira, M; Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Sader, HS1
Chen, R; Qian, CY; Qian, Q; Sun, MR; Wang, LY; Wang, ML; Zou, SL1
Cho, SY; Chung, DR; Ha, YE; Jung, CW; Kang, CI; Kang, ES; Ko, JH; Lee, JY; Lee, WJ; Peck, KR; Song, JH1
Al-Attas, A; Belal, F; El-Enany, N; Nasr, JJ1
Nicolau, DP; Sutherland, CA1
Cha, MK; Cho, SY; Chung, DR; Ha, YE; Kang, CI; Kim, SH; Peck, KR; Song, JH; Wi, YM1
Hwang, GY; Kim, J; Lee, HG; Uh, Y; Yoo, G; Yoon, KJ1
Davin-Regli, A; Franceschi, C; Pagès, JM; Pinet, E; Zambardi, G1
Berrazeg, M; Broutin, I; Fournier, D; Jeannot, K; Loeffert, S; Ntsogo Enguéné, VY; Plésiat, P1
Akiyama, M; Hasegawa, H; Hashimoto, T; Ishii, N; Kato, Y; Ozawa, H; Tomida, E1
Daniels, H; Delforge, M; Martens, PJ1
Brock, B; Gjedsted, J; Hardlei, TF; Juul, RV; Kreilgaard, M; Öbrink-Hansen, K; Storgaard, M; Thomsen, MK1
Ballard, A; Biddy, BA; Bouley, R; Burnham, CA; Chang, M; Dantas, G; Gonzales, PR; Mobashery, S; Pesesky, MW; Schroeder, VA; Suckow, MA; Wolter, WR1
Green, MD; Janowski, AB; Martin, JM; Michaels, MG1
Listernick, R1
Anderson, AM; Easley, K; Kandiah, S; Kim, T; Patel, M; Rab, S; Wong, J; Xue, W1
Arakawa, Y; Fujita, A; Jin, W; Kimura, K; Mikamo, H; Suematsu, H; Wachino, J; Yamada, K; Yamagishi, Y; Yokoyama, S1
Fowler, RC; Geyer, CN; Hanson, ND; Hawkey, P; Johnson, JR; Johnston, B; Weissman, SJ1
Linneman, TW; Lorenz, MA; Moenster, RP1
Ambrose, PG; Bhavnani, SM; Bulik, CC; Castanheira, M; Forrest, A; Friedrich, LV; Jones, RN; Mendes, RE; Nicasio, AM; Okusanya, OO; Steenbergen, JN; VanScoy, BD1
Bartlett, CS; Groth, ME; McMillian, WD; Redfern, J; Wasilko, SM1
Akiyama, K; Hamaoka, S; Katoh, H; Kinoshita, M; Naito, Y; Sawa, T; Shimizu, M1
Chen, Y; Gao, W; Li, X; Ouyang, W; Wei, J; Wen, Z; Xue, H1
Merluzzi, S; Pagotto, A; Pillinini, P; Valeri, M1
Cadnum, JL; Donskey, CJ; Jury, LA; Kundrapu, S; Musuuza, JS; Nerandzic, MM; Sethi, AK; Sunkesula, VC1
Freemantle, N; Nisar, S; Ray, D; Shallcross, LJ1
Agudelo, M; Aguilar, YA; Rodriguez, CA; Vesga, O; Zuluaga, AF1
Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ1
Cho, H; Huang, X; Jang, CH; Lee, K; Park, SH; Piao, YL; Yoon, EJ; Zhan, CG1
Al-Ajmi, J; Ali, HS; George, S; Khan, FY; Shaikh, N1
Choudhary, S; Makwana, M; Soni, JP; Tripathi, N1
Forland, SC; Maskiewicz, VK; Veillette, JJ; Winans, SA1
Akbar, M; Ayhan, DH; Bailey, SM; Daly, SM; Greenberg, DE; Tamer, YT; Toprak, E; Wong, M1
Mikamo, H; Sugimoto, N; Yamagishi, Y1
Henson, KE; Rybak, MJ; Sakoulas, G; Smith, JR; Yim, J1
Greene, S; Kailainathan, R; Koutsogiannis, Z; Wong, A1
Duplessis, CA; McGann, P; Perkins, MJ; Snesrud, E1
Brockhurst, MA; Davies, EV; James, CE; Winstanley, C1
Dizbay, M; Karaşahin, EF; Karaşahin, Ö; Özger, HS1
Compain, F; Grohs, P; Kaibi, I; Lavollay, M; Mainardi, JL; Morand, P; Podglajen, I; Taieb, G1
Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N1
Carlier, M; De Cock, PAJG; de Jaeger, A; De Paepe, P; Delanghe, JR; Della Pasqua, OE; Robays, H; van Dijkman, SC; Vande Walle, J; Verstraete, AG; Willems, J1
Manian, FA1
Kaye, KS; Navalkele, B; Pogue, JM1
Arai, K; Kato, M; Matsuoka, T; Mori, T; Ohashi, K; Shinoda, Y; Yoshida, S; Yoshimura, T1
Ahir, H; Foo, J; Merchant, S; Prabhu, V; Sarpong, E1
Ourique, C; Rego-Costa, F; Torres-Ramalho, P1
Kim, HS; Kim, HY; Kim, YK; Lee, J; Lee, JA; Lee, SS; Seo, YB; Song, W; Uh, Y1
Chiang, TT; Chiu, CC; Lin, TC; Wu, RX; Yang, YS1
Bennis, Y; Bodeau, S; Kontar, L; Lemaire-Hurtel, AS; Maizel, J; Masmoudi, K; Quinton, MC; Slama, M; Zerbib, Y1
Mueller, BA; Shaw, AR1
Kaur, A; Kaur, I; Mundi, DK; Singh, M1
Bailoor, K; Chen, T1
Aitken, SL; Foolad, F; McDaneld, PM1
Cheng, L; Gomez-Simmonds, A; Mehta, M; Nelson, BC; Shi, Q; Uhlemann, AC1
Anderson, CW; Cazares, KS; Denunzio, TM; Lustik, MB; Patel, SM1
Goodlet, KJ; Nailor, MD; Nicolau, DP1
Hindler, JA; Humphries, RM; Miller, SA; Wong-Beringer, A1
Kollef, MH; Micek, ST; Vazquez Guillamet, MC; Vazquez, R1
Castanheira, M; Flamm, RK; Pfaller, MA; Shortridge, D1
Jaramillo, J; Len, O; Martín, MT; Royuela, M1
Álvarez-Marín, R; Aznar, J; Lepe, JA; Ortiz de la Rosa, JM; Pachón, J; Rodríguez-Villodres, Á; Smani, Y1
Guerra Valero, YC; Lipman, J; Naicker, S; Ordenez Meija, JL; Parker, SL; Roberts, JA; Wallis, SC1
Cipelli, R; Dangoor, A; Hodgson, M; Lester, JF; Naik, J; Newsom-Davis, T; Patel, A; Shah, R; Summerhayes, M; Talbot, D; Talbot, T1
Aranda-Aguirre, E; Guerrero-Wooley, R; Li, W; Palavecino, E; Wilkin, A1
Bansal, N; Gopalakrishnan, R; Kumar D, S; Nambi, PS; Ramasubramanian, V; Sukhwani, KS1
Beckman, EJ1
Abu-Abed, S; Chan, B; Del Paggio, JC; Ellis, AK; Rawls, M; Rosen, A1
Bischoff, S; Ebert, M; Gerigk, M; Vogelmann, R; Walter, T1
Fitzgerald, D; Joyce, DA; Lee, YCG; O'Halloran, SJ; Popowicz, ND1
Lipman, J; Peake, SL; Roberts, JA; Roberts, MS; Sinnollareddy, MG1
Downes, KJ; Fisher, BT; Laskin, BL1
Jhaveri, R; Willis, ZI1
Ledger, TS1
Colby, J; Fissell, WH; Groszek, JJ; Patel, P; Seegmiller, A; Shotwell, M; Verhoven, SM; Verstraete, A1
Kaempfen, A; Mijuskovic, B; Wiggli, B1
Jackson, C; Joglekar, K; Natrajan, K1
Asano, T; Hirano, S; Imai, S; Kushiya, H; Miyasaka, D; Nakamura, T; Nakanishi, Y; Noji, T; Okamura, K; Shichinohe, T; Tanaka, K; Tsuchikawa, T1
Alobaid, A; Hiremath, S; Kanji, S; Patel, R; Porteous, R; Roberts, JA; Watpool, I; Xie, J; Zelenitsky, S; Zhang, G1
Cho, SB; Hong, JY; Jeong, YH; Joo, YE; Kang, YJ; Kim, JW; Kim, KH; Lee, WS; Myung, DS; Son, DJ1
Benaboud, S; Béranger, A; Bille, E; Gana, I; Genuini, M; Hirt, D; Lesage, F; Moulin, F; Oualha, M; Renolleau, S; Tréluyer, JM; Urien, S; Zheng, Y1
Caccese, E; Marinai, C; Messori, A; Trippoli, S; Tulli, G1
Lipman, J; Liu, J; Rhodes, NJ; Roberts, JA1
Gad, A; Hindi, Z; Zahoor, T; Zock, RZÀ1
An, G; Bach, T; D'Cunha, R; Li, P; Nalbant, D; Winokur, P; Young, BA; Zhang, J2
Farkas, A; Heil, EL; Nicolau, DP; Roberts, JA; Thom, KA1
Leong, D; Wu, PE1
Bergstrom, C; Gupta, A; Nagalla, S1
Carreno, J; Hunter, C; Lomaestro, B; Smiraglia, T; Tobin, E1
Bando, S; Egawa, S; Kasai, K; Kimura, T; Kira, S; Kiyota, H; Koide, H; Murakami, M; Yamada, H1
Anagnostopoulos, A; Depmeier, C; Jeger, V; Rifaat, M; Schneemann, M1
Aznar, E; Becares, J; Campelo-Gutierrez, C; Caro, JM; Diaz, BG; Gimenez-Manzorro, A; Izquierdo-Garcia, E; Saez de la Fuente, J1
Bernhardt, M; Boschert, EN; Dubin, JR; Lauer, MF1
Doi, T; Koga, H; Lane, GJ; Miyano, G; Nakamura, H; Ochi, T; Okawada, M; Seo, S; Yamataka, A1
Baldassarre, M; Barsic, B; Bartoletti, M; Bernardi, M; Bruns, T; Burra, P; Calbo, E; Caraceni, P; Cobos-Trigueros, N; D'Offizi, G; Domenicali, M; Galan-Ladero, MA; Giannella, M; Lewis, RE; Maraolo, AE; Merli, M; Muñoz, P; Paul, M; Petrosillo, N; Retamar, P; Rodriguez-Baño, J; Schramm, C; Seminari, E; Tedeschi, S; Torrani Cerenzia, M; Tumbarello, M; Verucchi, G; Viale, P; Zak-Doron, Y1
Abodakpi, H; Byerly, C; Chang, KT; Tam, VH; Zhou, J1
Blevins, AM; Juang, P; Kollef, M; Lashinsky, JN; McCammon, C; Micek, S1
Harris, PNA1
Batuecas-Mordillo, M; Bouley, R; Chang, M; Ding, D; Hermoso, JA; Janardhanan, J; Mahasenan, KV; Martínez-Caballero, S; Meisel, JE; Mobashery, S; Peng, Z; Schroeder, VA; Wolter, WR1
Hesford, C; Nakhosteen, A; Sayma, M; Tariq, Z; Walters, HR1
Beaulieu, C; Kurczewski, L; Yajnik, V1
Banerjee, R; Esbenshade, AJ; Quach, HT; Zhao, Z1
Albanèse, J; Bornet, C; Curti, C; Fersing, C; Guinard, B; Lamy, E; Mathias, F; Primas, N; Souab, HK; Vanelle, P1
Chiu, S; Ferguson, JK; Kozierowski, K; Munnoch, SA; Oldmeadow, C1
Cabri, W; Cerisoli, L; Ferrazzano, L; Martelli, G; Ricci, A; Tolomelli, A; Viola, A1
Li, J; Ma, W; Sun, S; Wang, D; Yu, C1
Brock, B; Friberg, LE; Kristoffersson, AN; Maarbjerg, SF; Nielsen, EI; Schrøder, H; Thorsted, A; Wang, M1
Doogue, M; Jensen, BP; Mortensen, JS; Zhang, M1
Autmizguine, J; Kassir, N; Lavigne, J; Litalien, C; Théorêt, Y; Thibault, C1
Charoenkwan, P; Choeyprasert, W; Fanhchaksai, K; Kamonrattana, R; Natesirinilkul, R; Sathitsamitphong, L1
Caverly, LJ; Huang, DB; Kalikin, LM; LiPuma, JJ; Spilker, T; Stillwell, T; Young, C1
Jumanne, S; Nyundo, A1
Burnham, CD; Dantas, G; Thänert, R; Yoneda, A1
Busch, DH; Katchanov, J; Lahmer, T; Rothe, K; Schmid, RM; Schneider, J; Spinner, CD; Wantia, N; Waschulzik, B1
Alves, GCDS; Chequer, FMD; Daróczi, G; Farkas, A; Roberts, JA; Sanches, C; Silva, SDD1
Campanile, A; Ciarambino, T; Giannico, OV; Giordano, M; Para, O; Signoriello, G; Tirelli, P1
Cho, SY; Chung, YN; Heo, WY; Huh, HJ; Kang, OK; Lee, JK; Lee, NY; Sung, DH; Yoo, IY1
Adams, R; Agus, A; Barnes, RA; Chau, I; Clarke, M; Coyle, V; Doran, A; Forde, C; Grayson, M; McAuley, DF; McDowell, C; McMullan, R; Plummer, R; Thomas, AL; Wilson, RH1
Anand, AR; Shah, D; Suganeswari, G1
Eller, P; Prattes, J; Reisinger, AC; Schilcher, G; Zollner-Schwetz, I1
Bruniera, FR; Costa, SF; Cury, AP; Higashino, H; Mendes, FR; Oliveira, FN; Rizeck, C; Rocha, V; Rossi, F; Schmidt, J1
Boucher, HW; Brown, ML; Butterton, JR; Chen, LF; David-Wang, A; Du, J; Kartsonis, NA; Kaye, KS; Losada, MC; Paschke, A; Patel, M; Rizk, ML; Rodríguez Gonzalez, D; Roquilly, A; Tipping, R; Titov, I; Wunderink, RG; Young, K1
Azad, SV; Balaji, A; Kumar, V; Surve, A; Venkatesh, P; Verma, S; Vohra, R1
Adams, ER; Bulgasim, I; Corless, C; Edwards, T; Fraser, AJ; Howard, A; Hubbard, ATM; Mason, J; Parry, CM; Roberts, AP; Roberts, P; van Aartsen, J1
Elmas, Ç; Erdal, B; Yalınay, M; Yazıcı, GN1
Dorn, C; Hitzenbichler, F; Kees, F; Kees, M; Liebchen, U; Paal, M; Schiesser, S1
Al-Shaer, MH; Alghamdi, WA; Peloquin, C1
Chrisikou, I; Kontoyannis, C; Orkoula, M2
He, A; He, L; Qian, Y1
Lin, FJ; Shao, CH; Tai, CH; Wang, CC; Wang, JT; Wu, CC1
Sivashanmugam, K; Srivastava, P1
Chiasson, JM; Cutrell, JB; Jodlowski, TZ; Kouma, MA; Smith, WJ1
Caissy, JA; El-Haffaf, I; Marsot, A1
Krnáč, D; Reiffová, K; Rolinski, B1
Jamieson, C; Jenkins, A; Santillo, M; Shanu, S1
Chen, Y; Liu, L; Xiang, Q1
Barreto, EF; Bjergum, MW; Jannetto, PJ; Rule, AD; Scheetz, MH1
Bansal, R; Deshpande, AA; Jagia, P; Sharma, V1
Abdul-Aziz, MH; Burrows, F; Buscher, H; Cheng, V; Cho, YJ; Corley, A; Diehl, A; Fraser, JF; Gilder, E; Jakob, SM; Kim, HS; Levkovich, BJ; Lim, SY; McGuinness, S; Parke, R; Pellegrino, V; Que, YA; Reynolds, C; Roberts, JA; Rudham, S; Shekar, K; Wallis, SC; Welch, SA; Zacharias, D1
Boelens, J; De Waele, JJ; Polet, M; Stove, V; Van Vooren, S; Vanhaecke, L; Verstraete, AG1
Burgess, DS; Clark, JA; Landmesser, KB1
Garg, N; Gupta, S; Khillan, V; Mohapatra, N; Pamecha, V; Patil, NS; Sindwani, G; Sinha, PK1
Imai, S; Itoh, T; Kadomura, S; Kashiwagi, H; Momo, K; Sato, Y; Sugawara, M; Takekuma, Y1
Ansari, OBA; Holmedal, SH; Johanssen, A; Schultz, JK; Toresen, A1
Azcarraga-Llobet, C; Berna-Rico, ED; Bueno-Sacristan, D; de Nicolas-Ruanes, MB; Dominguez-Santas, M; Garcia-Mouronte, E; Moreno Garcia-Del Real, C1
Dhamija, P; Goyal, T; Gupta, P; Trikha, V; Vardhan, G1
Almind, SR; Andreasen, MR; Frimodt-Møller, N; Hansen, KH; Hertz, FB; Jelsbak, L; Nielsen, KL; Schønning, K1
Albur, M; Attwood, M; Bowker, KE; MacGowan, AP; Noel, AR1
Doogue, M; Jensen, BP; Mortensen, JS1
Kim, HI; Kim, HS; Kim, YK; Lee, DH; Lee, SH; Park, S1
Akers, KS; Chung, KK; DeLuca, JP; Livezey, JR; Nadeau, RJ; Por, ED; Pruskowski, KA; Selig, DJ1
Benfield, T; Bigseth, RS; Petersen, A; Sandholdt, H; Thorlacius-Ussing, L; Østergaard, C1
Ang, B; Ang, LW; Chua, BH; Heng, ST; Lee, TH; Lin, R; Lye, DC; Ng, TM; Quek, J; Tan, SH; Tay, HL; Teng, CB; Yap, MY; Young, BE1
Annane, D; Bonten, MJM; Carneiro, J; Deja, M; Estevez, F; Harbarth, S; Jereb, M; Jorens, PG; Lawrence, C; Rothbart, A; Schedler, D; Seme, K; Šifrer, F; Spöhr, F; Tomič, V; van Duijn, PJ; Verbrugghe, W1
Sun, J; Xie, L; Xu, R; Zhu, D1
Chousakos, E; Rentziou, G1
Brar, NK; Petersen, FC; Shekhar, S1
Güler, N; Süleyman, A; Tamay, Z1
Amoureux, L; Casenaz, A; Guilloteau, A; Labattut, L; Magallon, A; Neuwirth, C; Piroth, L; Sixt, T1
Deligios, M; Fiamma, M; Paglietti, B; Rubino, S; Sacarlal, J; Santona, A; Simbine, SE; Sumbana, JJ; Taviani, E; Zimba, T1
Huang, Y; Xu, Y; Zhang, Y1
Babiak, P; Cizmarova, I; Kovac, A; Mikus, P; Parrak, V; Piestansky, J; Secnik, P1
Gillani, SW; Hussain, MW; Mahmood, RK; Rathore, HA; Saeed, MW; Vippadapu, P1
Alosaimy, S; Amaya, L; Biagi, M; Chandler, E; Cubillos, A; Davis, SL; Finch, N; Hobbs, ALV; Holger, D; Jorgensen, SCJ; Kufel, WD; Kunz Coyne, AJ; Lagnf, AM; Li, D; Molina, KC; Moore, WJ; Morrisette, T; Mubarez, M; Patch, M; Polisetty, RS; Rebold, N; Rico, M; Rybak, MJ; Sakoulas, G; Simon, SP; Smith, IMK; Tran, NN; Truong, J; Venugopalan, V; Veve, MP; Witucki, P; Wrin, J; Yost, C1
Ankravs, MJ; Bellomo, R; Deane, AM; Rechnitzer, T; Roberts, JA; Sharrock, L; Wallis, SC1
Al Jalali, V; Ballarini, N; Bauer, M; Bergmann, F; Jorda, A; König, F; Lackner, E; Nussbaumer-Pröll, A; Oesterreicher, Z; Reiter, B; Stimpfl, T; Wölfl-Duchek, M; Wulkersdorfer, B; Zeitlinger, M1
Akazawa, N; Itoh, N; Kuwahara, T; Yanaidani, T1
Bernardes, A; Duque, M; Lazaro, A; Lemos, M1
Acosta, JG; Aurora, M; Ciaramitaro, J; Cummings, BM; Gee, M; Hally, S; Kelleher, C; Keyes, ML; Lerou, PH; Lombay, J; Madhavan, V; Matute, JD; Nelson, BD; Roumiantsev, S; Rudnick, A; Swartz, K1
Azam, N; Cherkaoui, A; Crudeli, L; Fernandez, J; Fischer, A; Renzi, G; Schorderet, D; Schrenzel, J1
Laramie, KE; Miller, MA; Mueller, SW; Roper, SE; Torian, SC; Wiktor, AJ1
Cheng, B; Guo, P; Jia, P; Xu, Y; Yang, Q; Zhang, H; Zhu, Y1
Balasubramanium, G; Elangovan, R; Gupta, SS; Lodha, T; Muthulakshmi, T; Perumal, V; Sivaraman, GK; Visnuvinayagam, S; Yadav, A1
Arenere-Mendoza, M; Fernández-de-Gamarra-Martínez, E; Fernández-Polo, A; González-Suárez, S; Gutiérrez-Urbón, JM; Nicolás-Picó, J; Rodríguez-Mateos, ME; Sánchez-Yáñez, E1
Dong, L; Feng, J; Geng, H; Gu, S; He, C; Hou, G; Ji, T; Kang, W; Lai, J; Li, Y; Li, Z; Pang, D; Wang, Y; Zhao, L; Zhu, X; Zhu, Y1
Li, J; Li, N; Liu, B; Lü, X; Wang, H; Zhang, Y1
Assanelli, AA; Bernardi, M; Carletti, S; Carrabba, MG; Castagna, A; Ciceri, F; Clerici, D; Corti, C; Erbella, F; Farina, F; Galli, L; Giglio, F; Greco, R; Liberatore, C; Lorentino, F; Lugli, AP; Lupo Stanghellini, MT; Mancini, N; Mastaglio, S; Nitti, R; Oltolini, C; Peccatori, J; Poli, A; Ripa, M; Ruggeri, A; Scarpellini, P; Tassan Din, C; Xue, E1
Caldwell, JT; Dong, S; Fei, L; Goldstein, SL; Hasson, D; Kaplan, J; Slagle, C; Tang Girdwood, S; Tang, P; Vinks, AA1
Akita, H; Asukai, K; Fujii, Y; Hara, H; Haraguchi, N; Hasegawa, S; Kanemura, T; Matsuda, C; Mikamori, M; Miyata, H; Mukai, Y; Nishimura, J; Ohue, M; Omori, T; Sakon, M; Shinno, N; Sugase, T; Takahashi, H; Takeoka, T; Wada, H; Yamamoto, M; Yasui, M1
Gill, CM; Nicolau, DP1
Caljon, B; Crombé, F; De Geyter, D; Demuyser, T; Janssen, T; Muyldermans, A; Piérard, D; Seyler, L; Vanstokstraeten, R; Wybo, I1
An, G; Balevic, SJ; Chan, AW; Cohen-Wolkowiez, M; Conrad, T; Gu, K; Hemmersbach-Miller, M; Kirkpatrick, CMJ; Landersdorfer, CB; Schmader, KE; Swamy, GK; Walter, EB; Winokur, PL1
Dalğıç, D; Kandemir, T; Nağıyev, T; Üçkayabaşı, A1
Bauer, SR; Campbell, MJ; Dettmer, MR; Erickson, RM; Fertel, BS; Sacha, GL; Wesolek, JL1
Belley, A; Kaye, KS; Velicitat, P1
Hsu, CK; Lai, CC; Tsai, WW1
Cao, Y; Liu, C; Ren, H; Shang, Z; Wang, R; Xie, L; Yang, Y; Zhang, J1
Banjara, MR; Devkota, MD; Pokhrel, BM; Sharma, S1
Boelens, J; Messiaen, AS; Strubbe, G; Vandendriessche, S; Verhasselt, B1
Bautista, J; Beique, L; Cayen, J; Choi, K; Comeau, JL; Conly, J; Dalton, B; Delport, J; Dhami, R; Embree, J; Émond, Y; Evans, G; Frenette, C; Fryters, S; Happe, J; Katz, K; Kibsey, P; Langley, JM; Lee, BE; Lefebvre, MA; Leis, JA; McGeer, A; McKenna, S; Neville, HL; Pelude, L; Rudnick, W; Science, M; Slayter, K; Suh, KN; Thirion, DJG; Tse-Chang, A; Weiss, K1
Chen, CH; Ho, MW; Hsueh, PR; Ko, WC; Lin, HH; Tseng, KH; Wu, PH1
Ebrahimzadeh, MA; Gholami, M; Goli, HR; Jamal, Z1
Haller, IE; Heisler, S; Helmke, C; Hunger, R; Kirbach, J; Kobelt, E; Lünse, S; Mantke, R; Meyer, J; Paasch, C; Schildberg, C1
Demuyser, T; Echahidi, F; Olbrecht, M; Peeters, C; Piérard, D; Vandamme, P; Wybo, I1
Chen, WT; DeRyke, CA; Karlowsky, JA; Lob, SH; Motyl, MR; Sahm, DF; Siddiqui, F; Young, K1
Ali Khan, H; Amir, M; Ammad, M; Anjum, S; Arshad, N; Faryal, R; Khadija, B; Mazhar, K; Noorul Hasan, T; Rashid, Z; Sajjad Naqvi, S; Ullah, R; Ur Rehman, M; Yousaf, M1
Colman, R; De Cock, PA; De Paepe, P; Devreese, M; Dhont, E; Hermans, E; Vande Walle, J; Verougstraete, N; Zeitlinger, M1

Reviews

46 review(s) available for piperacillin and tazobactam

ArticleYear
β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs.
    Journal of medicinal chemistry, 2020, 03-12, Volume: 63, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Humans; Protein Structure, Secondary; Protein Structure, Tertiary; Treatment Outcome

2020
Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
    Drugs, 1994, Volume: 47, Issue:3

    Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Randomized Controlled Trials as Topic; Tazobactam

1994
Enterococcis: pathogens of the 90s.
    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573

    Topics: Abdominal Abscess; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin

1994
Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance.
    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573

    Topics: Abdominal Abscess; Bacteremia; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Peritonitis; Piperacillin; Surgical Wound Infection; Tazobactam; Virulence

1994
Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections.
    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573

    Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Injections, Intramuscular; Injections, Intravenous; Metabolic Clearance Rate; Penicillanic Acid; Piperacillin; Soft Tissue Infections; Tazobactam; Tissue Distribution

1994
Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573

    Topics: Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Necrosis; Penicillanic Acid; Piperacillin; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Ticarcillin

1994
Emerging trends in antimicrobial resistance in surgical infections. A review.
    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573

    Topics: Bacteroides; beta-Lactamase Inhibitors; Clostridium; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Humans; Methicillin Resistance; Penicillanic Acid; Piperacillin; Staphylococcus; Surgical Wound Infection; Tazobactam

1994
Combination beta-lactam and beta-lactamase-inhibitor therapy: pharmacokinetic and pharmacodynamic considerations.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Mar-15, Volume: 52, Issue:6 Suppl 2

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1995
Clinical use of beta-lactamase inhibitors in combination with extended-spectrum penicillins.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Mar-15, Volume: 52, Issue:6 Suppl 2

    Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Soft Tissue Infections; Tazobactam

1995
Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:5

    Topics: Bacterial Infections; beta-Lactamase Inhibitors; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

1995
Treatment of skin and soft-tissue infections.
    American journal of surgery, 1995, Volume: 169, Issue:5A Suppl

    Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Fasciitis; Humans; Necrosis; Penicillanic Acid; Piperacillin; Skin Diseases; Soft Tissue Infections; Surgical Wound Infection; Tazobactam

1995
Pharmacokinetic characteristics of piperacillin/tazobactam.
    Intensive care medicine, 1994, Volume: 20 Suppl 3

    Topics: beta-Lactamase Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Time Factors; Tissue Distribution; Tobramycin; Vancomycin

1994
Piperacillin/tazobactam in the treatment of polymicrobial infections.
    Intensive care medicine, 1994, Volume: 20 Suppl 3

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Humans; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1994
The treatment of severe intra-abdominal infections: the role of piperacillin/tazobactam.
    Intensive care medicine, 1994, Volume: 20 Suppl 3

    Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Clinical Trials as Topic; Drug Combinations; Humans; Penicillanic Acid; Piperacillin; Tazobactam

1994
Review of piperacillin/tazobactam in the treatment of bacteremic infections and summary of clinical efficacy.
    Intensive care medicine, 1994, Volume: 20 Suppl 3

    Topics: Bacteremia; beta-Lactamase Inhibitors; Clinical Trials as Topic; Drug Combinations; Humans; Penicillanic Acid; Piperacillin; Tazobactam

1994
Comparative susceptibility profile of piperacillin/tazobactam against anaerobic bacteria.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A

    Topics: Animals; Bacteria, Anaerobic; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1993
The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A

    Topics: Animals; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Tissue Distribution

1993
Piperacillin/tazobactam: a critical review of the evolving clinical literature.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 22, Issue:1

    Topics: Drug Therapy, Combination; Humans; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Treatment Failure

1996
Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
    Advances in pediatric infectious diseases, 1996, Volume: 12

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fluoroquinolones; Humans; Molecular Structure; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Ticarcillin

1996
[Development of beta-lactamase inhibitors].
    Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:5

    Topics: Animals; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Drug Therapy, Combination; Mice; Penicillanic Acid; Piperacillin; Tazobactam

1997
Beta-lactam/beta-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic host.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl D

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Models, Biological; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam

1998
Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.
    Drugs, 1999, Volume: 57, Issue:5

    Topics: Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1999
[Prevention of infection in war wounds].
    Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1999, Volume: 70, Issue:10

    Topics: Antibiotic Prophylaxis; Blast Injuries; Drug Therapy, Combination; Half-Life; Humans; Penicillanic Acid; Piperacillin; Practice Guidelines as Topic; Tazobactam; Warfare; Wound Infection; Wounds, Gunshot

1999
Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa.
    Pharmacotherapy, 2000, Volume: 20, Issue:9 Pt 2

    Topics: beta-Lactamases; Clavulanic Acid; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Inhibitors; Penicillanic Acid; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Ticarcillin

2000
[Fundamental and clinical studies on beta-lactamase inhibitors].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam

2001
[Antibiotics--TAZ/PIPC, synercid, linezolid, everninomicin].
    Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:4

    Topics: Acetamides; Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Linezolid; Oxazolidinones; Penicillanic Acid; Penicillins; Piperacillin; Protein Synthesis Inhibitors; Tazobactam; Virginiamycin

2001
[Piperacillin-tazobactam in the treatment of severe nosocomial infections].
    Recenti progressi in medicina, 2002, Volume: 93, Issue:3

    Topics: Bacteria; beta-Lactamase Inhibitors; Clinical Trials as Topic; Costs and Cost Analysis; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Tazobactam

2002
Role of pharmacodynamics in designing dosage regimens for beta-lactams.
    Connecticut medicine, 2003, Volume: 67, Issue:5

    Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Dose-Response Relationship, Drug; Humans; Meropenem; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins

2003
Antimicrobial resistance in gram-positive bacteria.
    The American journal of medicine, 2006, Volume: 119, Issue:6 Suppl 1

    Topics: Animals; beta-Lactamase Inhibitors; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterococcus faecalis; Gastrointestinal Tract; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin Resistance

2006
Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulation and steady-state pharmacokinetic data from hospitalized patients.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:11

    Topics: Drug Administration Schedule; Drug Therapy, Combination; Hospitalization; Humans; Infusions, Intravenous; Monte Carlo Method; Penicillanic Acid; Piperacillin; Tazobactam; Time Factors

2009
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials.
    BMC infectious diseases, 2009, Dec-02, Volume: 9

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Penicillanic Acid; Piperacillin; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome

2009
Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; Carbapenems; Drug Administration Schedule; Humans; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome

2013
Molecular Adsorbent Recirculating System (MARS(®)) removal of piperacillin/tazobactam in a patient with acetaminophen-induced acute liver failure.
    Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:2

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Overdose; Female; Humans; Inactivation, Metabolic; Liver Failure, Acute; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2013
Clinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysis.
    PloS one, 2015, Volume: 10, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Databases, Factual; Humans; Odds Ratio; Penicillanic Acid; Piperacillin; Renal Insufficiency; Tachycardia; Tazobactam

2015
Delftia lacustris septicemia in a pheochromocytoma patient: case report and literature review.
    Infectious diseases (London, England), 2015, Volume: 47, Issue:5

    Topics: Adrenal Gland Neoplasms; Aged; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Delftia; DNA, Bacterial; DNA, Ribosomal; Gram-Negative Bacterial Infections; Humans; Male; Penicillanic Acid; Pheochromocytoma; Piperacillin; RNA, Ribosomal, 16S; Sepsis; Sequence Analysis, DNA; Tazobactam

2015
Bloodstream infection with Oligella ureolytica: a case report and review of the literature.
    Le infezioni in medicina, 2016, Volume: 24, Issue:1

    Topics: Aged; Alcaligenaceae; Anti-Bacterial Agents; Aortic Valve Stenosis; Bacteremia; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Male; Penicillanic Acid; Piperacillin; Risk Factors; Tazobactam; Treatment Outcome

2016
Antibiotic Dosing in Continuous Renal Replacement Therapy.
    Advances in chronic kidney disease, 2017, Volume: 24, Issue:4

    Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Computer Simulation; Critical Illness; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Renal Replacement Therapy; Sepsis; Tazobactam; Thienamycins

2017
Liver abscess caused by Clostridium haemolyticum infection after transarterial chemoembolization for hepatocellular carcinoma: A case report.
    Medicine, 2018, Volume: 97, Issue:19

    Topics: Aged; Anti-Bacterial Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clostridium Infections; Female; Humans; Liver Abscess; Liver Neoplasms; Metronidazole; Penicillanic Acid; Piperacillin; Tazobactam

2018
Acute kidney injury and vancomycin/piperacillin/tazobactam in adult patients: a systematic review.
    Internal and emergency medicine, 2020, Volume: 15, Issue:2

    Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Piperacillin; Tazobactam; Vancomycin

2020
Capnocytophaga sputigena bloodstream infection in hematopoietic stem cell transplantations: two cases report and review of the literature.
    Revista do Instituto de Medicina Tropical de Sao Paulo, 2020, Volume: 62

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Capnocytophaga; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Meropenem; Middle Aged; Mucositis; Neutrophils; Piperacillin; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tazobactam; Transplantation, Autologous

2020
Role of Intralesional Antibiotic for Treatment of Subretinal Abscess - Case Report and Literature Review.
    Ocular immunology and inflammation, 2022, Feb-17, Volume: 30, Issue:2

    Topics: Abscess; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Humans; Male; Middle Aged; Piperacillin; Retinal Diseases; Retrospective Studies; Tazobactam; Visual Acuity; Vitrectomy

2022
Piperacillin-Tazobactam in Intensive Care Units: A Review of Population Pharmacokinetic Analyses.
    Clinical pharmacokinetics, 2021, Volume: 60, Issue:7

    Topics: Anti-Bacterial Agents; Critical Illness; Humans; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

2021
Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards.
    European journal of hospital pharmacy : science and practice, 2022, Volume: 29, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Ceftazidime; Floxacillin; Humans; Outpatients; Piperacillin; State Medicine; Tazobactam

2022
Preanalytical Stability of Flucloxacillin, Piperacillin, Tazobactam, Meropenem, Cefalexin, Cefazolin, and Ceftazidime in Therapeutic Drug Monitoring: A Structured Review.
    Therapeutic drug monitoring, 2022, 12-01, Volume: 44, Issue:6

    Topics: Anti-Bacterial Agents; Cefazolin; Ceftazidime; Cephalexin; Drug Monitoring; Drug Stability; Floxacillin; Humans; Meropenem; Piperacillin; Tazobactam

2022
Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini-review and population pharmacokinetic analysis.
    Journal of clinical pharmacy and therapeutics, 2022, Volume: 47, Issue:8

    Topics: Anti-Bacterial Agents; Critical Illness; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Tazobactam

2022
A Meta-Analysis on Clinical Outcomes of Ceftolozane versus Piperacillin in Combination with Tazobactam in Patients with Complicated Urinary Tract Infections.
    BioMed research international, 2022, Volume: 2022

    Topics: Anti-Bacterial Agents; Cephalosporins; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Tazobactam; Urinary Tract Infections

2022

Trials

112 trial(s) available for piperacillin and tazobactam

ArticleYear
Piperacillin/tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancy.
    Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; beta-Lactamase Inhibitors; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam

1992
Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12

    Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome

1992
Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:6

    Topics: Adult; Biological Assay; Blister; Drug Evaluation; Drug Interactions; Exudates and Transudates; Humans; Inflammation; Injections, Intravenous; Male; Penicillanic Acid; Piperacillin; Tazobactam; Tissue Distribution

1991
Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573

    Topics: Abdomen; Abdominal Abscess; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Europe; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam

1994
Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573

    Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; North America; Penicillanic Acid; Piperacillin; Tazobactam

1994
Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam.
    British journal of urology, 1995, Volume: 76, Issue:3

    Topics: Aged; Bacterial Infections; beta-Lactamases; Biopsy, Needle; Cefuroxime; Drug Therapy, Combination; Humans; Injections, Intravenous; Male; Penicillanic Acid; Piperacillin; Prospective Studies; Prostate; Prostatic Neoplasms; Tazobactam

1995
Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:12

    Topics: beta-Lactamase Inhibitors; Child; Child, Preschool; Humans; Infant; Metabolic Clearance Rate; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1994
[Comprehensive evaluation of pharmacokinetic and clinical studies on tazobactam/piperacillin in pediatric field].
    The Japanese journal of antibiotics, 1995, Volume: 48, Issue:3

    Topics: Adolescent; Bacteria; Bacterial Infections; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Male; Penicillanic Acid; Piperacillin; Tazobactam

1995
[Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field].
    The Japanese journal of antibiotics, 1995, Volume: 48, Issue:3

    Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Cholangitis; Cholecystitis; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Surgical Wound Infection; Tazobactam

1995
[A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia].
    The Japanese journal of antibiotics, 1995, Volume: 48, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; Drug Administration Schedule; Drug Combinations; Female; Humans; Injections, Intravenous; Lung Abscess; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Tazobactam

1995
[A comparative study of tazobactam/piperacillin and piperacillin in chronic respiratory tract infections].
    The Japanese journal of antibiotics, 1995, Volume: 48, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; Chronic Disease; Drug Administration Schedule; Drug Combinations; Female; Humans; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam

1995
Inhibition of the renal excretion of tazobactam by piperacillin.
    The Journal of antimicrobial chemotherapy, 1994, Volume: 34, Issue:4

    Topics: Animals; beta-Lactamase Inhibitors; Blood Proteins; Depression, Chemical; Dogs; Humans; Inulin; Kidney; Male; Penicillanic Acid; Piperacillin; Probenecid; Protein Binding; Tazobactam

1994
Piperacillin/tazobactam compared with ticarcillin/clavulanate in community-acquired bacterial lower respiratory tract infection.
    The Journal of antimicrobial chemotherapy, 1994, Volume: 34, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acids; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam; Ticarcillin

1994
[Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles].
    Presse medicale (Paris, France : 1983), 1995, Feb-25, Volume: 24, Issue:8

    Topics: Adult; Aged; Amikacin; beta-Lactamase Inhibitors; Ceftazidime; Drug Therapy, Combination; Fever; Humans; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam

1995
Piperacillin/tazobactam in the treatment of community-acquired and nosocomial respiratory tract infections: a review.
    Intensive care medicine, 1994, Volume: 20 Suppl 3

    Topics: Adult; Aged; Amikacin; beta-Lactamase Inhibitors; Community-Acquired Infections; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam

1994
Piperacillin/tazobactam in complicated urinary tract infections.
    Intensive care medicine, 1994, Volume: 20 Suppl 3

    Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Recurrence; Remission Induction; Tazobactam; Urinary Tract Infections

1994
Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; Bone and Bones; Drug Therapy, Combination; Female; Hip; Hip Prosthesis; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam

1994
Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:8

    Topics: Bacteroides Infections; Clavulanic Acids; Double-Blind Method; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Tazobactam; Ticarcillin

1993
Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
    Obstetrics and gynecology, 1994, Volume: 83, Issue:2

    Topics: Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Penicillanic Acid; Piperacillin; Tazobactam

1994
Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Surgery, gynecology & obstetrics, 1993, Volume: 176, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Peritoneal Diseases; Piperacillin; Tazobactam; Treatment Outcome

1993
Safety profile of piperacillin/tazobactam in phase I and III clinical studies.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A

    Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Penicillanic Acid; Piperacillin; Tazobactam

1993
A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A

    Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam

1993
The efficacy and safety of piperacillin/tazobactam in the therapy of bacteraemia.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A

    Topics: Abdomen; Adult; Bacteremia; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Neutropenia; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Skin Diseases, Infectious; Tazobactam

1993
Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Bacteremia; Bacteria; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Teicoplanin

1993
Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactam.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 16 Suppl 4

    Topics: Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1993
Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group.
    The American surgeon, 1993, Volume: 59, Issue:9

    Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cholangitis; Cholecystitis; Clindamycin; Combined Modality Therapy; Diverticulitis; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam

1993
Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:1

    Topics: Adult; Bacterial Infections; beta-Lactamase Inhibitors; Burns; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

1996
[Comparison of the therapeutic efficacy of the piperacillin/tazobactame combination vs. ampicillin and gentamycin in in the management of post-cesarean endometritis].
    Ginecologia y obstetricia de Mexico, 1996, Volume: 64

    Topics: Adolescent; Adult; Age Factors; Ampicillin; Anti-Bacterial Agents; Cesarean Section; Drug Therapy, Combination; Endometritis; Enzyme Inhibitors; Female; Gentamicins; Humans; Parity; Penicillanic Acid; Penicillins; Piperacillin; Pregnancy; Tazobactam

1996
Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:2

    Topics: Adult; Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Cross-Over Studies; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Female; Humans; Male; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Serum Bactericidal Test; Sulbactam; Tazobactam; Ticarcillin

1997
[Clinical study of tazobactam/piperacillin in obstetrics and gynecological infections].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Genital Diseases, Female; Humans; Infusions, Intravenous; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1996
[Use of piperacillin-tazobactam in abdominal surgery].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1997, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Peritonitis; Piperacillin; Sepsis; Surgical Wound Infection; Tazobactam; Treatment Outcome

1997
Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH).
    Intensive care medicine, 1997, Volume: 23, Issue:8

    Topics: Adult; Aged; beta-Lactamases; Drug Therapy, Combination; Enzyme Inhibitors; Female; Hemofiltration; Humans; Least-Squares Analysis; Male; Middle Aged; Multiple Organ Failure; Penicillanic Acid; Penicillins; Piperacillin; Renal Insufficiency; Tazobactam

1997
Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:11

    Topics: Adult; Area Under Curve; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1997
Influence of piperacillin-tazobactam on pharmacokinetics of gentamicin given once daily.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1997, Dec-01, Volume: 54, Issue:23

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Area Under Curve; Cross-Over Studies; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Female; Gentamicins; Half-Life; Humans; Male; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1997
Piperacillin/tazobactam versus imipenem: a double-blind, randomized formulary feasibility study at a major teaching hospital.
    Diagnostic microbiology and infectious disease, 1998, Volume: 31, Issue:2

    Topics: Adolescent; Adult; beta-Lactamase Inhibitors; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Feasibility Studies; Female; Hospitals, Teaching; Humans; Imipenem; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Thienamycins; Treatment Outcome

1998
Piperacillin/tazobactam versus cefepime as initial empirical antimicrobial therapy in febrile neutropenic patients: a prospective randomized pilot study.
    European journal of medical research, 1998, Jul-20, Volume: 3, Issue:7

    Topics: Anti-Infective Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Fever; Humans; Neutropenia; Penicillanic Acid; Pilot Projects; Piperacillin; Prognosis; Prospective Studies; Tazobactam

1998
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl D

    Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin

1998
Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1998, Volume: 6, Issue:4

    Topics: Adolescent; Adult; Aged; Amikacin; Analysis of Variance; Anti-Bacterial Agents; Ceftazidime; Chi-Square Distribution; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prognosis; Prospective Studies; Tazobactam; Treatment Failure; Treatment Outcome

1998
Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:11

    Topics: Acute Disease; Adult; Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam

1998
Pharmacodynamic interactions of ciprofloxacin, piperacillin, and piperacillin/tazobactam in healthy volunteers.
    Journal of clinical pharmacology, 1998, Volume: 38, Issue:11

    Topics: Adolescent; Adult; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Cross-Over Studies; Drug Interactions; Enzyme Inhibitors; Female; Humans; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1998
Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:12

    Topics: Aged; beta-Lactamase Inhibitors; Cefotaxime; Clostridioides difficile; Cross Infection; Cross-Over Studies; Diarrhea; Drug Combinations; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Female; Humans; Male; Opportunistic Infections; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

1998
Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: a Canadian hospital perspective.
    The Annals of pharmacotherapy, 1999, Volume: 33, Issue:2

    Topics: Adult; Anti-Infective Agents; Bacterial Infections; British Columbia; Cilastatin; Costs and Cost Analysis; Decision Trees; Double-Blind Method; Drug Therapy, Combination; Economics, Pharmaceutical; Enzyme Inhibitors; Female; Humans; Imipenem; Male; Models, Economic; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Protease Inhibitors; Statistics, Nonparametric; Tazobactam; Thienamycins; Treatment Outcome

1999
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1999, Volume: 7, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin

1999
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients.
    Haematologica, 1999, Volume: 84, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin

1999
Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomized clinical trial.
    Endoscopy, 1999, Volume: 31, Issue:2

    Topics: Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Endoscopy; Enteral Nutrition; Enzyme Inhibitors; Female; Gastrostomy; Humans; Incidence; Intubation, Gastrointestinal; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Surgical Wound Infection; Tazobactam

1999
Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
    The European journal of surgery = Acta chirurgica, 1999, Volume: 165, Issue:9

    Topics: Abdominal Abscess; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cefuroxime; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Intestinal Perforation; Male; Metronidazole; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Rupture, Spontaneous; Surgical Wound Infection; Tazobactam

1999
[Biliary diffusion of tazocillin in man].
    Pathologie-biologie, 1999, Volume: 47, Issue:8

    Topics: Bile; Diffusion; Drug Combinations; Humans; Intraoperative Care; Penicillanic Acid; Piperacillin; Tazobactam

1999
Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:8

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Peritonitis; Piperacillin; Tazobactam; Treatment Outcome

2000
Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Skin Diseases, Infectious; Tazobactam

2001
A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
    Chinese medical journal, 1998, Volume: 111, Issue:11

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Clavulanic Acid; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli Infections; Female; Humans; Male; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Respiratory Tract Infections; Tazobactam; Ticarcillin; Urinary Tract Infections

1998
The role of topical antibiotic prophylaxis in patients undergoing contaminated head and neck surgery with flap reconstruction.
    The Laryngoscope, 2001, Volume: 111, Issue:2

    Topics: Administration, Topical; Adult; Aged; Antibiotic Prophylaxis; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mouthwashes; Otorhinolaryngologic Neoplasms; Penicillanic Acid; Piperacillin; Prospective Studies; Surgical Flaps; Surgical Wound Infection; Tazobactam; Therapeutic Irrigation

2001
The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Glycopeptides; Gram-Positive Bacterial Infections; Hematology; Hospital Units; Humans; Infection Control; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

1999
Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study.
    Annals of surgical oncology, 2001, Volume: 8, Issue:2

    Topics: Aged; Amikacin; Aztreonam; Chi-Square Distribution; Clindamycin; Cross Infection; Drug Therapy, Combination; Humans; Middle Aged; Neoplasms; Opportunistic Infections; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Postoperative Complications; Prognosis; Prospective Studies; Tazobactam

2001
Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2001, Volume: 9, Issue:5

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Drug Therapy, Combination; Enzyme Inhibitors; Fever; Gentamicins; Germany; Humans; Neoplasms; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Sulbactam; Tazobactam; Treatment Outcome

2001
Evaluating possible pharmacokinetic interactions between tobramycin, piperacillin, and a combination of piperacillin and tazobactam in patients with various degrees of renal impairment.
    Journal of clinical pharmacology, 2001, Volume: 41, Issue:9

    Topics: Adult; Aged; Aging; Anti-Bacterial Agents; Area Under Curve; beta-Lactamase Inhibitors; Creatinine; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Tobramycin

2001
A randomized prospective multicentre trial of cefpirome versus piperacillin-tazobactam in febrile neutropenia.
    Leukemia & lymphoma, 2001, Volume: 42, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Cefpirome; Cephalosporins; Enzyme Inhibitors; Female; Fever; France; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome

2001
Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:9

    Topics: Abdominal Abscess; Adolescent; Appendicitis; Bacterial Infections; Cefotaxime; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome

2001
[Multicentre clinical trial on efficacy and safety of domestic piperacillin/tazobactam for treatment of acute bacterial infections].
    Zhonghua yi xue za zhi, 2001, Jan-10, Volume: 81, Issue:1

    Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Drug Therapy, Combination; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Skin Diseases; Tazobactam; Treatment Outcome

2001
Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections.
    International journal of antimicrobial agents, 2002, Volume: 19, Issue:2

    Topics: Adolescent; Adult; Aged; Cilastatin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Pyelonephritis; Sample Size; Tazobactam; Thienamycins; Urinary Tract Infections

2002
Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactam.
    Pharmacotherapy, 2002, Volume: 22, Issue:5

    Topics: Adolescent; Adult; Area Under Curve; beta-Lactamase Inhibitors; Chromatography, High Pressure Liquid; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Female; Half-Life; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

2002
Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Jun-01, Volume: 34, Issue:11

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Female; Humans; Lactams; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Skin Diseases; Staphylococcus aureus; Tazobactam; Treatment Outcome

2002
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:1

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome

2002
General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Double-Blind Method; Enzyme Inhibitors; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Skin Diseases, Bacterial; Tazobactam

2002
Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam when administered by continuous infusion and intermittent dosing.
    Clinical therapeutics, 2002, Volume: 24, Issue:7

    Topics: Adult; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam

2002
Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam.
    BJU international, 2002, Volume: 90, Issue:7

    Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Injections, Intramuscular; Male; Penicillanic Acid; Penicillins; Piperacillin; Postoperative Complications; Prospective Studies; Prostatic Diseases; Tazobactam; Transurethral Resection of Prostate

2002
[A multicenter clinical trial of piperacillin/tazobactam in burn infection].
    Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2002, Volume: 18, Issue:2

    Topics: Adult; Burns; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Sepsis; Tazobactam; Treatment Outcome

2002
Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Gentamicins; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Treatment Outcome

2003
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:5

    Topics: Adult; Aged; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Humans; Lactams; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Urinary Tract Infections

2003
[Carbapenem antibiotic ertapenem in the treatment of extrahospital intraabdominal infections].
    Khirurgiia, 2003, Issue:4

    Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome

2003
Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study.
    Infectious diseases in obstetrics and gynecology, 2003, Volume: 11, Issue:1

    Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ertapenem; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lactams; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Tazobactam; Treatment Outcome

2003
Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin/skin structure infections.
    The Journal of infection, 2004, Volume: 48, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Ertapenem; Female; Humans; Infusions, Intravenous; Lactams; Logistic Models; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Skin Diseases; Statistics, Nonparametric; Tazobactam; Treatment Outcome

2004
Vancomycin does not benefit persistently febrile neutropenic people with cancer.
    Cancer treatment reviews, 2004, Volume: 30, Issue:1

    Topics: Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Female; Fever; Follow-Up Studies; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Probability; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Tazobactam; Treatment Outcome; Vancomycin

2004
Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
    International journal of hematology, 2004, Volume: 79, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Disease Susceptibility; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Treatment Outcome

2004
Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:10

    Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Follow-Up Studies; Humans; Infant; Male; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Recurrence; Tazobactam; Treatment Outcome

2004
Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Pediatric hematology and oncology, 2004, Volume: 21, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Fever; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Infections; Meropenem; Neoplasms; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins

2004
Empirical antibiotic treatment with piperacillin-tazobactam in patients with microbiologically-documented biliary tract infections.
    World journal of gastroenterology, 2004, Aug-01, Volume: 10, Issue:15

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biliary Tract Diseases; Biliary Tract Neoplasms; Drug Combinations; Empirical Research; Female; Humans; Infections; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam

2004
Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12

    Topics: Algorithms; Computer Simulation; Cross Infection; Drug Interactions; Enzyme Inhibitors; Half-Life; Humans; Models, Biological; Monte Carlo Method; Penicillanic Acid; Penicillins; Piperacillin; Population; Tazobactam

2004
Randomized comparison of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infection.
    Asian journal of surgery, 2004, Volume: 27, Issue:3

    Topics: Abdominal Abscess; Adult; Anti-Bacterial Agents; Cilastatin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2004
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
    Current medical research and opinion, 2005, Volume: 21, Issue:5

    Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Protease Inhibitors; Spain; Tazobactam; Treatment Outcome

2005
Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:2

    Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

2005
Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial.
    British journal of haematology, 2005, Volume: 130, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Male; Meropenem; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Thienamycins

2005
Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
    Bone marrow transplantation, 2006, Volume: 37, Issue:4

    Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neutropenia; Penicillanic Acid; Peripheral Blood Stem Cell Transplantation; Piperacillin; Predictive Value of Tests; Prospective Studies; Survival Rate; Tazobactam; Transplantation, Autologous; Treatment Outcome

2006
Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Enzyme Inhibitors; Europe; Fever; Hematologic Neoplasms; Humans; Infant; Injections, Intravenous; Middle Aged; Middle East; Neutropenia; North America; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome

2006
Clinical experience with three combination regimens for the treatment of high-risk febrile neutropenia.
    Annals of the Academy of Medicine, Singapore, 2006, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Immunocompromised Host; Male; Meropenem; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Risk Assessment; Risk Factors; Tazobactam; Thienamycins

2006
Comparison of piperacillin/tazobactam and imipenem/cilastatin, both in combination with tobramycin, administered every 6 h for treatment of nosocomial pneumonia.
    Respiratory medicine, 2006, Volume: 100, Issue:9

    Topics: Anti-Bacterial Agents; Cilastatin; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Protease Inhibitors; Tazobactam; Tobramycin; Treatment Outcome

2006
Pharmacoeconomics of continuous versus intermittent infusion of piperacillin-tazobactam for the treatment of complicated intraabdominal infection.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006, Apr-15, Volume: 63, Issue:8

    Topics: Abdomen; Adult; Bacterial Infections; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam

2006
[Antibiotic prophylaxis in cesarean section -- piperacillin versus piperacillin/tazobactam in 300 cesarean sections].
    Zentralblatt fur Gynakologie, 2006, Volume: 128, Issue:3

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cesarean Section; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pregnancy; Tazobactam

2006
Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia--a double blind prospective multicentre study.
    Infection, 2006, Volume: 34, Issue:3

    Topics: Adult; Cilastatin; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Penicillanic Acid; Piperacillin; Pneumonia; Prospective Studies; Pseudomonas Infections; Tazobactam; Treatment Outcome

2006
Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Oct-20, Volume: 24, Issue:30

    Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents, Alkylating; Busulfan; Ceftriaxone; Female; Fever; Health Care Costs; Hematologic Neoplasms; Home Care Services; Hospital Charges; Humans; Inpatients; Male; Middle Aged; Neutropenia; Patient Readmission; Penicillanic Acid; Piperacillin; Stem Cell Transplantation; Tazobactam; Transplantation, Autologous

2006
Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2

    Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Databases, Factual; Diabetic Foot; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Penicillanic Acid; Piperacillin; Quinolines; Tazobactam

2007
Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia.
    Critical care medicine, 2008, Volume: 36, Issue:5

    Topics: Aged; Anti-Bacterial Agents; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Prospective Studies; Pulmonary Alveoli; Tazobactam

2008
Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study.
    Current medical research and opinion, 2008, Volume: 24, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Carbapenems; Cross Infection; Doripenem; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Prospective Studies; Tazobactam; Treatment Outcome

2008
[Clinical effects and safety of piperacillin/tazobactam in treating neutropenic febrile patients with malignant hematopathy].
    Zhonghua yi xue za zhi, 2009, Jan-06, Volume: 89, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome

2009
Tazobactam/piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: comparison with imipenem/cilastatin.
    Pulmonary pharmacology & therapeutics, 2010, Volume: 23, Issue:5

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Cilastatin; Community-Acquired Infections; Drug Combinations; Female; Humans; Imipenem; Injections, Intravenous; Male; Nursing Homes; Penicillanic Acid; Piperacillin; Pneumonia, Aspiration; Prospective Studies; Protease Inhibitors; Tazobactam; Treatment Outcome

2010
[Perioperative antibiotic prophylaxis in radical retropubic prostatectomy: a randomised pilot study of perioperative and postoperative administration].
    Aktuelle Urologie, 2011, Volume: 42, Issue:1

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Body Temperature; C-Reactive Protein; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Neoplasm Staging; Penicillanic Acid; Perioperative Care; Pilot Projects; Piperacillin; Postoperative Complications; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Surgical Wound Infection; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination

2011
Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia.
    Pediatric hematology and oncology, 2011, Volume: 28, Issue:4

    Topics: Acute Disease; Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Female; Humans; Leukemia; Male; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Young Adult

2011
Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:10

    Topics: Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cephalosporins; Female; Human Experimentation; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Plasma; Tazobactam; Time Factors; Young Adult

2012
Population pharmacokinetics of piperacillin at two dose levels: influence of nonlinear pharmacokinetics on the pharmacodynamic profile.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Anti-Bacterial Agents; Cross-Over Studies; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Monte Carlo Method; Nonlinear Dynamics; Penicillanic Acid; Piperacillin; Tazobactam

2012
Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study.
    Infection, 2013, Volume: 41, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacterial Infections; Diabetic Foot; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Quinolines; Tazobactam; Treatment Outcome

2013
Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
    Pediatric hematology and oncology, 2013, Volume: 30, Issue:2

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Sulbactam; Tazobactam

2013
Pulmonary penetration of piperacillin and tazobactam in critically ill patients.
    Clinical pharmacology and therapeutics, 2014, Volume: 96, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Lung; Male; Middle Aged; Monte Carlo Method; Penicillanic Acid; Permeability; Piperacillin; Tazobactam

2014
Serum galactomannan screening for diagnosis of invasive pulmonary aspergillosis in children after stem cell transplantation or with high-risk leukemia.
    Pediatric hematology and oncology, 2015, Volume: 32, Issue:2

    Topics: Adolescent; Adult; Allografts; Autografts; Child; Child, Preschool; Female; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Invasive Pulmonary Aspergillosis; Leukemia; Male; Mannans; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

2015
Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients.
    Journal of clinical pharmacology, 2015, Volume: 55, Issue:8

    Topics: Adult; Aged; Anti-Bacterial Agents; Body Mass Index; Body Weight; Computer Simulation; Creatinine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Biological; Monte Carlo Method; Obesity; Penicillanic Acid; Piperacillin; Tazobactam

2015
Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    BMC infectious diseases, 2017, 06-07, Volume: 17, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Republic of Korea; Tazobactam; Urinary Tract Infections

2017
Incidence of acute kidney injury among pediatric hematology/oncology patients receiving vancomycin in combination with piperacillin/tazobactam or cefepime.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:7

    Topics: Acute Kidney Injury; Adolescent; Cefepime; Child; Child, Preschool; Female; Hematologic Neoplasms; Humans; Male; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin

2019
A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.
    Asian Pacific journal of cancer prevention : APJCP, 2019, 09-01, Volume: 20, Issue:9

    Topics: Administration, Intravenous; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Febrile Neutropenia; Female; Follow-Up Studies; Humans; Male; Neoplasms; Piperacillin; Prospective Studies; Retrospective Studies; Tazobactam; Treatment Outcome

2019
Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis (the EASI-SWITCH trial): study protocol for a randomised controlled trial.
    Trials, 2020, May-27, Volume: 21, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Cost-Benefit Analysis; Drug Administration Schedule; Equivalence Trials as Topic; Humans; Meropenem; Multicenter Studies as Topic; Neoplasms; Neutropenia; Piperacillin; Pragmatic Clinical Trials as Topic; Quality of Life; Sepsis; Tazobactam; Treatment Outcome

2020
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 12-06, Volume: 73, Issue:11

    Topics: Adult; Aged; Anti-Bacterial Agents; Azabicyclo Compounds; Cilastatin; Hospitals; Humans; Imipenem; Piperacillin; Tazobactam; Ventilators, Mechanical

2021
Randomized control trial on perioperative antibiotic prophylaxis in live liver donors: Are three doses enough?
    Journal of hepato-biliary-pancreatic sciences, 2022, Volume: 29, Issue:10

    Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Humans; Liver; Piperacillin; Tazobactam

2022
The effects of antibiotic cycling and mixing on acquisition of antibiotic resistant bacteria in the ICU: A post-hoc individual patient analysis of a prospective cluster-randomized crossover study.
    PloS one, 2022, Volume: 17, Issue:5

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross-Over Studies; Gram-Negative Bacteria; Humans; Intensive Care Units; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Tazobactam

2022
Comparison of pharmacokinetics and stability of generics of cefepime, linezolid and piperacillin/tazobactam with their respective originator drugs: an intravenous bioequivalence study in healthy volunteers.
    The Journal of antimicrobial chemotherapy, 2022, 10-28, Volume: 77, Issue:11

    Topics: Anti-Bacterial Agents; Cefepime; Drugs, Generic; Healthy Volunteers; Humans; Linezolid; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Therapeutic Equivalency

2022
Fully Automated EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) from Positive Blood Cultures: Diagnostic Accuracy and Implementation.
    Journal of clinical microbiology, 2022, 10-19, Volume: 60, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactamases; Blood Culture; Cefepime; Ceftazidime; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Prospective Studies; Tazobactam

2022

Other Studies

560 other study(ies) available for piperacillin and tazobactam

ArticleYear
The synthesis and SAR of rhodanines as novel class C beta-lactamase inhibitors.
    Bioorganic & medicinal chemistry letters, 2000, Oct-02, Volume: 10, Issue:19

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Drug Evaluation, Preclinical; Enzyme Inhibitors; Molecular Structure; Piperacillin; Rhodanine; Structure-Activity Relationship

2000
Allyl and propargyl substituted penam sulfones as versatile intermediates toward the syntheses of new beta-lactamase inhibitors.
    Bioorganic & medicinal chemistry letters, 2001, Apr-23, Volume: 11, Issue:8

    Topics: Alkenes; Alkynes; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Enzyme Inhibitors; Escherichia coli; Inhibitory Concentration 50; Molecular Conformation; Penicillanic Acid; Sulfones; Tazobactam; Triazoles

2001
Spirocyclopropyl beta-lactams as mechanism-based inhibitors of serine beta-lactamases. Synthesis by rhodium-catalyzed cyclopropanation of 6-diazopenicillanate sulfone.
    Journal of medicinal chemistry, 2003, Jun-19, Volume: 46, Issue:13

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Catalysis; Crystallography, X-Ray; Cyclopropanes; Diazonium Compounds; Enzyme Inhibitors; Escherichia coli; Microbial Sensitivity Tests; Models, Molecular; Pseudomonas aeruginosa; Rhodium; Serine; Serratia marcescens; Spiro Compounds; Structure-Activity Relationship; Sulbactam

2003
Structure-activity relationship of 6-methylidene penems bearing 6,5 bicyclic heterocycles as broad-spectrum beta-lactamase inhibitors: evidence for 1,4-thiazepine intermediates with C7 R stereochemistry by computational methods.
    Journal of medicinal chemistry, 2006, Jul-27, Volume: 49, Issue:15

    Topics: Aldehydes; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Enterobacter aerogenes; Enterobacteriaceae Infections; Escherichia coli Infections; Gram-Negative Bacteria; Heterocyclic Compounds, 2-Ring; Imidazoles; Mice; Microbial Sensitivity Tests; Models, Molecular; Pyrazoles; Stereoisomerism; Structure-Activity Relationship; Thiazepines; Thiophenes

2006
Evolution of TEM-type enzymes: biochemical and genetic characterization of two new complex mutant TEM enzymes, TEM-151 and TEM-152, from a single patient.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Evolution, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation

2007
Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: beta-Lactamases; Chromosomes; Chromosomes, Bacterial; Citrobacter; Cloning, Molecular; DNA, Bacterial; Escherichia coli; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Genes, Bacterial; Molecular Sequence Data

2007
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillinase; Plasmids; Sequence Analysis, DNA

2007
Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clavulanic Acid; Cloning, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA

2007
Biochemical characterization of PER-2 and genetic environment of blaPER-2.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7

    Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Catalysis; Citrobacter freundii; Conjugation, Genetic; DNA, Bacterial; DNA, Recombinant; Enterobacteriaceae; Genes, Bacterial; Humans; Hydrolysis; Isoelectric Focusing; Kinetics; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Conformation; Protein Sorting Signals; Sequence Analysis, DNA

2007
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chryseobacterium; Flavobacteriaceae Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA

2007
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10

    Topics: Anti-Bacterial Agents; Cephalosporinase; Culture Media; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Models, Molecular; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet

2007
TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalysis; Ceftazidime; Clavulanic Acid; Escherichia coli; Escherichia coli Proteins; Isoenzymes; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA

2007
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity

2007
Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Aztreonam; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Clavulanic Acid; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrolysis; Kinetics; Molecular Weight; Penicillanic Acid; Penicillins; Recombinant Proteins; Serratia; Sulbactam; Tazobactam

2007
First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Aeromonas; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; France; Integrons; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Substrate Specificity

2007
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Amino Acid Sequence; beta-Lactams; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillinase; Sequence Alignment; Sequence Analysis, DNA; Substrate Specificity

2008
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Brachyspira; Cloning, Molecular; Diarrhea; Feces; Gram-Negative Bacterial Infections; Humans; Kinetics; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Sequence Analysis, DNA

2008
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary

2008
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity

2008
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovenia

2009
Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3

    Topics: Alleles; Amino Acid Sequence; Amino Acid Substitution; Base Sequence; beta-Lactamases; Burkholderia cepacia complex; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Hydrolysis; Isoelectric Point; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Sequence Analysis, DNA; Sequence Homology, Amino Acid

2009
Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cardiidae; Ceftazidime; Ceftriaxone; Cephalosporin Resistance; Electrophoresis, Gel, Pulsed-Field; France; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Salmonella enterica; Serotyping

2009
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6

    Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa

2009
Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7

    Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed

2009
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Aztreonam; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Protein Binding; Protein Structure, Secondary

2009
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8

    Topics: Amino Acid Sequence; Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Campylobacter jejuni; Carbenicillin; Cephalosporins; Chickens; Cloxacillin; Isoelectric Focusing; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Piperacillin; Polymerase Chain Reaction; Sequence Alignment; Ticarcillin

2009
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Catheters, Indwelling; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Pseudomonas; Pseudomonas Infections; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity

2010
BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Belgium; beta-Lactamases; Cephalosporinase; Cephalosporins; Cross Infection; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2010
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Fresh Water; Gram-Negative Bacteria; Health Surveys; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas fluorescens; Water Microbiology

2010
Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactamases; Catalytic Domain; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Penicillanic Acid; Spectrometry, Mass, Electrospray Ionization; Sulbactam; Tazobactam

2010
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA

2010
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea

2010
Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporinase; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Hydrogen Bonding; Kinetics; Microbial Sensitivity Tests; Molecular Structure; Mutagenesis, Site-Directed; Penicillanic Acid; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Substrate Specificity; Sulbactam; Tazobactam

2010
Overexpression of the adeB gene in clinical isolates of tigecycline-nonsusceptible Acinetobacter baumannii without insertion mutations in adeRS.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Male; Membrane Transport Proteins; Middle Aged; Minocycline; Molecular Sequence Data; Mutagenesis, Insertional; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline

2010
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Ampicillin; beta-Lactamases; Computational Biology; Escherichia coli; Hydrogen Bonding; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Protein Structure, Secondary; Ticarcillin

2010
Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase.
    Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Boronic Acids; Circular Dichroism; Clavulanic Acid; Crystallography, X-Ray; Drug Design; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Dynamics Simulation; Mutagenesis; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Sulfhydryl Compounds

2013
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:4

    Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship

2013
Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease.
    Clinical pharmacology and therapeutics, 1992, Volume: 51, Issue:1

    Topics: Adult; beta-Lactamase Inhibitors; Creatine; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Penicillanic Acid; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Renal Dialysis; Tazobactam; Time Factors

1992
Effect of pH on antibiotics used to treat anaerobic infection.
    The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:5

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Cefoxitin; Clindamycin; Drug Therapy, Combination; Hydrogen-Ion Concentration; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1992
Effect of piperacillin/tazobactam therapy on intestinal microflora.
    Scandinavian journal of infectious diseases, 1992, Volume: 24, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Feces; Female; Humans; Intestines; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Yeasts

1992
Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:9

    Topics: Animals; beta-Lactamase Inhibitors; beta-Lactamases; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Rabbits; Tazobactam

1992
Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:9

    Topics: Adipose Tissue; Adult; Aged; beta-Lactamase Inhibitors; Chromatography, High Pressure Liquid; Colon; Female; Half-Life; Humans; Infusions, Intravenous; Intestinal Mucosa; Male; Middle Aged; Muscles; Penicillanic Acid; Piperacillin; Premedication; Rectum; Skin; Specimen Handling; Tazobactam

1992
Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1992, Volume: 11, Issue:8

    Topics: beta-Lactamase Inhibitors; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1992
[In vitro activity of tazobactam and piperacillin combination against 224 strains of Pseudomonas aeruginosa according to the production of beta-lactamase].
    Pathologie-biologie, 1991, Volume: 39, Issue:5

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporinase; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; In Vitro Techniques; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam

1991
[In vitro antibacterial activity of piperacillin-tazobactam combination on hospital isolates and regression curve].
    Pathologie-biologie, 1991, Volume: 39, Issue:5

    Topics: Acinetobacter; beta-Lactamase Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Enterobacteriaceae; Haemophilus; Humans; In Vitro Techniques; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus; Tazobactam

1991
[In vitro synergistic activity of piperacillin-tazobactam combination against beta-lactam antibiotics resistant strains of Enterobacteriaceae].
    Pathologie-biologie, 1991, Volume: 39, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; In Vitro Techniques; Penicillanic Acid; Piperacillin; Tazobactam

1991
[Strict anaerobic bacteria: comparative study of various beta-lactam antibiotics in combination with tazobactam or sulbactam].
    Pathologie-biologie, 1991, Volume: 39, Issue:5

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamase Inhibitors; Cefotaxime; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; In Vitro Techniques; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam

1991
Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27, Issue:5

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Cell Membrane Permeability; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1991
Piperacillin/tazobactam in the treatment of serious acute soft tissue infection.
    Drugs under experimental and clinical research, 1991, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam

1991
[Chemical structure, anti-bacterial activity and pharmacokinetics of penicillins].
    Nihon rinsho. Japanese journal of clinical medicine, 1991, Volume: 49, Issue:10

    Topics: beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Humans; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Ticarcillin

1991
Beta-lactamase inhibitors: relation between kinetic data and in-vitro synergism studies.
    Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1991, Volume: 275, Issue:4

    Topics: beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Synergism; Enterobacter cloacae; Escherichia coli; Klebsiella; Penicillanic Acid; Piperacillin; Proteus vulgaris; Pseudomonas aeruginosa; Staphylococcus aureus; Sulbactam; Tazobactam

1991
In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin).
    Infection, 1991, Volume: 19 Suppl 5

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cefozopran; Cefpirome; Cephalosporins; Drug Stability; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Tazobactam

1991
Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
    The Journal of antimicrobial chemotherapy, 1991, Volume: 27, Issue:6

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clavulanic Acids; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1991
Antimicrobial activities of piperacillin alone and in combination with tazobactam against beta-lactamase-producing bacteria.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 1991, Volume: 90, Issue:10

    Topics: Ampicillin Resistance; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1991
Comparative in-vitro activity of piperacillin and piperacillin plus tazobactam towards beta-lactamase producing clinical isolates.
    Journal of chemotherapy (Florence, Italy), 1990, Volume: 2, Issue:5

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1990
The effect of tazobactam on bilirubin-albumin binding.
    Pharmacology & toxicology, 1990, Volume: 66, Issue:1

    Topics: Albumins; Bilirubin; Binding, Competitive; Chemical Phenomena; Chemistry; Humans; Infant, Newborn; Penicillanic Acid; Piperacillin; Tazobactam

1990
Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 25, Issue:2

    Topics: Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Enzyme Induction; Half-Life; Kinetics; Penicillanic Acid; Piperacillin; Tazobactam; Ticarcillin

1990
In vitro effect of YTR (tazobactam) on plasmid and chromosomally mediated beta-lactamases.
    Chemotherapy, 1990, Volume: 36, Issue:3

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Chromosomes; Citrobacter; Drug Synergism; Enterobacter; Enzyme Induction; Humans; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas; Serratia marcescens; Tazobactam

1990
Turbidimetric and microscopic analysis of Bacteroides fragilis exposed to tazobactam and piperacillin alone and in combination.
    Chemotherapy, 1990, Volume: 36, Issue:3

    Topics: Bacteroides fragilis; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Nephelometry and Turbidimetry; Penicillanic Acid; Piperacillin; Tazobactam

1990
Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 25, Issue:4

    Topics: Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acids; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam

1990
Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:5

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Escherichia coli; Escherichia coli Infections; Meningitis; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Rabbits; Tazobactam

1990
The in-vitro activity of piperacillin/tazobactam, ciprofloxacin, ceftazidime and imipenem against multiple resistant gram-negative bacteria.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 25, Issue:6

    Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Citrobacter; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Serratia; Tazobactam

1990
Antibacterial activity of piperacillin and tazobactam against beta-lactamase-producing clinical isolates.
    Chemotherapy, 1990, Volume: 36, Issue:5

    Topics: beta-Lactamases; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Penicillanic Acid; Piperacillin; Tazobactam

1990
Beta-lactamase inhibitors and Acinetobacter spp.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:3

    Topics: Acinetobacter; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Species Specificity; Sulbactam; Tazobactam

1990
In vitro activity of cefepime, a new parenteral cephalosporin, against recent European blood isolates and in comparison with piperacillin/tazobactam.
    Chemotherapy, 1990, Volume: 36, Issue:4

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Staphylococcus; Tazobactam

1990
Piperacillin/tazobactam and ticarcillin/clavulanic acid against resistant Enterobacteriaceae.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:4

    Topics: beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Hydrogen-Ion Concentration; Penicillanic Acid; Piperacillin; Tazobactam; Ticarcillin

1990
Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:9

    Topics: 4-Quinolones; Anti-Infective Agents; Bacteria, Anaerobic; Bacteroides fragilis; beta-Lactamase Inhibitors; Drug Therapy, Combination; Fluoroquinolones; Fusobacterium; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Quinolones; Tazobactam

1990
[Efficiency of tazobactam as inhibitor of beta-lactamases, combined with piperacillin, against resistant strains to this penicillin].
    Medicina clinica, 1989, Mar-18, Volume: 92, Issue:10

    Topics: Amoxicillin; beta-Lactamases; Chemical Phenomena; Chemistry; Clavulanic Acids; Drug Evaluation; Drug Therapy, Combination; Enterobacteriaceae; Female; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Tazobactam

1989
Protection of piperacillin and ticarcillin from beta-lactamase hydrolysis by tazobactam (YTR-830) and clavulanic acid.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 24, Issue:1

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acids; Escherichia coli; Hydrolysis; Penicillanic Acid; Penicillins; Piperacillin; Staphylococcus aureus; Tazobactam; Ticarcillin

1989
In vitro activity of YTR 830.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:3

    Topics: Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Proteus vulgaris; Sulbactam; Tazobactam; Ticarcillin

1989
In vitro and in vivo efficacy of YTR-830H and piperacillin combinations versus beta-lactamase-producing bacteria.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:3

    Topics: Animals; Bacteria; beta-Lactamases; Cefoxitin; Clavulanic Acids; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Tazobactam

1989
Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:8

    Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Ticarcillin

1989
In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Cephalosporinase; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Ticarcillin

1989
Determination of tazobactam and piperacillin in human plasma, serum, bile and urine by gradient elution reversed-phase high-performance liquid chromatography.
    Journal of chromatography, 1989, Nov-10, Volume: 496, Issue:1

    Topics: Anti-Bacterial Agents; Bile; Chromatography, High Pressure Liquid; Humans; Penicillanic Acid; Piperacillin; Spectrophotometry, Ultraviolet; Tazobactam

1989
Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:11

    Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam

1989
High-performance liquid chromatographic determination of a new beta-lactamase inhibitor and its metabolite in combination therapy with piperacillin in biological materials.
    Journal of chromatography, 1988, Sep-23, Volume: 431, Issue:1

    Topics: Animals; beta-Lactamase Inhibitors; Chromatography, High Pressure Liquid; Dogs; Feces; Humans; Hydrogen-Ion Concentration; Indicators and Reagents; Penicillanic Acid; Piperacillin; Rats; Species Specificity; Spectrophotometry, Ultraviolet; Tazobactam; Tissue Distribution

1988
In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:8

    Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enzyme Inhibitors; Klebsiella pneumoniae; Least-Squares Analysis; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam; Time Factors

1995
A multicentre in vitro evaluation of piperacillin/tazobactam in Germany.
    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573

    Topics: beta-Lactamase Inhibitors; Drug Therapy, Combination; Enterobacteriaceae; Germany; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1994
Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections.
    The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573

    Topics: Abdomen; Animals; Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Gentamicins; Imipenem; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Rats; Rats, Sprague-Dawley; Tazobactam

1994
Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Jul-15, Volume: 52, Issue:14

    Topics: Chromatography, High Pressure Liquid; Drug Incompatibility; Humans; Ondansetron; Penicillanic Acid; Piperacillin; Tazobactam

1995
[Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Pathologie-biologie, 1995, Volume: 43, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; Enzyme Inhibitors; Gentamicins; Humans; In Vitro Techniques; Penicillanic Acid; Penicillin Resistance; Piperacillin; Tazobactam; Ticarcillin

1995
[In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
    Pathologie-biologie, 1995, Volume: 43, Issue:4

    Topics: Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Imipenem; In Vitro Techniques; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins

1995
Effects of tazobactam on the frequency of the emergence of resistant strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (beta-lactamase derepressed mutants).
    The Journal of antibiotics, 1995, Volume: 48, Issue:9

    Topics: Animals; beta-Lactamase Inhibitors; beta-Lactamases; Citrobacter freundii; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Male; Mice; Microbial Sensitivity Tests; Mutation; Penicillanic Acid; Piperacillin; Proteus vulgaris; Tazobactam

1995
In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species.
    Diagnostic microbiology and infectious disease, 1995, Volume: 21, Issue:2

    Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefotaxime; Ceftazidime; Ceftriaxone; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Sulbactam; Tazobactam

1995
A piperacillin-tazobactam resistant Escherichia coli strain isolated from a faecal sample of a healthy volunteer.
    FEMS immunology and medical microbiology, 1995, Volume: 11, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Enzyme Inhibitors; Escherichia coli; Feces; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Plasmids; Population Surveillance; Tazobactam

1995
Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, May-01, Volume: 52, Issue:9

    Topics: beta-Lactamase Inhibitors; Drug Packaging; Drug Stability; Humans; Penicillanic Acid; Piperacillin; Polypropylenes; Polyvinyl Chloride; Syringes; Tazobactam

1995
[In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin].
    Pathologie-biologie, 1995, Volume: 43, Issue:3

    Topics: Amikacin; Amoxicillin; beta-Lactamase Inhibitors; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Inhibitors; In Vitro Techniques; Netilmicin; Penicillanic Acid; Piperacillin; Tazobactam

1995
Penetration of piperacillin-tazobactam into bronchial secretions after multiple doses to intensive care patients.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:12

    Topics: Adult; Aged; beta-Lactamase Inhibitors; Bronchi; Drug Combinations; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam

1994
Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:12

    Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Clavulanic Acids; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Streptococcus pneumoniae; Sulbactam; Tazobactam; Ticarcillin

1994
[Drugs: piperacillin/tazobactam].
    Enfermedades infecciosas y microbiologia clinica, 1995, Volume: 13, Issue:2

    Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Humans; Penicillanic Acid; Piperacillin; Tazobactam

1995
Pharmacokinetics of tazobactam M1 metabolite after administration of piperacillin/tazobactam in subjects with renal impairment.
    Journal of clinical pharmacology, 1994, Volume: 34, Issue:12

    Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Penicillanic Acid; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Dialysis; Renal Insufficiency; Tazobactam

1994
Biliary elimination and hepatic disposition of an association of piperacillin and tazobactam: experimental evaluation.
    Drugs under experimental and clinical research, 1994, Volume: 20, Issue:6

    Topics: Animals; beta-Lactamase Inhibitors; Bile; Biotransformation; Chromatography, High Pressure Liquid; Drug Therapy, Combination; In Vitro Techniques; Liver; Penicillanic Acid; Perfusion; Piperacillin; Rabbits; Tazobactam

1994
Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
    American journal of hospital pharmacy, 1994, Sep-15, Volume: 51, Issue:18

    Topics: beta-Lactamase Inhibitors; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Humans; Penicillanic Acid; Pharmaceutical Vehicles; Piperacillin; Ranitidine; Sodium Chloride; Solutions; Tazobactam

1994
Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected beta-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteria. In Vitro Susceptibility Surveilla
    Diagnostic microbiology and infectious disease, 1994, Volume: 19, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Ciprofloxacin; Gram-Negative Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1994
[In vitro synergistic effects of tazobactam/piperacillin with various antibiotics].
    The Japanese journal of antibiotics, 1994, Volume: 47, Issue:10

    Topics: beta-Lactamase Inhibitors; Drug Synergism; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus; Tazobactam

1994
Inoculum effects on Etests and agar dilution minimum inhibitory concentrations. Piperacillin and piperacillin-tazobactam against Staphylococcus aureus.
    Diagnostic microbiology and infectious disease, 1994, Volume: 19, Issue:3

    Topics: Bacteriological Techniques; beta-Lactamase Inhibitors; beta-Lactamases; Colony Count, Microbial; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Staphylococcus aureus; Tazobactam

1994
The sensitivity of clinical isolates of anaerobic species to piperacillin-tazobactam and other antimicrobial agents.
    The Journal of antimicrobial chemotherapy, 1994, Volume: 34, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1994
[Single-dose toxicity studies of tazobactam/piperacillin and tazobactam].
    The Journal of toxicological sciences, 1994, Volume: 19 Suppl 2

    Topics: Animals; beta-Lactamase Inhibitors; Dogs; Drug Therapy, Combination; Female; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Penicillanic Acid; Piperacillin; Rats; Rats, Sprague-Dawley; Respiration; Tazobactam

1994
[A six-month intraperitoneal repeated dose toxicity study of tazobactam/piperacillin and tazobactam in rats].
    The Journal of toxicological sciences, 1994, Volume: 19 Suppl 2

    Topics: Animals; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Glycogen; Injections, Intraperitoneal; Male; Organ Size; Penicillanic Acid; Piperacillin; Rats; Rats, Sprague-Dawley; Tazobactam

1994
[A six-month intravenous repeated dose toxicity study of tazobactam/piperacillin and tazobactam in dogs].
    The Journal of toxicological sciences, 1994, Volume: 19 Suppl 2

    Topics: Animals; beta-Lactamase Inhibitors; Dogs; Drug Therapy, Combination; Female; Injections, Intravenous; Male; Penicillanic Acid; Piperacillin; Tazobactam

1994
[Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam(1)--Fertility and general reproduction study in rats with intraperitoneal administration].
    The Journal of toxicological sciences, 1994, Volume: 19 Suppl 2

    Topics: Animals; beta-Lactamase Inhibitors; Drug Therapy, Combination; Embryonic and Fetal Development; Female; Fertility; Injections, Intraperitoneal; Male; Penicillanic Acid; Piperacillin; Pregnancy; Rats; Rats, Sprague-Dawley; Reproduction; Tazobactam

1994
[Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam (2)--Teratological study in rats with intravenously administration].
    The Journal of toxicological sciences, 1994, Volume: 19 Suppl 2

    Topics: Abnormalities, Drug-Induced; Animals; Animals, Newborn; beta-Lactamase Inhibitors; Drug Therapy, Combination; Embryonic and Fetal Development; Female; Injections, Intravenous; Male; Penicillanic Acid; Piperacillin; Pregnancy; Rats; Rats, Sprague-Dawley; Reproduction; Tazobactam

1994
[Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam (3)--Perinatal and postnatal study in rats with intraperitoneal administration].
    The Journal of toxicological sciences, 1994, Volume: 19 Suppl 2

    Topics: Animals; Animals, Newborn; beta-Lactamase Inhibitors; Drug Therapy, Combination; Embryonic and Fetal Development; Female; Injections, Intraperitoneal; Male; Penicillanic Acid; Piperacillin; Pregnancy; Rats; Rats, Sprague-Dawley; Reproduction; Tazobactam

1994
[Antigenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
    The Journal of toxicological sciences, 1994, Volume: 19 Suppl 2

    Topics: Animals; Antigens; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Guinea Pigs; Humans; Immunization; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Passive Cutaneous Anaphylaxis; Penicillanic Acid; Piperacillin; Rats; Rats, Sprague-Dawley; Tazobactam

1994
[Mutagenicity tests of tazobactam/piperacillin, tazobactam and piperacillin].
    The Journal of toxicological sciences, 1994, Volume: 19 Suppl 2

    Topics: Animals; Cricetinae; Cricetulus; Drug Therapy, Combination; Escherichia coli; Male; Mice; Mice, Inbred ICR; Mutagenesis; Mutagenicity Tests; Penicillanic Acid; Piperacillin; Salmonella typhimurium; Tazobactam

1994
Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:10

    Topics: Bacteria; beta-Lactamase Inhibitors; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam

1994
Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:10

    Topics: Anti-Infective Agents; Bacteria, Anaerobic; Cefoxitin; Ciprofloxacin; Fluoroquinolones; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Penicillanic Acid; Piperacillin; Piperazines; Quinolones; Tazobactam

1994
In vivo efficacies of beta-lactam-beta-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:11

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Drug Therapy, Combination; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam

1994
Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, Pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test results.
    Diagnostic microbiology and infectious disease, 1994, Volume: 20, Issue:3

    Topics: Anti-Bacterial Agents; Ceftazidime; Clavulanic Acids; Enterobacteriaceae; Enterococcus faecalis; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillanic Acid; Piperacillin; Predictive Value of Tests; Pseudomonas aeruginosa; Staphylococcus; Tazobactam; Ticarcillin

1994
Stability of piperacillin sodium in the presence of tazobactam sodium in 5% dextrose and normal saline injections.
    Journal of clinical pharmacy and therapeutics, 1994, Volume: 19, Issue:6

    Topics: beta-Lactamase Inhibitors; Chromatography, High Pressure Liquid; Drug Interactions; Drug Stability; Glucose; Hydrogen-Ion Concentration; Penicillanic Acid; Piperacillin; Sodium Chloride; Tazobactam

1994
Use of a predictor panel to evaluate susceptibility test methods proposed for piperacillin-tazobactam.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:12

    Topics: beta-Lactamase Inhibitors; Drug Therapy, Combination; Evaluation Studies as Topic; Gram-Negative Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Predictive Value of Tests; Quality Control; Tazobactam

1993
Susceptibility of beta-lactamase-producing enterococci to piperacillin with tazobactam.
    Diagnostic microbiology and infectious disease, 1993, Volume: 17, Issue:3

    Topics: beta-Lactamase Inhibitors; Culture Media; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Piperacillin, Tazobactam Drug Combination; Streptomycin; Tazobactam

1993
Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella spp.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:1

    Topics: beta-Lactamase Inhibitors; Drug Synergism; Drug Therapy, Combination; Humans; Legionella; Legionellosis; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1994
Antibacterial activity of clavulanate and tazobactam on Peptostreptococcus spp.
    The Journal of antimicrobial chemotherapy, 1994, Volume: 33, Issue:2

    Topics: Amoxicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Peptostreptococcus; Piperacillin; Tazobactam

1994
Different ratios of the piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum beta-lactamase.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:2

    Topics: Animals; beta-Lactamase Inhibitors; beta-Lactamases; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Klebsiella Infections; Klebsiella pneumoniae; Meningitis, Bacterial; Penicillanic Acid; Piperacillin; Rabbits; Tazobactam

1994
In vitro extracellular and intracellular activities of clavulanic acid and those of piperacillin and ceftriaxone alone and in combination with tazobactam against clinical isolates of Legionella species.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:2

    Topics: Animals; Ceftriaxone; Cells, Cultured; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Therapy, Combination; Extracellular Space; Guinea Pigs; Intracellular Fluid; Legionella; Legionella pneumophila; Legionnaires' Disease; Macrophages, Alveolar; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1994
The activity of piperacillin/tazobactam against clinical isolates collected in 20 UK centres and the design of a disc test for susceptibility testing.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:1

    Topics: Bacteria, Aerobic; Bacterial Infections; beta-Lactamase Inhibitors; Culture Media; Diffusion; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam; United Kingdom

1993
Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:2

    Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Drug Combinations; Drug Therapy, Combination; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Spectinomycin; Tazobactam; Thienamycins; Virginiamycin

1993
Multicentre survey of the comparative in-vitro activity of piperacillin/tazobactam against bacteria from hospitalized patients in the British Isles.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:2

    Topics: Bacteria, Anaerobic; Drug Combinations; Drug Therapy, Combination; Enterococcus; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Reproducibility of Results; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; Tazobactam

1993
Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:9

    Topics: Adult; beta-Lactamase Inhibitors; Biological Assay; Chromatography, High Pressure Liquid; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Serum Bactericidal Test; Tazobactam; Ticarcillin

1993
Behaviour of beta-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other beta-lactam/beta-lactamase inhibitor combinations.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Drug Synergism; Drug Therapy, Combination; Enzyme Induction; Indicators and Reagents; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Staphylococcus aureus; Tazobactam

1993
Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A

    Topics: beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Tazobactam

1993
Therapy of soft tissue infections with piperacillin/tazobactam.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Risk Factors; Skin Diseases, Infectious; Tazobactam

1993
Susceptibility survey of piperacillin alone and in the presence of tazobactam.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A

    Topics: Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1993
Effect of piperacillin/tazobactam treatment on human bowel microflora.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A

    Topics: Adult; Aged; Aged, 80 and over; Bacteria; beta-Lactamase Inhibitors; Drug Therapy, Combination; Feces; Female; Humans; Intestines; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam

1993
Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections.
    The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam

1993
Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests.
    Journal of clinical microbiology, 1993, Volume: 31, Issue:3

    Topics: Ampicillin Resistance; beta-Lactamase Inhibitors; Dose-Response Relationship, Drug; Drug Combinations; Haemophilus influenzae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Quality Control; Tazobactam

1993
Breakpoint determination: piperacillin/tazobactam.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:7

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1993
Stability of piperacillin sodium-tazobactam sodium in peritoneal dialysis solutions.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Sep-15, Volume: 52, Issue:18

    Topics: beta-Lactamase Inhibitors; Dialysis Solutions; Drug Stability; Enzyme Inhibitors; Humans; Penicillanic Acid; Penicillins; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Tazobactam

1995
In vitro activity of piperacillin/tazobactam against recent clinical isolates from hospitalized patients in ten Belgian hospitals.
    Acta clinica Belgica, 1995, Volume: 50, Issue:5

    Topics: Bacteria; beta-Lactamase Inhibitors; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1995
Hypersensitivity reaction during prolonged use of piperacillin/tazobactam in treatment of osteomyelitis.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:9

    Topics: beta-Lactamase Inhibitors; Drug Hypersensitivity; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Middle Aged; Osteomyelitis; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1995
Chemical modification of tazobactam. Synthesis of 2 beta-[(4-substituted)-1,2,3-triazol-1-yl]methyl penicillanic acid sulfone derivatives.
    The Journal of antibiotics, 1995, Volume: 48, Issue:11

    Topics: Ampicillin; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Drug Synergism; Electrochemistry; Enzyme Inhibitors; Escherichia coli; Gram-Negative Bacteria; Klebsiella pneumoniae; Molecular Structure; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Structure-Activity Relationship; Tazobactam; Triazoles

1995
In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1996, Volume: 104, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Ceftazidime; Ciprofloxacin; Enzyme Inhibitors; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination; Xanthomonas

1996
Life-threatening neutropenia secondary to piperacillin/tazobactam therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:4

    Topics: Adult; Drug Therapy, Combination; Humans; Male; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1995
Comparative activity of piperacillin/tazobactam against 5625 isolates from hospitalised patients. Multicentre Study Group.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:2

    Topics: Bacteria; Belgium; beta-Lactamase Inhibitors; Drug Combinations; Drug Evaluation, Preclinical; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals; Humans; Luxembourg; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Quality Control; Tazobactam

1996
An evaluation of the in vitro activity of piperacillin/tazobactam.
    Pathology, 1996, Volume: 28, Issue:2

    Topics: Bacteroides fragilis; beta-Lactamase Inhibitors; Escherichia coli; Haemophilus influenzae; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus; Streptococcus pneumoniae; Tazobactam

1996
High-performance liquid chromatographic determination of tazobactam and piperacillin in human plasma and urine.
    Journal of chromatography. B, Biomedical applications, 1996, Jun-28, Volume: 682, Issue:1

    Topics: Chromatography, High Pressure Liquid; Circadian Rhythm; Drug Stability; Enzyme Inhibitors; Humans; Linear Models; Penicillanic Acid; Penicillins; Piperacillin; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tazobactam; Temperature

1996
Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:2

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Female; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia, Bacterial; Tazobactam; Ticarcillin

1996
A new time-kill method of assessing the relative efficacy of antimicrobial agents alone and in combination developed using a representative beta-lactam, aminoglycoside and fluoroquinolone.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:2

    Topics: Acinetobacter; Ciprofloxacin; Citrobacter freundii; Drug Therapy, Combination; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Models, Biological; Penicillanic Acid; Piperacillin; Serratia marcescens; Tazobactam

1996
Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.
    The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:3

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Piperacillin; Tazobactam

1996
Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:5

    Topics: Ampicillin; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Gastrointestinal Diseases; Gram-Positive Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam; Vancomycin

1996
Studies on penam sulfones. I. Synthesis and beta-lactamase inhibitory activity of 2 beta-alkoxycarbonyl penicillanic acid sulfones.
    The Journal of antibiotics, 1996, Volume: 49, Issue:9

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Drug Synergism; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Structure-Activity Relationship; Sulfones; Tazobactam

1996
Pharmacokinetics of piperacillin, tazobactam and its metabolite in renal impairment.
    International journal of clinical pharmacology and therapeutics, 1996, Volume: 34, Issue:11

    Topics: Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Half-Life; Humans; Kidney Diseases; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1996
Timed killing kinetic studies of the interaction between ciprofloxacin and beta-lactams against gram-negative bacilli.
    Diagnostic microbiology and infectious disease, 1996, Volume: 26, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Ceftazidime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Therapy, Combination; Enterobacter cloacae; Enzyme Inhibitors; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens; Tazobactam; Ticarcillin; Time Factors

1996
Reversible bone marrow depression by high-dose piperacillin/tazobactam.
    British journal of haematology, 1996, Volume: 95, Issue:4

    Topics: Adolescent; Body Weight; Bone Marrow Diseases; Drug Therapy, Combination; Female; Fever; Humans; Neutropenia; Pancytopenia; Penicillanic Acid; Piperacillin; Tazobactam; Weight Loss

1996
In-vitro pharmacodynamic studies of piperacillin/tazobactam with gentamicin and ciprofloxacin.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; beta-Lactamase Inhibitors; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Gentamicins; Kinetics; Macrolides; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

1997
Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.
    FEMS microbiology letters, 1997, Mar-01, Volume: 148, Issue:1

    Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Kinetics; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1997
Importance of beta-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: studies with piperacillin-tazobactam and piperacillin-sulbactam.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:4

    Topics: Bacteria; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli; Klebsiella; Microbial Sensitivity Tests; Models, Biological; Penicillanic Acid; Penicillins; Piperacillin; Sulbactam; Tazobactam

1997
An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:4

    Topics: Ampicillin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fibrin; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Nafcillin; Penicillanic Acid; Penicillins; Piperacillin; Staphylococcus aureus; Sulbactam; Tazobactam; Vancomycin

1997
Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:5

    Topics: Aged; Area Under Curve; Chromatography, High Pressure Liquid; Drug Combinations; Enzyme Inhibitors; Female; Half-Life; Humans; Hydrocephalus; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1997
Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:5

    Topics: Abdominal Abscess; Animals; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Enzyme Inhibitors; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Rats; Rats, Sprague-Dawley; Tazobactam

1997
Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF.
    Hematology and cell therapy, 1997, Volume: 39, Issue:2

    Topics: Adenocarcinoma; Adult; Amikacin; Colonic Neoplasms; DNA, Viral; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Liver Neoplasms; Neutropenia; Parvoviridae Infections; Parvovirus B19, Human; Pefloxacin; Penicillanic Acid; Piperacillin; Recombinant Proteins; Tazobactam

1997
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:2

    Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections

1997
Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl B

    Topics: Anti-Infective Agents; Bacteroides; Bacteroides fragilis; Cefoxitin; Ciprofloxacin; Clostridium perfringens; Fluoroquinolones; Fusobacterium; Gram-Negative Anaerobic Bacteria; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Penicillanic Acid; Peptostreptococcus; Piperacillin; Prevotella melaninogenica; Quinolones; Tazobactam

1997
Assessment of biliary excretion of piperacillin-tazobactam in humans.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:8

    Topics: Adult; beta-Lactamase Inhibitors; Bile; Cholecystectomy; Drainage; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1997
Mechanism of suppression of piperacillin resistance in enterobacteria by tazobactam.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:10

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Chromatography, High Pressure Liquid; Citrobacter freundii; Enterobacter cloacae; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Mutation; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Plasmids; Tazobactam

1997
Potentiation of beta-lactams against Pseudomonas aeruginosa strains by Ro 48-1256, a bridged monobactam inhibitor of AmpC beta-lactamases.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 40, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Drug Synergism; Enzyme Inhibitors; Imipenem; Meropenem; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Piperacillin; Porins; Pseudomonas aeruginosa; Tazobactam; Thienamycins

1997
High rates of resistance to piperacillin/tazobactam among Escherichia coli and Klebsiella pneumoniae strains isolated in a Greek hospital.
    Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:1

    Topics: Enzyme Inhibitors; Escherichia coli; Greece; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Tazobactam

1997
Pharmacokinetic-pharmacodynamic modelling of the in vitro antiinfective effect of piperacillin-tazobactam combinations.
    International journal of clinical pharmacology and therapeutics, 1997, Volume: 35, Issue:10

    Topics: beta-Lactamase Inhibitors; Colony-Forming Units Assay; Computer Simulation; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Humans; Models, Biological; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1997
Comparative in vitro evaluation of piperacillin/tazobactam in a tertiary care hospital.
    Journal of chemotherapy (Florence, Italy), 1997, Volume: 9, Issue:5

    Topics: Amoxicillin; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Tazobactam

1997
Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
    American journal of perinatology, 1998, Volume: 15, Issue:1

    Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; Cilastatin; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Imipenem; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Protease Inhibitors; Retrospective Studies; Tazobactam; Thienamycins

1998
Piperacillin/tazobactam therapy for diabetic foot infection.
    Foot & ankle international, 1998, Volume: 19, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Diabetic Foot; Drug Combinations; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Staphylococcal Infections; Tazobactam

1998
In-vitro activity of piperacillin and tazobactam combination against clinically significant bacteria.
    East African medical journal, 1998, Volume: 75, Issue:3

    Topics: beta-Lactamase Inhibitors; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Zimbabwe

1998
Susceptibility survey of piperacillin/tazobactam and some beta-lactam comparators in Italy.
    Drugs under experimental and clinical research, 1998, Volume: 24, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cross Infection; Enzyme Inhibitors; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Humans; Italy; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

1998
Carbapenemase-producing Pseudomonas aeruginosa in UK.
    Lancet (London, England), 1998, Aug-15, Volume: 352, Issue:9127

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Enzyme Inhibitors; Gentamicins; Humans; Imipenem; Meropenem; Metalloproteins; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; United Kingdom

1998
[Transferability of tazobactam/piperacillin (TAZ/PIPC) to cerebrospinal fluid of rabbit with meningitis caused by Staphylococcus aureus].
    The Japanese journal of antibiotics, 1998, Volume: 51, Issue:6

    Topics: Animals; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Meningitis, Bacterial; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Rabbits; Staphylococcal Infections; Tazobactam; Time Factors

1998
[A three-dimensional model for in vitro study of the association of three antibiotics. Application to the activity of piperacillin, tazobactam and amikacin against five strains of enterobacteria as a function of their phenotype of beta-lactam resistance].
    Pathologie-biologie, 1998, Volume: 46, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Inhibitors; Microbial Sensitivity Tests; Models, Biological; Penicillanic Acid; Penicillins; Phenotype; Piperacillin; Tazobactam

1998
Immune thrombocytopenia caused by piperacillin/tazobactam.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 27, Issue:3

    Topics: Aged; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Thrombocytopenia

1998
[A national multicenter study of the in-vitro activity of piperacillin-tazobactam. The Spanish Piperacillin-Tazobactam Group].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 1998, Volume: 11, Issue:2

    Topics: Bacteria; beta-Lactamase Inhibitors; Chi-Square Distribution; Drug Combinations; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Spain; Tazobactam

1998
[Evaluation of in vitro susceptibility of hospital bacterial isolates to piperacillin and tazocin (piperacillin/tazobactam].
    Medycyna doswiadczalna i mikrobiologia, 1998, Volume: 50, Issue:1-2

    Topics: beta-Lactamase Inhibitors; Body Fluids; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Species Specificity; Tazobactam

1998
A hospital outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
    The Journal of hospital infection, 1999, Volume: 41, Issue:1

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple; Enzyme Inhibitors; Humans; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Penicillin Resistance; Piperacillin; Tazobactam

1999
Determination of free interstitial concentrations of piperacillin-tazobactam combinations by microdialysis.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:6

    Topics: Animals; Area Under Curve; Chromatography, High Pressure Liquid; Drug Interactions; Drug Therapy, Combination; Extracellular Space; Male; Microdialysis; Penicillanic Acid; Penicillins; Piperacillin; Rats; Rats, Wistar; Tazobactam; Tissue Distribution

1998
Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:4

    Topics: Anti-Bacterial Agents; Cephalosporinase; Clavulanic Acid; Enzyme Induction; Enzyme Inhibitors; Genes, Bacterial; Humans; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Ticarcillin

1999
Piperacillin and tazobactam exhibit linear pharmacokinetics after multiple standard clinical doses.
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:6

    Topics: Drug Therapy, Combination; Humans; Male; Metabolic Clearance Rate; Penicillanic Acid; Piperacillin; Tazobactam

1999
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:1

    Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoxitin; Ceftizoxime; Chloramphenicol; Clavulanic Acid; Clindamycin; Drug Therapy, Combination; Enzyme Inhibitors; Imipenem; Metronidazole; Mezlocillin; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Species Specificity; Sulbactam; Tazobactam; Thienamycins; Ticarcillin

1999
Comparison of five beta-lactam antibiotics against common nosocomial pathogens using the time above MIC at different creatinine clearances.
    Pharmacotherapy, 1999, Volume: 19, Issue:12

    Topics: Anti-Bacterial Agents; Bacteria; Cefepime; Ceftazidime; Cephalosporins; Creatinine; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Models, Biological; Penicillanic Acid; Piperacillin; Tazobactam; Time Factors

1999
Effect of conalbumin on the activity of Syn 2190, a 1,5 dihydroxy-4-pyridon monobactam inhibitor of AmpC beta-lactamases.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:1

    Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Conalbumin; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enzyme Inhibitors; Escherichia coli; Iron Chelating Agents; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam

2000
High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:2

    Topics: Bacterial Outer Membrane Proteins; Base Sequence; beta-Lactamases; Biological Transport; Ceftazidime; Cephalosporins; Chromosomes; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Microbial; Enzyme Inhibitors; Gene Expression Regulation, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleic Acid Hybridization; Penicillanic Acid; Penicillins; Piperacillin; Promoter Regions, Genetic; Sequence Homology, Nucleic Acid; Tazobactam

2000
Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2000, Volume: 4, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam; Ticarcillin

2000
[Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood stem cell transplantation for breast cancer].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2000, Volume: 13, Issue:2

    Topics: Amikacin; Antineoplastic Agents; Breast Neoplasms; Drug Costs; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Neutropenia; Penicillanic Acid; Piperacillin; Spain; Tazobactam; Teicoplanin; Transplantation Conditioning; Treatment Failure; Treatment Outcome; Vancomycin

2000
Control of glycopeptide-resistant enterococci in an oncology unit.
    Pharmacotherapy, 2000, Volume: 20, Issue:9 Pt 2

    Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fever; Glycopeptides; Humans; Infection Control; Neoplasms; Neutropenia; Oncology Service, Hospital; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome

2000
Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill.
    Diagnostic microbiology and infectious disease, 2000, Volume: 38, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Chi-Square Distribution; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Fluoroquinolones; Humans; Naphthyridines; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2000
Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit.
    Shock (Augusta, Ga.), 2000, Volume: 14, Issue:3

    Topics: Burn Units; Cephalosporins; Clinical Protocols; Cross Infection; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin; Vancomycin Resistance; Wounds and Injuries

2000
Possible role of cellular immunity: a case of cellulitis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Volume: 32, Issue:1

    Topics: Cellulitis; Clindamycin; Drug Eruptions; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hypersensitivity, Delayed; Middle Aged; Nafcillin; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Vancomycin

2001
Emergence of piperacillin/tazobactam-resistant Escherichia coli.
    Intensive care medicine, 2000, Volume: 26, Issue:10

    Topics: beta-Lactamase Inhibitors; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli Infections; France; Humans; Infection Control; Intensive Care Units; Patient Selection; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

2000
Eradication of a resistant Pseudomonas aeruginosa strain after a cluster of infections in a hematology/oncology unit.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2000, Volume: 6, Issue:3

    Topics: Bacteremia; Cross Infection; Drug Resistance, Multiple; Enzyme Inhibitors; Hospitals, General; Humans; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; Oncology Service, Hospital; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sanitary Engineering; Scotland; Species Specificity; Sputum; Tazobactam

2000
Thermophilic multidrug-resistant Campylobacter fetus infection with hypersplenism and histiocytic phagocytosis in a patient with acquired immunodeficiency syndrome.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Jan-15, Volume: 32, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Ceftazidime; Cephalosporins; Diarrhea; Drug Resistance, Microbial; Enzyme Inhibitors; Erythromycin; Histiocytes; Histiocytosis; Humans; Hypersplenism; Male; Penicillanic Acid; Penicillins; Phagocytosis; Piperacillin; Quinolones; Splenic Infarction; Splenomegaly; Tazobactam

2001
Systemic antibiotics fail to clear multidrug-resistant Klebsiella from a pediatric ICU.
    Chest, 2001, Volume: 119, Issue:3

    Topics: Amikacin; beta-Lactamase Inhibitors; Cohort Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Klebsiella; Klebsiella Infections; Male; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

2001
Faecal concentrations of piperacillin and tazobactam in elderly patients.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:1

    Topics: Aged; Aged, 80 and over; Clostridioides difficile; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Feces; Female; Humans; Male; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

2001
Conjugative resistance to tazobactam plus piperacillin among extended-spectrum beta-lactamase-producing nosocomial Klebsiella pneumoniae.
    Scandinavian journal of infectious diseases, 2001, Volume: 33, Issue:7

    Topics: Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cross Infection; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Penicillanic Acid; Penicillins; Piperacillin; Polymerase Chain Reaction; Tazobactam; Turkey

2001
An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone.
    Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Disease Susceptibility; Female; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam

2001
Molecular epidemiology of antibiotic-resistant gram-negative bacilli in a neonatal intensive care unit during a nonoutbreak period.
    Pediatrics, 2001, Volume: 108, Issue:5

    Topics: Anti-Bacterial Agents; Ceftazidime; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Gentamicins; Gram-Negative Bacteria; Humans; Intensive Care Units, Neonatal; Molecular Epidemiology; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

2001
Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Chromosomes, Bacterial; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Inhibitors; Escherichia coli; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

2001
Elimination of the piperacillin/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:6

    Topics: Acute Kidney Injury; Adult; Aged; Analysis of Variance; Drug Therapy, Combination; Enzyme Inhibitors; Female; Hemodiafiltration; Hemofiltration; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

2001
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies.
    Clinical transplantation, 2001, Volume: 15, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage; Ciprofloxacin; Female; Heart Transplantation; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Nocardia; Nocardia Infections; Penicillanic Acid; Piperacillin; Postoperative Complications; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination

2001
Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:3

    Topics: Adult; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas Infections; Regression Analysis; Risk Factors; Tazobactam

2002
[In vitro interaction of tazobactam/piperacillin combined with aminoglycosides against Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli AND Staphylococcus aureus].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Drug Antagonism; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam

2002
Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of piperacillin and tazobactam in tazocin injectable powder.
    Journal of pharmaceutical and biomedical analysis, 2002, Jul-31, Volume: 29, Issue:5

    Topics: Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Particle Size; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Powders; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tazobactam

2002
New and rapid fully automated method for determination of tazobactam and piperacillin in fatty tissue and serum by column-switching liquid chromatography.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2002, Aug-05, Volume: 775, Issue:2

    Topics: Adipose Tissue; Automation; Chromatography, High Pressure Liquid; Humans; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Tazobactam

2002
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
    Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:3

    Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins

2002
Infecting one animal with two different strains of the same bacteria may cause misleading results.
    Chemotherapy, 2002, Volume: 48, Issue:3

    Topics: Abscess; Animals; Disease Models, Animal; Enzyme Inhibitors; Hindlimb; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Reproducibility of Results; Tazobactam

2002
Successful medical management of emphysematous pyelonephritis.
    The American journal of medicine, 2002, Aug-15, Volume: 113, Issue:3

    Topics: Adult; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Emphysema; Female; Follow-Up Studies; Humans; Insulin; Magnetic Resonance Imaging; Penicillanic Acid; Piperacillin; Pyelonephritis; Tazobactam; Tomography, X-Ray Computed; Treatment Outcome

2002
Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.
    Diagnostic microbiology and infectious disease, 2002, Volume: 44, Issue:1

    Topics: Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sensitivity and Specificity; Tazobactam

2002
Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysis.
    Diagnostic microbiology and infectious disease, 2002, Volume: 44, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Biological Availability; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Severity of Illness Index; Tazobactam; Treatment Outcome

2002
Morganella morganii causing solitary liver abscess complicated by pyopericardium and left pleural effusion in a nondiabetic patient.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2002, Volume: 35, Issue:3

    Topics: Diabetes Mellitus; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Humans; Leukocyte Count; Liver Abscess; Middle Aged; Morganella morganii; Penicillanic Acid; Pericardium; Piperacillin; Pleural Effusion; Radiography; Suppuration; Tazobactam

2002
Piperacillin/Tazobactam inducing seizures in a hemodialysed patient.
    Clinical nephrology, 2002, Volume: 58, Issue:4

    Topics: Enzyme Inhibitors; Female; Humans; Kidney Failure, Chronic; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Renal Dialysis; Seizures; Tazobactam; Treatment Failure

2002
Efficacy and tolerability of prophylactic treatment with intravenous piperacillin/tazobactam in patients undergoing hematopoietic stem cell transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2002, Volume: 4, Issue:3

    Topics: Adolescent; Adult; Antibiotic Prophylaxis; Bacterial Infections; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Penicillanic Acid; Pilot Projects; Piperacillin; Tazobactam; Transplantation, Autologous; Transplantation, Homologous

2002
Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors.
    Journal of vascular and interventional radiology : JVIR, 2002, Volume: 13, Issue:11

    Topics: Adenocarcinoma; Aged; Antibiotic Prophylaxis; Carcinoma, Neuroendocrine; Cephalexin; Chemoembolization, Therapeutic; Humans; Liver Abscess; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam

2002
Postoperative infection with group A beta-hemolytic Streptococcus after blepharoplasty.
    American journal of ophthalmology, 2002, Volume: 134, Issue:6

    Topics: Blepharoplasty; Combined Modality Therapy; Debridement; Drug Therapy, Combination; Eye Infections, Bacterial; Eyelid Diseases; Fasciitis, Necrotizing; Female; Humans; Hyperbaric Oxygenation; Middle Aged; Penicillanic Acid; Piperacillin; Postoperative Complications; Rhytidoplasty; Streptococcus pyogenes; Tazobactam

2002
Sciatic nerve palsy as presenting sign of a perianal abscess.
    Joint bone spine, 2003, Volume: 70, Issue:1

    Topics: Abscess; Anus Diseases; Diagnosis, Differential; Drainage; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Sciatic Neuropathy; Tazobactam; Treatment Outcome

2003
[Initial empirical antimicrobial therapy with piperacillin/tazobactam in intra-abdominal infections due to perforation of the large intestine and rectum and in postoperative complications after resection of the large intestine and rectum].
    Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti, 2002, Volume: 81, Issue:12

    Topics: Abdominal Abscess; Adult; Aged; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Intestinal Perforation; Intestine, Large; Male; Middle Aged; Penicillanic Acid; Penicillins; Peritonitis; Piperacillin; Postoperative Complications; Rectal Diseases; Retrospective Studies; Surgical Wound Dehiscence; Tazobactam

2002
Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical study.
    Intensive care medicine, 2003, Volume: 29, Issue:7

    Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Escherichia coli; France; Humans; Intensive Care Units; Penicillanic Acid; Piperacillin; Prospective Studies; Risk Factors; Tazobactam

2003
Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.
    British journal of clinical pharmacology, 2003, Volume: 55, Issue:6

    Topics: Adult; Aged; Area Under Curve; Enzyme Inhibitors; Female; Humans; Lung; Male; Microdialysis; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia; Sepsis; Tazobactam

2003
Thrombocytosis under ciprofloxacin and tazobactam/piperacillin.
    Platelets, 2003, Volume: 14, Issue:5

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Platelet Count; Pneumonia, Bacterial; Tazobactam; Thrombocytosis

2003
[Pharmacokinetics of antibiotics in inflamed and healthy lung tissue].
    Wiener medizinische Wochenschrift (1946), 2003, Volume: 153, Issue:15-16

    Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Empyema, Pleural; Extracellular Space; Humans; Lung; Microbial Sensitivity Tests; Microdialysis; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Tazobactam; Thoracotomy

2003
Intracameral antibiotic agents for endophthalmitis prophylaxis: a pharmacokinetic model.
    Journal of cataract and refractive surgery, 2003, Volume: 29, Issue:9

    Topics: Anti-Bacterial Agents; Endophthalmitis; Enzyme Inhibitors; Eye; Half-Life; Humans; Methicillin Resistance; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin

2003
Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.
    Diagnostic microbiology and infectious disease, 2003, Volume: 47, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Argentina; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Tazobactam

2003
[Candida parapsilosis endocarditis after prolonged antibiotic therapy].
    Revista espanola de anestesiologia y reanimacion, 2002, Volume: 49, Issue:4

    Topics: Candida; Candidiasis; Cardiac Tamponade; Cefazolin; Disease Susceptibility; Drug Therapy, Combination; Endocarditis; Fatal Outcome; Humans; Ischemia; Leg; Male; Middle Aged; Opportunistic Infections; Penicillanic Acid; Piperacillin; Postoperative Complications; Superinfection; Tazobactam

2002
Nosocomial bacteremia and catheter infection by Bacillus cereus in an immunocompetent patient.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:9

    Topics: Aged; Bacillaceae Infections; Bacillus cereus; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Cross Infection; Digestive System Surgical Procedures; Drug Therapy, Combination; Humans; Immunocompetence; Male; Penicillanic Acid; Piperacillin; Tazobactam

2003
False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam.
    The New England journal of medicine, 2003, Dec-11, Volume: 349, Issue:24

    Topics: Antigens, Fungal; Aspergillosis; Aspergillus; beta-Lactamase Inhibitors; Cross Reactions; Drug Therapy, Combination; False Positive Reactions; Galactose; Humans; Mannans; Penicillanic Acid; Piperacillin; Tazobactam

2003
[Thoracic wall crossing (pseudo-?) tumor in a child: abscess-forming thoracic actinomycosis caused by Actinomyces meyeri et israeli].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2004, Volume: 176, Issue:1

    Topics: Actinomyces; Actinomycosis; Anti-Infective Agents; beta-Lactamase Inhibitors; Child; Clindamycin; Diagnosis, Differential; Enzyme Inhibitors; Female; Humans; Lung Abscess; Penicillanic Acid; Piperacillin; Radiography, Thoracic; Tazobactam; Thoracic Diseases; Thoracic Wall; Tomography, X-Ray Computed; Ultrasonography

2004
Increase in the rate of nosocomial Clostridium difficile-associated diarrhoea during shortages of piperacillin-tazobactam and piperacillin.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:3

    Topics: Clostridioides difficile; Cross Infection; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; United States

2004
Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Colony Count, Microbial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Moxifloxacin; Penicillanic Acid; Penicillins; Piperacillin; Quinolines; Tazobactam

2004
In vitro antimicrobial activity of doripenem, a new carbapenem.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:4

    Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Cephalosporins; Doripenem; Drug Therapy, Combination; Enterobacteriaceae; Gram-Positive Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Tazobactam

2004
Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.
    Chemotherapy, 2004, Volume: 50, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam

2004
Piperacillin/tazobactam-induced acute delirium in a peritoneal dialysis patient.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Infections; Confusion; Delirium; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Hallucinations; Humans; Kidney Failure, Chronic; Male; Middle Aged; Penicillanic Acid; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Tazobactam

2004
Comparative study of the effects of ceftizoxime, piperacillin, and piperacillin-tazobactam concentrations on antibacterial activity and selection of antibiotic-resistant mutants of Enterobacter cloacae and Bacteroides fragilis in vitro and in vivo in mixe
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5

    Topics: Abscess; Animals; Bacteroides fragilis; Ceftizoxime; Cephalosporins; Colony Count, Microbial; Drug Resistance; Enterobacter cloacae; Enzyme Inhibitors; Female; Mice; Mice, Inbred BALB C; Mutation; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

2004
Impact of tazobactam pharmacokinetics on the antimicrobial effect of piperacillin-tazobactam combinations.
    International journal of antimicrobial agents, 2004, Volume: 23, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamases; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Humans; Mathematics; Models, Biological; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome

2004
In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae.
    Diagnostic microbiology and infectious disease, 2004, Volume: 49, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Culture Media, Conditioned; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Tazobactam; Thienamycins

2004
[Pyogenic sacroiliitis complicated by iliopsoas muscle abscess].
    Recenti progressi in medicina, 2004, Volume: 95, Issue:3

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Arthritis, Infectious; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Penicillanic Acid; Piperacillin; Psoas Abscess; Sacroiliac Joint; Streptococcal Infections; Streptococcus; Suppuration; Tazobactam; Time Factors

2004
Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6

    Topics: Antigens, Fungal; Aspergillus; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Galactose; Mannans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

2004
Effect of the increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centers.
    Infection control and hospital epidemiology, 2004, Volume: 25, Issue:5

    Topics: Academic Medical Centers; Anti-Bacterial Agents; Enterococcus; Humans; Ohio; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin Resistance

2004
Safety evaluation of piperacillin/tazobactam in very low birth weight infants.
    Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:2

    Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Therapy, Combination; Enterocolitis, Necrotizing; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Infant, Very Low Birth Weight; Male; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome

2004
In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 54, Issue:2

    Topics: Azepines; Bacteria; beta-Lactamases; Ceftazidime; Cephalosporins; Clavulanic Acid; Dealkylation; Enzyme Inhibitors; Escherichia coli; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Staphylococcus aureus; Sulfuric Acid Esters; Tazobactam

2004
Effect of subinhibitory concentration of piperacillin/tazobactam on Pseudomonas aeruginosa.
    Journal of medical microbiology, 2004, Volume: 53, Issue:Pt 9

    Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Humans; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Oxidative Stress; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Surface Properties; Tazobactam

2004
Simultaneous analysis of piperacillin and tazobactam in rabbits: application to pharmacokinetic study.
    Biomedical chromatography : BMC, 2005, Volume: 19, Issue:1

    Topics: Animals; Body Fluids; Diffusion Chambers, Culture; Female; Penicillanic Acid; Piperacillin; Rabbits; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tazobactam

2005
Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration.
    Journal of clinical pharmacology, 2005, Volume: 45, Issue:2

    Topics: Aged; Area Under Curve; Chromatography, High Pressure Liquid; Critical Care; Drug Therapy, Combination; Female; Half-Life; Hemofiltration; Humans; Inpatients; Intensive Care Units; Kidney; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Time Factors

2005
A comparison of intravitreal piperacillin/tazobactam with ceftazidime in experimental Pseudomonas aeruginosa endophthalmitis.
    Experimental eye research, 2005, Volume: 80, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Colony Count, Microbial; Drug Therapy, Combination; Endophthalmitis; Enzyme Inhibitors; Eye Infections, Bacterial; Female; Injections; Male; Penicillanic Acid; Piperacillin; Pseudomonas Infections; Rabbits; Retina; Tazobactam; Treatment Outcome; Vitreous Body

2005
[Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens].
    Medycyna doswiadczalna i mikrobiologia, 2004, Volume: 56, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; Ticarcillin

2004
Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC.
    Biomedical chromatography : BMC, 2005, Volume: 19, Issue:8

    Topics: Anti-Bacterial Agents; Calibration; Chromatography, High Pressure Liquid; Hemofiltration; Humans; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Tazobactam; Ultrafiltration

2005
Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:6

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Cytotoxins; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Intestines; Penicillanic Acid; Piperacillin; Spores, Bacterial; Tazobactam

2005
The efficacy of piperacillin/tazobactam in experimental Pseudomonas aeruginosa endophthalmitis: a histopathological and microbiological evaluation.
    Current eye research, 2005, Volume: 30, Issue:1

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Male; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Tazobactam; Treatment Outcome; Vitreous Body

2005
Pseudomonal sepsis with subcutaneous nodules in an HIV-infected individual with high CD4 counts.
    The Journal of infection, 2005, Volume: 51, Issue:5

    Topics: Anti-Bacterial Agents; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Gentamicins; Glucocorticoids; HIV Infections; Humans; Lymphocyte Count; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Disease, Chronic Obstructive; Respiration, Artificial; Sepsis; Skin Diseases; Tazobactam; Treatment Outcome

2005
Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    The Israel Medical Association journal : IMAJ, 2005, Volume: 7, Issue:5

    Topics: Adult; Amikacin; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Child; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Inhibitors; Escherichia coli; Humans; In Vitro Techniques; Israel; Klebsiella pneumoniae; Microbial Sensitivity Tests; Odds Ratio; Penicillanic Acid; Piperacillin; Prevalence; Tazobactam

2005
[Preliminary study on the release of DNA from Pseudomona aeruginosa induced by piperacillin/tazobactam in vitro].
    Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns, 2005, Volume: 21, Issue:2

    Topics: Anti-Bacterial Agents; DNA, Bacterial; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam

2005
Severe intra-abdominal infection due to Streptococcus Milleri following adjustable gastric banding.
    Obesity surgery, 2005, Volume: 15, Issue:4

    Topics: Abdominal Abscess; Body Mass Index; Combined Modality Therapy; Device Removal; Drainage; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Balloon; Gastroplasty; Humans; Middle Aged; Obesity, Morbid; Penicillanic Acid; Piperacillin; Postoperative Complications; Severity of Illness Index; Streptococcal Infections; Streptococcus milleri Group; Tazobactam

2005
Shelf lives of aseptically prepared medicines--stability of piperacillin/tazobactam in PVC and non-PVC bags.
    Journal of pharmaceutical and biomedical analysis, 2005, Sep-01, Volume: 39, Issue:1-2

    Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Stability; Penicillanic Acid; Piperacillin; Polyvinyl Chloride; Tazobactam

2005
Penetration of piperacillin and tazobactam into inflamed soft tissue of patients with diabetic foot infection.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Diabetic Foot; Extracellular Fluid; Female; Humans; Inflammation; Male; Microdialysis; Middle Aged; Penicillanic Acid; Piperacillin; Soft Tissue Infections; Tazobactam

2005
Group C streptococcal sepsis complicating Fournier gangrene.
    Southern medical journal, 2005, Volume: 98, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Debridement; Diabetes Mellitus, Type 2; Drug Combinations; Fournier Gangrene; Humans; Male; Penicillanic Acid; Perineum; Piperacillin; Scrotum; Sepsis; Streptococcal Infections; Tazobactam

2005
Fever, pulmonary haemorrhage, and acute renal failure in a young girl.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2005, Volume: 11, Issue:5

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Diagnosis, Differential; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hemorrhage; Humans; Lung Diseases; Multiple Organ Failure; Penicillanic Acid; Piperacillin; Tazobactam; Weil Disease

2005
Orally administered recombinant metallo-beta-lactamase preserves colonization resistance of piperacillin-tazobactam-treated mice.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:12

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacteria; beta-Lactam Resistance; beta-Lactamases; Drug Synergism; Mice; Penicillanic Acid; Piperacillin; Tazobactam

2005
In vitro evaluation of new beta-lactamase inhibitor: YTR830H and derivatives.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl

    Topics: Anti-Bacterial Agents; Bacteria; Drug Combinations; Enzyme Inhibitors; Morganella; Penicillanic Acid; Piperacillin; Structure-Activity Relationship; Tazobactam

1989
Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Gastric Juice; Hydrogen-Ion Concentration; Mice; Microbial Sensitivity Tests; Mucins; Penicillanic Acid; Piperacillin; Swine; Tazobactam

1989
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl

    Topics: Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acid; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam

1989
Pharmacokinetics of YTR830H and piperacillin after intravenous coadministration.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl

    Topics: Adolescent; Adult; Area Under Curve; Drug Combinations; Enzyme Inhibitors; Humans; Infusions, Intravenous; Kinetics; Metabolic Clearance Rate; Penicillanic Acid; Piperacillin; Reference Values; Tazobactam

1989
Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function.
    Neurology, 2005, Dec-13, Volume: 65, Issue:11

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Brain; Cefepime; Cefixime; Cephalosporins; Confusion; Consciousness Disorders; Delirium; Epididymitis; Humans; Kidney; Male; Metabolic Clearance Rate; Neurotoxicity Syndromes; Penicillanic Acid; Piperacillin; Recovery of Function; Secondary Prevention; Systemic Inflammatory Response Syndrome; Tazobactam; Urinary Tract Infections; Withholding Treatment

2005
Efficiency of tazobactam/piperacillin in lethal peritonitis is enhanced after preconditioning of rats with O3/O2-pneumoperitoneum.
    Shock (Augusta, Ga.), 2006, Volume: 25, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Interleukin-1; Male; Ozone; Penicillanic Acid; Peritonitis; Piperacillin; Pneumoperitoneum; Rats; Rats, Wistar; Tazobactam; Tumor Necrosis Factor-alpha

2006
Detection of bacterial strains producing sulbactam- or tazobactam-sensitive beta-lactamases by the use of disks containing the inhibitors alone instead of combining them with antibiotics.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2006, Volume: 114, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Enterobacteriaceae; Enzyme Inhibitors; Klebsiella pneumoniae; Microbial Sensitivity Tests; Morganella morganii; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam

2006
Piperacillin/tazobactam in treatment of brain abscess.
    Scandinavian journal of infectious diseases, 2006, Volume: 38, Issue:3

    Topics: Anti-Bacterial Agents; Basal Ganglia; Brain Abscess; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Radiography; Tazobactam; Treatment Outcome

2006
Picture of the month. Infected urachal cyst.
    Archives of pediatrics & adolescent medicine, 2006, Volume: 160, Issue:3

    Topics: Anti-Bacterial Agents; Combined Modality Therapy; Diagnosis, Differential; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Infant; Male; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Ultrasonography; Umbilicus; Urachal Cyst

2006
In-vitro evaluation of "piperacillin and tazobactum" combination in a tertiary-care hospital--a preliminary study.
    Indian journal of pathology & microbiology, 2006, Volume: 49, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

2006
Elimination of piperacillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemofilters: evaluation of the sieving coefficient.
    Blood purification, 2006, Volume: 24, Issue:4

    Topics: Acrylic Resins; Acrylonitrile; Anti-Bacterial Agents; Biocompatible Materials; Critical Care; Drug Therapy, Combination; Hemofiltration; Humans; In Vitro Techniques; Membranes, Artificial; Penicillanic Acid; Piperacillin; Polymers; Statistics, Nonparametric; Sulfones; Tazobactam

2006
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins

2006
Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats.
    Critical care medicine, 2006, Volume: 34, Issue:9

    Topics: Amphibian Proteins; Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacteremia; Bacterial Translocation; beta-Lactamase Inhibitors; Bile Ducts; Endotoxins; Enterococcus faecalis; Enzyme Inhibitors; Escherichia coli; Jaundice, Obstructive; Ligation; Liver; Lymph Nodes; Magainins; Male; Penicillanic Acid; Peptides; Peritoneum; Piperacillin; Prospective Studies; Random Allocation; Rats; Rats, Wistar; Tazobactam; Tumor Necrosis Factor-alpha; Xenopus Proteins

2006
In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:2

    Topics: Bacteria; Cefoperazone; Drug Combinations; Humans; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam

2007
Can the ravages of uncontrolled systemic inflammatory response be regulated by amphibian antimicrobial peptides?
    Critical care medicine, 2006, Volume: 34, Issue:9

    Topics: Amphibian Proteins; Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Translocation; Bile Ducts; Disease Models, Animal; Endotoxins; Jaundice, Obstructive; Magainins; Penicillanic Acid; Peptides; Piperacillin; Rats; Tazobactam; Xenopus Proteins

2006
Influence of culture site-specific MIC distributions on the pharmacokinetic and pharmacodynamic properties of piperacillin/tazobactam and piperacillin: a data analysis.
    Clinical therapeutics, 2006, Volume: 28, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Infections; Data Interpretation, Statistical; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2006
[Hepatic abscess due to Klebsiella pneumoniae in an Asian immigrant].
    Enfermedades infecciosas y microbiologia clinica, 2006, Volume: 24, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Biliary Fistula; China; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Combined Modality Therapy; Diagnosis, Differential; Drainage; Duodenal Diseases; Emigration and Immigration; Hepatitis; Humans; Intestinal Fistula; Jaundice, Obstructive; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Male; Penicillanic Acid; Piperacillin; Spain; Sphincterotomy, Endoscopic; Tazobactam

2006
[Peritonsillar abscess: a life threatening disease--diagnostic and therapeutic aspects].
    Laryngo- rhino- otologie, 2007, Volume: 86, Issue:5

    Topics: Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Male; Mediastinitis; Multiple Organ Failure; Penicillanic Acid; Peritonsillar Abscess; Piperacillin; Radiography, Thoracic; Shock, Septic; Tazobactam; Tobramycin; Tomography, X-Ray Computed; Tonsillectomy

2007
Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospita
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli; Greece; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Prospective Studies; Tazobactam; Time Factors

2007
Experience with the use of piperacillin-tazobactam in pediatric non-renal solid organ transplantation.
    Pediatric transplantation, 2007, Volume: 11, Issue:1

    Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Mycoses; Organ Transplantation; Penicillanic Acid; Piperacillin; Tazobactam

2007
An improved high-performance liquid chromatographic method with a solid-phase extraction for the determination of piperacillin and tazobactam: application to pharmacokinetic study of different dosage in Chinese healthy volunteers.
    Biomedical chromatography : BMC, 2007, Volume: 21, Issue:7

    Topics: Anti-Bacterial Agents; China; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Humans; Penicillanic Acid; Piperacillin; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tazobactam

2007
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
    Hawaii medical journal, 2007, Volume: 66, Issue:3

    Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole

2007
In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Ceftriaxone; Drug Combinations; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam

2007
[Infection with Aeromonas hydrophila after use of leeches (Hirudo medicinalis) in a free microvascular osteo-(myo-)cutaneous flap--suggestions for successful management].
    Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V..., 2007, Volume: 39, Issue:2

    Topics: Adult; Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Drug Therapy, Combination; Follow-Up Studies; Foot; Gram-Negative Bacterial Infections; Hirudo medicinalis; Humans; Leeching; Male; Penicillanic Acid; Piperacillin; Radiography; Surgical Flaps; Tazobactam; Time Factors; Treatment Outcome

2007
Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Burns; Cephalothin; Debridement; Drug Administration Schedule; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam

2007
Appropriate comparators for alternate dosing strategies.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jul-15, Volume: 45, Issue:2

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Monte Carlo Method; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Risk Assessment; Tazobactam; Treatment Outcome

2007
Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
    The Journal of trauma, 2007, Volume: 63, Issue:2

    Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clinical Protocols; Critical Care; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Probability; Retrospective Studies; Sensitivity and Specificity; Tazobactam; Treatment Outcome

2007
Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual.
    The Annals of pharmacotherapy, 2007, Volume: 41, Issue:10

    Topics: Adult; Drug Therapy, Combination; Humans; Male; Obesity, Morbid; Penicillanic Acid; Piperacillin; Tazobactam

2007
Control of multi-resistant bacteria and ventilator-associated pneumonia: is it possible with changes in antibiotics?
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2007, Volume: 11, Issue:4

    Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Prospective Studies; Tazobactam

2007
False-positive Aspergillus antigen testing due to application of piperacillin/tazobactam--is it still an issue?
    Diagnostic microbiology and infectious disease, 2008, Volume: 60, Issue:1

    Topics: Adult; Antigens, Fungal; Aspergillosis; False Positive Reactions; Galactose; Humans; Immunoenzyme Techniques; Mannans; Penicillanic Acid; Piperacillin; Tazobactam

2008
Sensitivity pattern of gram negative bacilli to three beta-lactam/beta-lactamase inhibitor combinations using the automated API system.
    Indian journal of medical microbiology, 2007, Volume: 25, Issue:3

    Topics: Acinetobacter; Amoxicillin; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Enterobacteriaceae; Enzyme Inhibitors; Gram-Negative Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas; Stenotrophomonas; Tazobactam; Ticarcillin

2007
[Treatment of a septic shock due to multiresistant Acinetobacter baumannii with tigecycline in combination].
    Annales francaises d'anesthesie et de reanimation, 2007, Volume: 26, Issue:12

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Minocycline; Penicillanic Acid; Piperacillin; Shock, Septic; Tazobactam; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination

2007
Irreproducible piperacillin/tazobactam minimum inhibitory concentrations in microdilution tests with Escherichia coli strains.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:1

    Topics: Anti-Bacterial Agents; Escherichia coli; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

2008
Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
    Peptides, 2008, Volume: 29, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; DNA-Binding Proteins; Drug Synergism; Enterococcus faecalis; Escherichia coli; Granulocyte Colony-Stimulating Factor; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Peptides, Cyclic; Peritonitis; Piperacillin; Survival Rate; Tazobactam; Time Factors

2008
Efficacy of the bovine antimicrobial peptide indolicidin combined with piperacillin/tazobactam in experimental rat models of polymicrobial peritonitis.
    Critical care medicine, 2008, Volume: 36, Issue:1

    Topics: Animals; Anti-Infective Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gram-Positive Bacterial Infections; Male; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Rats; Rats, Wistar; Shock, Septic; Tazobactam; Treatment Outcome

2008
Piperacillin/tazobactam-heteroresistant Pseudomonas aeruginosa from urinary infection, successfully treated by piperacillin/tazobactam.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:3

    Topics: Adult; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Male; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Urinary Tract Infections

2008
Suspected drug reaction with piperacillin/tazobactam, in a premature infant.
    British journal of clinical pharmacology, 2008, Volume: 65, Issue:6

    Topics: Anti-Bacterial Agents; Exanthema; Humans; Infant, Newborn; Infant, Premature; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Tazobactam

2008
Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
    The Indian journal of medical research, 2008, Volume: 127, Issue:1

    Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Humans; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Urinary Tract Infections

2008
Piperacillin/tazobactam-induced Sweet syndrome in a patient with chronic lymphocytic leukemia and autoimmune cholangitis.
    The American Journal of dermatopathology, 2008, Volume: 30, Issue:2

    Topics: Aged; Autoimmune Diseases; Biopsy, Needle; Cholangitis; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Penicillanic Acid; Piperacillin; Severity of Illness Index; Sweet Syndrome; Tazobactam

2008
Continuous infusion of beta-lactams in the intensive care unit--best way to hit the target?
    Critical care medicine, 2008, Volume: 36, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactams; Body Fluids; Epithelium; Humans; Infusions, Intravenous; Intensive Care Units; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Tazobactam

2008
Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: a retrospective study.
    BMC infectious diseases, 2008, May-17, Volume: 8

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cohort Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; France; Humans; Incidence; Intensive Care Units; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Treatment Outcome

2008
Inhibition of OXA-1 beta-lactamase by penems.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Bridged Bicyclo Compounds; Enzyme Inhibitors; Escherichia coli; Heterocyclic Compounds; Kinetics; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Structure-Activity Relationship; Tazobactam

2008
False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:5

    Topics: Aged; Antigens, Fungal; Aspergillosis; Aspergillus; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; Galactose; Humans; Mannans; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

2008
Serological studies of piperacillin antibodies.
    Transfusion, 2008, Volume: 48, Issue:11

    Topics: Adsorption; Anemia, Hemolytic; Antibodies; Antibody Specificity; beta-Lactamase Inhibitors; Blood Donors; Coombs Test; Drug Hypersensitivity; Erythrocyte Membrane; Humans; Penicillanic Acid; Penicillin G; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasma; Tazobactam

2008
Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:4

    Topics: Anti-Bacterial Agents; Automation; beta-Lactamases; Deoxyribonucleases, Type II Site-Specific; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Polymerase Chain Reaction; Sequence Analysis, DNA; Tazobactam

2008
Comparison of the effect of ciprofloxacin and Tazocin on the incidence of meticillin-resistant Staphylococcus aureus (MRSA) in an Intensive Care Unit.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Ciprofloxacin; Cross Infection; Data Interpretation, Statistical; Drug Combinations; Electrophoresis, Gel, Pulsed-Field; Hand Disinfection; Hygiene; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Personnel, Hospital; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcal Infections; Tazobactam

2008
Evaluating the ototoxicity of topical piperacillin-tazobactam.
    International journal of pediatric otorhinolaryngology, 2008, Volume: 72, Issue:12

    Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cell Membrane; Cochlea; Drug Combinations; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Hair Cells, Auditory; Male; Microscopy, Electron, Scanning; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam

2008
Dacryocystitis: an unusual form of Mucorales infection.
    The Journal of the Kentucky Medical Association, 2008, Volume: 106, Issue:11

    Topics: Adult; Anti-Bacterial Agents; Dacryocystitis; Enzyme Inhibitors; Female; Humans; Mucorales; Mucormycosis; Penicillanic Acid; Piperacillin; Tazobactam; Tobramycin; Vancomycin

2008
High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009, Jan-01, Volume: 877, Issue:1-2

    Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Humans; Penicillanic Acid; Piperacillin; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tazobactam

2009
Pharmacokinetic/pharmacodynamic modeling to predict in vivo effectiveness of various dosing regimens of piperacillin/tazobactam and piperacillin monotherapy against gram-negative pulmonary isolates from patients managed in intensive care units in 2002.
    Clinical therapeutics, 2008, Volume: 30, Issue:12

    Topics: Acinetobacter baumannii; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Drug Therapy, Combination; Enterobacteriaceae; Gram-Negative Bacterial Infections; Half-Life; Humans; Intensive Care Units; Lung Diseases; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Patient Admission; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; United States

2008
[Fournier's gangrene caused by Streptococcus agalactiae in a non-pregnant woman].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Clindamycin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 1; Disease Susceptibility; Drug Therapy, Combination; Female; Fournier Gangrene; Humans; Metronidazole; Obesity; Penicillanic Acid; Perineum; Piperacillin; Reoperation; Streptococcal Infections; Streptococcus agalactiae; Tazobactam

2009
Pylephlebitis after a duodenal ulcer in a patient with metastasised colon carcinoma treated with chemotherapy and bevacizumab: a case report.
    The Netherlands journal of medicine, 2009, Volume: 67, Issue:2

    Topics: Aged; Amoxicillin; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bacterial Infections; Bevacizumab; Clavulanic Acid; Colorectal Neoplasms; Duodenal Ulcer; Humans; Male; Penicillanic Acid; Piperacillin; Portal Vein; Tazobactam; Thrombophlebitis

2009
First identification of class A carbapenemase-producing Klebsiella pneumoniae in the Republic of Ireland.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2009, Apr-02, Volume: 14, Issue:13

    Topics: Bacterial Proteins; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Tazobactam

2009
In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli.
    The new microbiologica, 2009, Volume: 32, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam

2009
Clostridium perfringens liver abscess after pancreatic resection.
    Surgical infections, 2009, Volume: 10, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Clostridium Infections; Fatal Outcome; Female; Humans; Liver; Liver Abscess; Neoadjuvant Therapy; Pancreatectomy; Pancreatic Neoplasms; Penicillanic Acid; Piperacillin; Postoperative Complications; Tazobactam

2009
Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2009, Volume: 11, Issue:3

    Topics: Aged, 80 and over; Albendazole; Animals; Anti-Infective Agents; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Ivermectin; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Protein C; Recombinant Proteins; Respiratory Distress Syndrome; Shock, Septic; Strongyloides stercoralis; Strongyloidiasis; Superinfection; Tazobactam; Treatment Outcome

2009
Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections.
    Diagnostic microbiology and infectious disease, 2009, Volume: 64, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome

2009
[Evaluation of occurrence of Alcaligenes faecalis in clinical samples of patients of the university hospital in Bydgoszcz].
    Medycyna doswiadczalna i mikrobiologia, 2009, Volume: 61, Issue:1

    Topics: Alcaligenes faecalis; Carbapenems; Drug Resistance, Bacterial; Environmental Microbiology; Environmental Monitoring; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Suppuration; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination; Urine

2009
In vitro synergy studies based on tazobactam/piperacillin against clinical isolates of metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Synergism; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2009
Epidural abscess and meningitis, a complication of spinal anesthesia in a bacteraemic patient.
    JPMA. The Journal of the Pakistan Medical Association, 2009, Volume: 59, Issue:8

    Topics: Anesthesia, Spinal; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Enzyme Inhibitors; Epidural Abscess; Humans; Male; Meningitis, Bacterial; Middle Aged; Penicillanic Acid; Piperacillin; Spinal Puncture; Streptococcal Infections; Streptococcus agalactiae; Tazobactam

2009
Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Gentamicins; Humans; Imipenem; Integrons; Meropenem; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam; Thienamycins

2009
Comparative pharmacodynamics of intermittent and prolonged infusions of piperacillin/tazobactam using Monte Carlo simulations and steady-state pharmacokinetic data from hospitalized patients.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:11

    Topics: Adult; Aged; Drug Administration Schedule; Gram-Negative Bacterial Infections; Hospitalization; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Penicillanic Acid; Piperacillin; Tazobactam

2009
Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots.
    Diagnostic microbiology and infectious disease, 2009, Volume: 65, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; Drugs, Generic; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2009
Identification of optimal renal dosage adjustments for traditional and extended-infusion piperacillin-tazobactam dosing regimens in hospitalized patients.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Area Under Curve; Bayes Theorem; Cross Infection; Drug Combinations; Female; Hospitalization; Humans; Infusions, Intravenous; Kidney; Kidney Function Tests; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Pneumococcal; Reproducibility of Results; Tazobactam; United States; United States Food and Drug Administration

2010
In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains.
    Yonsei medical journal, 2010, Volume: 51, Issue:1

    Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Tobramycin

2010
Comparative in vitro study of the antimicrobial activities of different commercial antibiotic products for intravenous administration.
    BMC clinical pharmacology, 2010, Jan-29, Volume: 10

    Topics: Animals; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Campylobacter Infections; Drug Resistance; Drug Resistance, Multiple, Bacterial; Humans; Infusions, Intravenous; Injections, Intravenous; Meropenem; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins; Tissue Distribution

2010
Daily serum piperacillin monitoring is advisable in critically ill patients.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug Monitoring; Female; France; Hospitals, Teaching; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Serum; Tazobactam; Time Factors

2010
Proteomic analysis of Escherichia coli with experimentally induced resistance to piperacillin/tazobactam.
    Research in microbiology, 2010, Volume: 161, Issue:4

    Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Two-Dimensional; Escherichia coli; Escherichia coli Proteins; Mass Spectrometry; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Proteomics; Tazobactam

2010
An unusual case of septic shock in a geriatric patient.
    Connecticut medicine, 2010, Volume: 74, Issue:3

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Antidiuretic Agents; Capnocytophaga; Female; Fluid Therapy; Gram-Negative Bacterial Infections; Humans; Multiple Organ Failure; Penicillanic Acid; Piperacillin; Risk Factors; Shock, Septic; Tazobactam; Vancomycin; Vasopressins

2010
Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators.
    Critical care (London, England), 2010, Volume: 14, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Clinical Trials, Phase III as Topic; Doripenem; Female; Health Resources; Humans; Imipenem; Length of Stay; Male; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Prospective Studies; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome

2010
Contribution of a plasmid-borne blaOXA-58 gene with its hybrid promoter provided by IS1006 and an ISAba3-like element to beta-lactam resistance in acinetobacter genomic species 13TU.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillanic Acid; Piperacillin; Plasmids; Promoter Regions, Genetic; Recombination, Genetic; Sequence Analysis, DNA; Species Specificity; Tazobactam

2010
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.
    Critical care (London, England), 2010, Volume: 14, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Sepsis; Shock, Septic; Tazobactam; Thienamycins

2010
Protective effect of citropin 1.1 and tazobactam-piperacillin against oxidative damage and lethality in mice models of gram-negative sepsis.
    The Journal of surgical research, 2011, Volume: 171, Issue:2

    Topics: Amphibian Proteins; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antimicrobial Cationic Peptides; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Oxidative Stress; Penicillanic Acid; Piperacillin; Tazobactam

2011
Septicemic melioidosis.
    The Journal of the Association of Physicians of India, 2010, Volume: 58

    Topics: Humans; Male; Melioidosis; Penicillanic Acid; Piperacillin; Sepsis; Tazobactam; Time Factors; Treatment Outcome

2010
Right atrial thrombus in a six- year- old Indian boy with metabolic syndrome.
    Journal of pediatric endocrinology & metabolism : JPEM, 2010, Volume: 23, Issue:6

    Topics: Acanthosis Nigricans; Anti-Bacterial Agents; Anticoagulants; Child; Drug Therapy, Combination; Echocardiography, Doppler; Heart Atria; Heart Diseases; Heparin, Low-Molecular-Weight; Humans; Male; Metabolic Syndrome; Obesity; Penicillanic Acid; Piperacillin; Positive-Pressure Respiration; Tazobactam; Thrombosis; Treatment Outcome; Warfarin

2010
In vitro selection of ertapenem and piperacillin/tazobactam-resistant strains of Bacteroides fragilis and analysis of their virulence in gnotobiotic mice.
    Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; beta-Lactams; Ertapenem; Germ-Free Life; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Piperacillin; Tazobactam; Virulence

2010
Importance of infusion volume and pump characteristics in extended administration of ß-lactam antibiotics.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactams; Drug Administration Routes; Humans; Meropenem; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins

2010
Delayed-type hypersensitivity reaction to piperacillin/tazobactam in a patient with an infected total knee replacement.
    The Journal of bone and joint surgery. British volume, 2010, Volume: 92, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Bone Cements; Drug Combinations; Drug Hypersensitivity; Female; Humans; Hypersensitivity, Delayed; Penicillanic Acid; Piperacillin; Prosthesis-Related Infections; Reoperation; Tazobactam

2010
Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Dialysis Solutions; Drug Monitoring; Female; Hemofiltration; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Dialysis; Tazobactam

2011
Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam.
    The European journal of health economics : HEPAC : health economics in prevention and care, 2012, Volume: 13, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cost-Benefit Analysis; Critical Care; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Markov Chains; Meropenem; Middle Aged; Models, Economic; Penicillanic Acid; Piperacillin; Pneumonia; Quality-Adjusted Life Years; Tazobactam; Thienamycins; Treatment Failure; United Kingdom

2012
Drug fever due to piperacillin/tazobactam loaded into bone cement.
    Journal of Korean medical science, 2011, Volume: 26, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Arthritis; Bone Cements; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Humans; Penicillanic Acid; Piperacillin; Tazobactam

2011
Severe human parechovirus sepsis beyond the neonatal period.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 51, Issue:1

    Topics: Anti-Bacterial Agents; Blood Coagulation Disorders; Ceftriaxone; Enterocolitis, Necrotizing; Enzyme Inhibitors; Fever; Heart Failure; Hepatitis; Humans; Infant; Male; Parechovirus; Penicillanic Acid; Picornaviridae Infections; Piperacillin; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sepsis; Sequence Analysis, RNA; Tazobactam

2011
Biliary tract infection caused by Vibrio fluvialis in an immunocompromised patient.
    Infection, 2011, Volume: 39, Issue:5

    Topics: Abdominal Pain; Aged, 80 and over; Anti-Bacterial Agents; Bile Ducts, Intrahepatic; Choledocholithiasis; Diabetes Mellitus; Diagnosis, Differential; Female; Gallstones; Humans; Immunocompromised Host; Kidney Failure, Chronic; Liver Cirrhosis; Penicillanic Acid; Piperacillin; Risk Factors; Taiwan; Tazobactam; Treatment Outcome; Vibrio; Vibrio Infections; Vomiting

2011
In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Clavulanic Acid; DNA, Bacterial; Escherichia coli; Escherichia coli Proteins; Evolution, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Penicillanic Acid; Piperacillin; Plasmids; Selection, Genetic; Tazobactam

2011
Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units.
    The new microbiologica, 2011, Volume: 34, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Czech Republic; Drug Resistance, Multiple, Bacterial; Gentamicins; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam

2011
In vivo comparison of CXA-101 (FR264205) with and without tazobactam versus piperacillin-tazobactam using human simulated exposures against phenotypically diverse gram-negative organisms.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thigh

2012
First identification of blaIMI-1 in an Enterobacter cloacae clinical isolate from France.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Adult; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacter cloacae; Enterobacteriaceae Infections; France; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tazobactam

2012
Bubbles in the urinary bladder.
    The Netherlands journal of medicine, 2012, Volume: 70, Issue:1

    Topics: Anti-Bacterial Agents; Cystitis; Female; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Shock, Septic; Tazobactam; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Diseases

2012
In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Anti-Infective Agents; Bacteroides fragilis; Clindamycin; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

2012
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
    Critical care medicine, 2012, Volume: 40, Issue:5

    Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltration; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins; Vancomycin

2012
Antibiotics as first-line therapy for acute appendicitis: evidence for a change in clinical practice.
    World journal of surgery, 2012, Volume: 36, Issue:9

    Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adult; Anti-Bacterial Agents; Appendicitis; Ciprofloxacin; Female; Humans; Male; Metronidazole; Penicillanic Acid; Piperacillin; Prospective Studies; Randomized Controlled Trials as Topic; Tazobactam

2012
A case of severe toxicity during coadministration of vincristine and piperacillin: are drug transporters involved in vincristine hypersensitivity and drug-drug interactions?
    Journal of pediatric hematology/oncology, 2012, Volume: 34, Issue:8

    Topics: Abdominal Pain; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autonomic Nervous System Diseases; Biological Transport; Child; Cholestasis; Cyclophosphamide; Cytochrome P-450 CYP3A; Daunorubicin; Drug Combinations; Drug Interactions; Facial Pain; Female; Humans; Intestinal Obstruction; Intestinal Pseudo-Obstruction; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Nalbuphine; Neoplasm Proteins; Neuralgia; Penicillanic Acid; Piperacillin; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Seizures; Tazobactam; Vincristine

2012
Antibiotics as first-line therapy for acute appendicitis: evidence for a change in clinical practice.
    World journal of surgery, 2012, Volume: 36, Issue:9

    Topics: Anti-Bacterial Agents; Appendicitis; Ciprofloxacin; Female; Humans; Male; Metronidazole; Penicillanic Acid; Piperacillin; Tazobactam

2012
Pseudomonas aeruginosa septic arthritis of knee after intra-articular ozone injection.
    The new microbiologica, 2012, Volume: 35, Issue:3

    Topics: Aged, 80 and over; Arthritis, Infectious; Body Temperature; Humans; Injections, Intra-Articular; Knee Joint; Male; Microbial Sensitivity Tests; Ozone; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam

2012
Risk factors for infection or colonization with CTX-M extended-spectrum-β-lactamase-positive Escherichia coli.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Regression Analysis; Risk Factors; Tazobactam

2012
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    The Journal of surgical research, 2013, Volume: 181, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tazobactam; Treatment Outcome; Vancomycin; Wounds and Injuries

2013
The interaction between piperacillin-tazobactam and Aspergillus galactomannan antigenemia assay: is the story over?
    Infection, 2013, Volume: 41, Issue:1

    Topics: Aspergillus; Cross Reactions; Galactose; Humans; Mannans; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Tazobactam

2013
Ear pain and facial palsy.
    BMJ (Clinical research ed.), 2012, Sep-07, Volume: 345

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Ear Canal; Facial Paralysis; Female; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Necrosis; Otitis Externa; Penicillanic Acid; Piperacillin; Tazobactam

2012
[Disseminated nocardiosis in a patient with haemophilia: a problem of differential diagnosis].
    Le infezioni in medicina, 2012, Volume: 20, Issue:3

    Topics: Anti-Bacterial Agents; Diagnosis, Differential; Drug Therapy, Combination; Hemophilia A; Humans; Immunocompromised Host; Inpatients; Male; Middle Aged; Nocardia asteroides; Nocardia Infections; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome

2012
Piperacillin-induced thrombocytopenia reversed by high-flux hemodialysis in an uremic patient.
    Hemodialysis international. International Symposium on Home Hemodialysis, 2012, Volume: 16 Suppl 1

    Topics: Aged; Anti-Bacterial Agents; Enzyme Inhibitors; Female; Humans; Penicillanic Acid; Piperacillin; Platelet Count; Renal Dialysis; Tazobactam; Thrombocytopenia; Uremia

2012
Case-control study of drug monitoring of β-lactams in obese critically ill patients.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult

2013
Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital.
    Singapore medical journal, 2012, Volume: 53, Issue:11

    Topics: Academic Medical Centers; Adult; Bacteremia; Carbapenems; Ceftazidime; Drug Resistance, Multiple; Febrile Neutropenia; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prevalence; Prospective Studies; Risk Factors; Sepsis; Singapore; Tazobactam; Treatment Outcome; Universities

2012
[Systemic hantavirus-infection in a comatose HIV patient].
    Wiener medizinische Wochenschrift (1946), 2013, Volume: 163, Issue:1-2

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-HIV Agents; Coma; Critical Care; Diagnosis, Differential; Drug Therapy, Combination; Hemorrhagic Fever with Renal Syndrome; Hepatitis B, Chronic; Humans; Male; Penicillanic Acid; Piperacillin; Puumala virus; Respiratory Distress Syndrome; Sepsis; Tazobactam

2013
The impact of the increased use of piperacillin/tazobactam on the selection of antibiotic resistance among invasive Escherichia coli and Klebsiella pneumoniae isolates.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2013, Volume: 17, Issue:8

    Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

2013
Effectiveness and safety of generic formulation of piperacillin/tazobactam (Astaz-P) for treatment of infected patients at Siriraj Hospital.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2013, Volume: 96 Suppl 2

    Topics: Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Child; Drugs, Generic; Female; Hospitals; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thailand; Young Adult

2013
Sequential antibiotic and growth factor releasing chitosan-PAAm semi-IPN hydrogel as a novel wound dressing.
    Journal of biomaterials science. Polymer edition, 2013, Volume: 24, Issue:7

    Topics: Acrylic Resins; Animals; Anti-Bacterial Agents; Bandages; Biocompatible Materials; Cell Line; Chitosan; Epidermal Growth Factor; Hydrogels; Kinetics; Mice; Penicillanic Acid; Piperacillin; Tazobactam; Water; Wounds and Injuries

2013
Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cohort Studies; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Treatment Outcome; Urinary Tract Infections

2013
Relationship between ceftolozane-tazobactam exposure and drug resistance amplification in a hollow-fiber infection model.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Diffusion Chambers, Culture; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Enzyme Inhibitors; Escherichia coli; Gene Expression; Genetic Engineering; Kinetics; Models, Biological; Penicillanic Acid; Piperacillin; Tazobactam

2013
Alternative diagnosis to heparin-induced thrombocytopenia in two critically ill patients despite a positive PF4/heparin-antibody test.
    Upsala journal of medical sciences, 2013, Volume: 118, Issue:4

    Topics: Aged; Critical Illness; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Femoral Neck Fractures; Heparin; Humans; Methotrexate; Pancytopenia; Penicillanic Acid; Piperacillin; Platelet Count; Platelet Factor 4; Purpura, Thrombocytopenic; Tazobactam; Thrombocytopenia; Transfusion Reaction

2013
Postoperative bacteriuria, pyuria and urinary tract infection in patients with an orthotopic sigmoid colon neobladder replacement.
    The Journal of antibiotics, 2014, Volume: 67, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Bacteriuria; Cefepime; Cephalosporins; Colon, Sigmoid; Cystectomy; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Leukocyte Count; Levofloxacin; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Postoperative Complications; Prevalence; Pyuria; Staphylococcus aureus; Sulfamethoxazole; Tazobactam; Thienamycins; Trimethoprim; Urinary Diversion; Urinary Tract Infections

2014
Population analysis of Escherichia coli isolates with discordant resistance levels by piperacillin-tazobactam broth microdilution and agar dilution testing.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:3

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

2014
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.
    BMC infectious diseases, 2014, Jan-15, Volume: 14

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Clostridioides difficile; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ribotyping; Spores, Bacterial; Tazobactam; Tigecycline; Vancomycin

2014
Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
    International journal of antimicrobial agents, 2014, Volume: 43, Issue:4

    Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Critical Illness; Extracellular Fluid; Female; Half-Life; Hemofiltration; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Sepsis; Tazobactam

2014
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins

2014
Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2014, Volume: 24

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Burns; Cephalosporinase; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2014
Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients.
    The journal of trauma and acute care surgery, 2014, Volume: 77, Issue:3 Suppl 2

    Topics: Adult; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Critical Illness; Cross-Sectional Studies; Female; Humans; Kidney Diseases; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Wounds and Injuries; Young Adult

2014
[70-year-old man with treatment-refractory pneumonia].
    Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:19

    Topics: Aged; Anti-Bacterial Agents; Combined Modality Therapy; Diagnosis, Differential; Empyema, Pleural; Humans; Male; Penicillanic Acid; Piperacillin; Pleural Effusion; Pneumonia, Bacterial; Tazobactam; Thoracic Surgery, Video-Assisted; Treatment Failure; Ultrasonography

2014
Capnocytophaga sputigena bacteremia in a patient with chronic lymphocytic leukemia.
    Annals of laboratory medicine, 2014, Volume: 34, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Capnocytophaga; Gram-Negative Bacterial Infections; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Sequence Homology, Nucleic Acid; Tazobactam; Transplantation, Homologous; Treatment Outcome

2014
[Whirlpool-dermatitis with "hot hands"].
    Deutsche medizinische Wochenschrift (1946), 2014, Volume: 139, Issue:28-29

    Topics: Adolescent; Drug Therapy, Combination; Hand Dermatoses; Humans; Hydrotherapy; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Water Microbiology

2014
Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography/tandem mass spectrometry.
    Journal of chemotherapy (Florence, Italy), 2015, Volume: 27, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Child; Chromatography, Liquid; Drug Monitoring; Humans; Limit of Detection; Linezolid; Meropenem; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Tandem Mass Spectrometry; Tazobactam; Thienamycins

2015
Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS/MS method with semi-automated sample preparation.
    Clinical chemistry and laboratory medicine, 2015, Volume: 53, Issue:5

    Topics: Analytic Sample Preparation Methods; Anti-Bacterial Agents; Automation; Blood Chemical Analysis; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Isotopes; Linezolid; Meropenem; Penicillanic Acid; Piperacillin; Tandem Mass Spectrometry; Tazobactam; Thienamycins; Time Factors

2015
Catheter-related bacteremia by Cupriavidus metallidurans.
    Diagnostic microbiology and infectious disease, 2015, Volume: 81, Issue:1

    Topics: Adult; Aged; Bacteremia; Catheter-Related Infections; Cupriavidus; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tazobactam

2015
Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam.
    International journal of antimicrobial agents, 2015, Volume: 45, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Disease Models, Animal; Enterobacter cloacae; Humans; Mesothelin; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam

2015
A validated LC-MS/MS method for the quantification of piperacillin/tazobactam on dried blood spot.
    Bioanalysis, 2014, Volume: 6, Issue:21

    Topics: Adult; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Dried Blood Spot Testing; Drug Monitoring; Drug Stability; Freezing; Humans; Infant, Newborn; Penicillanic Acid; Piperacillin; Tandem Mass Spectrometry; Tazobactam

2014
Do formulation differences between the reference listed drug and generic piperacillin-tazobactam impact reconstitution?
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:3

    Topics: Administration, Intravenous; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Drugs, Generic; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2015
Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
    Annals of laboratory medicine, 2015, Volume: 35, Issue:1

    Topics: Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Inhibitory Concentration 50; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Republic of Korea; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tazobactam; Tertiary Care Centers; Thienamycins

2015
Rapid-onset piperacillin-tazobactam induced thrombocytopenia.
    Journal of pharmacy practice, 2015, Volume: 28, Issue:2

    Topics: Anti-Bacterial Agents; Female; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thrombocytopenia

2015
A 68-year-old type 2 diabetic man of Korean ethnicity with fever, abdominal pain, and right eye visual disturbance.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Feb-15, Volume: 60, Issue:4

    Topics: Abdominal Pain; Aged; Anti-Bacterial Agents; Bacteremia; Diabetes Mellitus, Type 2; Endophthalmitis; Eye Infections, Bacterial; Fever; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Male; Metronidazole; Penicillanic Acid; Piperacillin; Radiography; Tazobactam; Vision Disorders

2015
Hyperhemolysis syndrome in patients with sickle cell anemia: report of three cases.
    Transfusion, 2015, Volume: 55, Issue:6 Pt 2

    Topics: Adolescent; Anemia, Hemolytic; Anemia, Sickle Cell; Anti-Bacterial Agents; Erythrocyte Transfusion; Hemolysis; Humans; Male; Penicillanic Acid; Piperacillin; Retrospective Studies; Syndrome; Tazobactam

2015
Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China.
    American journal of infection control, 2015, Apr-01, Volume: 43, Issue:4

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ceftazidime; China; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Utilization Review; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Inpatients; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Tertiary Care Centers

2015
Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:6

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Drug Combinations; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins; United States

2015
Population Pharmacokinetics and Pharmacodynamics of Piperacillin/Tazobactam in Patients with Nosocomial Infections.
    European journal of drug metabolism and pharmacokinetics, 2016, Volume: 41, Issue:4

    Topics: Anti-Bacterial Agents; Body Weight; Cross Infection; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2016
Generic piperacillin/tazobactam is not associated with galactomannan false-positivity in adult patients with cancer: a case-control study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:7

    Topics: Adult; Aged; Anti-Bacterial Agents; Antigens, Fungal; Aspergillosis; Case-Control Studies; False Positive Reactions; Female; Galactose; Humans; Male; Mannans; Middle Aged; Neoplasms; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Time Factors

2015
A green capillary zone electrophoresis method for the simultaneous determination of piperacillin, tazobactam and cefepime in pharmaceutical formulations and human plasma.
    Biomedical chromatography : BMC, 2015, Volume: 29, Issue:12

    Topics: Cefepime; Cephalosporins; Dosage Forms; Electrophoresis, Capillary; Green Chemistry Technology; Humans; Linear Models; Penicillanic Acid; Piperacillin; Reproducibility of Results; Sensitivity and Specificity; Tazobactam

2015
Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals.
    Clinical therapeutics, 2015, Jul-01, Volume: 37, Issue:7

    Topics: Adult; Anti-Infective Agents; beta-Lactamases; Cefepime; Cephalosporins; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; United States

2015
In vitro activities of 21 antimicrobial agents alone and in combination with aminoglycosides or fluoroquinolones against extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefixime; Ceftazidime; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

2015
Multidrug-Resistant Corynebacterium striatum Bacteremia: First Case in Korea.
    Annals of laboratory medicine, 2015, Volume: 35, Issue:4

    Topics: Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Corynebacterium; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Quadriplegia; Republic of Korea; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tazobactam

2015
Role of the culture medium in porin expression and piperacillin-tazobactam susceptibility in Escherichia coli.
    Journal of medical microbiology, 2015, Volume: 64, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactamases; Culture Media; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Penicillanic Acid; Piperacillin; Porins; Tazobactam

2015
Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Adaptation, Physiological; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Gene Expression; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protein Structure, Secondary; Protein Structure, Tertiary; Pseudomonas aeruginosa; Tazobactam; Ticarcillin

2015
Causative drug detection by drug-induced lymphocyte stimulation test in drug-induced linear IgA bullous dermatosis.
    The British journal of dermatology, 2016, Volume: 175, Issue:5

    Topics: Aged; Ampicillin; Anti-Bacterial Agents; Drug Combinations; Drug Eruptions; Female; Humans; Linear IgA Bullous Dermatosis; Lymphocyte Activation; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam

2016
Lymphoproliferative associated type 1 cryoglobulinemia.
    Acta clinica Belgica, 2016, Volume: 71, Issue:2

    Topics: Aged, 80 and over; Biopsy; Cryoglobulinemia; Humans; Immunoglobulin M; Immunohistochemistry; Lymphoproliferative Disorders; Male; Methylprednisolone; Penicillanic Acid; Piperacillin; Rituximab; Tazobactam

2016
Population pharmacokinetics of piperacillin in the early phase of septic shock: does standard dosing result in therapeutic plasma concentrations?
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Penicillanic Acid; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Shock, Septic; Tazobactam

2015
Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.
    Nature chemical biology, 2015, Volume: 11, Issue:11

    Topics: Allosteric Regulation; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Drug Synergism; Drug Therapy, Combination; Female; Gene Expression; Humans; Linezolid; Meropenem; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Operon; Penicillanic Acid; Penicillin-Binding Proteins; Piperacillin; Staphylococcal Infections; Tazobactam; Thienamycins

2015
Piperacillin-Tazobactam Usage at a Tertiary Pediatric Hospital: An Antimicrobial Stewardship Review.
    Journal of the Pediatric Infectious Diseases Society, 2016, Volume: 5, Issue:3

    Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Child; Hospitals, Pediatric; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam

2016
A 13-Year-Old Boy with Pancytopenia and a Sacrococcygeal Abscess.
    Pediatric annals, 2015, Volume: 44, Issue:9

    Topics: Abscess; Adolescent; Anti-Bacterial Agents; Diagnosis, Differential; Glucocorticoids; Humans; Male; Pancytopenia; Penicillanic Acid; Piperacillin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Sacrococcygeal Region; Tazobactam; Vancomycin

2015
Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy.
    BMC research notes, 2015, Oct-17, Volume: 8

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Regression Analysis; Risk Factors; Tazobactam; Vancomycin

2015
Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Japan; Klebsiella Infections; Klebsiella oxytoca; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Penicillanic Acid; Piperacillin; Tazobactam

2015
Evaluation of CTX-M steady-state mRNA, mRNA half-life and protein production in various STs of Escherichia coli.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Disk Diffusion Antimicrobial Tests; Escherichia coli; Genotype; Humans; Immunoblotting; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA Stability; RNA, Messenger; Tazobactam

2016
Effect of piperacillin/tazobactam restriction on usage and rates of acute renal failure.
    Journal of medical microbiology, 2016, Volume: 65, Issue:2

    Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam

2016
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Computer Simulation; Drug Therapy, Combination; Escherichia coli; Gene Expression; Microbial Sensitivity Tests; Models, Statistical; Organisms, Genetically Modified; Penicillanic Acid; Piperacillin; Plasmids; Tazobactam; Transcription, Genetic

2016
Surgical Site Infections in Patients With Type 3 Open Fractures: Comparing Antibiotic Prophylaxis With Cefazolin Plus Gentamicin Versus Piperacillin/Tazobactam.
    Journal of orthopaedic trauma, 2016, Volume: 30, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cohort Studies; Drug Combinations; Female; Fractures, Open; Gentamicins; Humans; Longitudinal Studies; Male; Middle Aged; Patient Readmission; Penicillanic Acid; Piperacillin; Prevalence; Retrospective Studies; Risk Factors; Surgical Wound Infection; Survival Rate; Tazobactam; Treatment Outcome; Vermont

2016
Protective effects of intravenous immunoglobulin and antimicrobial agents on acute pneumonia in leukopenic mice.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016, Volume: 22, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Body Temperature; Colistin; Cytokines; Edema; Immunoglobulin G; Immunoglobulins, Intravenous; Leukopenia; Lung; Male; Mice; Mice, Inbred ICR; Penicillanic Acid; Peroxidase; Piperacillin; Pneumonia, Bacterial; Pre-Exposure Prophylaxis; Protective Agents; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2016
Clinical characteristics and antimicrobial patterns in complicated intra-abdominal infections: a 6-year epidemiological study in southern China.
    International journal of antimicrobial agents, 2016, Volume: 47, Issue:3

    Topics: Anti-Bacterial Agents; Carbapenems; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Epidemiologic Studies; Escherichia coli; Female; Gentamicins; Humans; Intraabdominal Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Treatment Outcome

2016
Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?
    BMC infectious diseases, 2016, Apr-18, Volume: 16

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Hospitals; Humans; Intestines; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Risk Factors; Tazobactam

2016
A cross-sectional study of blood cultures and antibiotic use in patients admitted from the Emergency Department: missed opportunities for antimicrobial stewardship.
    BMC infectious diseases, 2016, Apr-18, Volume: 16

    Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Bacteremia; Cross-Sectional Studies; Emergency Service, Hospital; Female; Hospitals, University; Humans; Male; Microbiological Techniques; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam

2016
Impact on Bacterial Resistance of Therapeutically Nonequivalent Generics: The Case of Piperacillin-Tazobactam.
    PloS one, 2016, Volume: 11, Issue:5

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Drugs, Generic; Mice; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Therapeutic Equivalency

2016
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin

2016
Modeling and Re-Engineering of Azotobacter vinelandii Alginate Lyase to Enhance Its Catalytic Efficiency for Accelerating Biofilm Degradation.
    PloS one, 2016, Volume: 11, Issue:6

    Topics: Alginates; Amino Acid Sequence; Anti-Bacterial Agents; Azotobacter vinelandii; Biofilms; Catalysis; Glucuronic Acid; Hexuronic Acids; Mutagenesis, Site-Directed; Mutant Proteins; Penicillanic Acid; Piperacillin; Polysaccharide-Lyases; Pseudomonas aeruginosa; Tazobactam

2016
Epidemiology and Outcome of Ventilator-Associated Pneumonia in a Heterogeneous ICU Population in Qatar.
    BioMed research international, 2016, Volume: 2016

    Topics: Acinetobacter; Adolescent; Adult; Aged; Anti-Infective Agents; Comorbidity; Critical Care; Data Collection; Drug Resistance, Multiple, Bacterial; Female; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Pseudomonas; Qatar; Retrospective Studies; Risk Factors; Tazobactam; Treatment Outcome; Young Adult

2016
Pneumocephalus in Child Following Bilateral Otomastoiditis and Nasal Septum Infection.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2016, Volume: 26, Issue:7

    Topics: Amikacin; Anti-Bacterial Agents; Humans; Infant; Male; Mastoiditis; Nasal Septum; Otitis Media; Penicillanic Acid; Piperacillin; Pneumocephalus; Pseudomonas Infections; Subdural Effusion; Tazobactam; Tomography, X-Ray Computed; Treatment Outcome

2016
A simple and rapid RP-HPLC method for the simultaneous determination of piperacillin and tazobactam in human plasma.
    Journal of pharmaceutical and biomedical analysis, 2016, Nov-30, Volume: 131

    Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Humans; Liquid-Liquid Extraction; Penicillanic Acid; Piperacillin; Solid Phase Extraction; Tazobactam; Time Factors

2016
Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy.
    PLoS biology, 2016, Volume: 14, Issue:9

    Topics: Anti-Bacterial Agents; Base Sequence; Carrier Proteins; Cell Line; Drug Resistance, Bacterial; Escherichia coli Proteins; Gene Knockdown Techniques; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Oligodeoxyribonucleotides, Antisense; Penicillanic Acid; Piperacillin; Sulfamethoxazole; Tazobactam; Trimethoprim

2016
Proposed breakpoint of piperacillin/tazobactam against extended spectrum β-lactamases producing bacteria in bacteremia.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacteriaceae; Female; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam

2017
β-Lactamase Inhibitors Enhance the Synergy between β-Lactam Antibiotics and Daptomycin against Methicillin-Resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Daptomycin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam

2017
Recognition of gamma-hydroxybutyric acid withdrawal: Rapid progression and prolonged symptomatology.
    Emergency medicine Australasia : EMA, 2017, Volume: 29, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Australia; Baclofen; Benzodiazepines; Diazepam; Humans; Hydroxybutyrates; Male; Penicillanic Acid; Phenobarbital; Piperacillin; Pneumonia; Psychomotor Agitation; Substance Withdrawal Syndrome; Sweating; Tazobactam; Tremor

2017
Clostridium sphenoides Chronic Osteomyelitis Diagnosed Via Matrix-Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry, Conflicting With 16S rRNA Sequencing but Confirmed by Whole Genome Sequencing.
    Military medicine, 2017, Volume: 182, Issue:1

    Topics: Anti-Bacterial Agents; Chronic Disease; Clostridium; Clostridium Infections; Daptomycin; Fractures, Open; Humans; Male; Osteomyelitis; Penicillanic Acid; Piperacillin; Radius Fractures; RNA, Ribosomal, 16S; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tazobactam; Ulna Fractures; Whole Genome Sequencing; Young Adult

2017
Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model.
    BMC microbiology, 2017, 01-05, Volume: 17, Issue:1

    Topics: Bacteriophages; beta-Lactamases; Biodiversity; Biofilms; Biological Evolution; Culture Media; Cystic Fibrosis; Drug Resistance, Microbial; Penicillanic Acid; Phenotype; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tazobactam

2017
Treatment efficacy and superinfection rates in complicated urinarytract infections treated with ertapenem or piperacillin tazobactam.
    Turkish journal of medical sciences, 2016, Dec-20, Volume: 46, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Ertapenem; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Superinfection; Tazobactam; Treatment Outcome

2016
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4

    Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Tazobactam; Thienamycins

2017
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
    Le infezioni in medicina, 2017, Mar-01, Volume: 25, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin

2017
Dose optimization of piperacillin/tazobactam in critically ill children.
    The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Tazobactam

2017
Should We Revisit the Nephrotoxic Potential of Piperacillin-Tazobactam as Well?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, 07-01, Volume: 65, Issue:1

    Topics: Acute Kidney Injury; Cefepime; Humans; Piperacillin; Tazobactam; Vancomycin

2017
Reply to Manian.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, 07-01, Volume: 65, Issue:1

    Topics: Acute Kidney Injury; Cefepime; Humans; Piperacillin; Tazobactam; Vancomycin

2017
Effectiveness of a Computer-facilitated, Pharmacist-driven Antimicrobial Stewardship Program for Infection Management.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2017, Volume: 137, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenems; Computer Systems; Cost Savings; Databases, Factual; Drug Monitoring; Drug Utilization; Drug Utilization Review; Humans; Infection Control; Methicillin-Resistant Staphylococcus aureus; Monitoring, Physiologic; Penicillanic Acid; Pharmacists; Piperacillin; Tazobactam

2017
Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.
    Journal of medical economics, 2017, Volume: 20, Issue:8

    Topics: Anti-Bacterial Agents; Bacteriological Techniques; Cephalosporins; Clinical Protocols; Drug Combinations; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Male; Metronidazole; Models, Econometric; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality-Adjusted Life Years; Tazobactam; United Kingdom

2017
Unusual course of a haematoma of the thigh.
    BMJ case reports, 2017, May-22, Volume: 2017

    Topics: Anti-Bacterial Agents; Delayed Diagnosis; Drainage; Female; Hematoma; Humans; Linezolid; Magnetic Resonance Imaging; Middle Aged; Muscle, Skeletal; Osteomyelitis; Penicillanic Acid; Piperacillin; Soft Tissue Infections; Tazobactam; Thigh

2017
Recurrence of Cytomegalovirus Viremia Causing Gastrointestinal Tract Bleeding at Different Sites in an Immuno-competent Patient.
    The American journal of the medical sciences, 2017, Volume: 353, Issue:6

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Blood Transfusion; Colitis; Colon; Cytomegalovirus; Cytomegalovirus Infections; Diarrhea; Esomeprazole; Gastrointestinal Hemorrhage; Gastrointestinal Tract; Humans; Immunocompetence; Male; Penicillanic Acid; Piperacillin; Pneumonia; Pulmonary Disease, Chronic Obstructive; Steroids; Tazobactam; Treatment Outcome; Viremia

2017
Neurotoxic Concentration of Piperacillin during Continuous Infusion in Critically Ill Patients.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9

    Topics: Aged; Anti-Bacterial Agents; Critical Care; Critical Illness; Drug Monitoring; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nervous System Diseases; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam

2017
ENT infection caused by
    Nigerian journal of clinical practice, 2017, Volume: 20, Issue:7

    Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Endoscopy; Enterobacteriaceae; Enterobacteriaceae Infections; Facial Nerve Diseases; Female; Humans; Laryngoscopy; Oral Ulcer; Otitis Externa; Piperacillin; Tazobactam; Treatment Outcome; Vocal Cord Paralysis

2017
Fungating groin mass in a woman with a history of follicular lymphoma.
    BMJ case reports, 2017, Aug-16, Volume: 2017

    Topics: Anti-Bacterial Agents; Antineoplastic Agents; Ceftriaxone; Cyclophosphamide; Diagnosis, Differential; Escherichia coli Infections; Female; Groin; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Penicillanic Acid; Piperacillin; Positron-Emission Tomography; Rituximab; Tazobactam; Tomography, X-Ray Computed; Vincristine

2017
Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Enterobacteriaceae; Enterobacteriaceae Infections; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

2017
Reply to Aitken et al., "Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?"
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam

2017
Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
    Military medicine, 2017, Volume: 182, Issue:9

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Hospitals, Military; Humans; Incidence; Logistic Models; Male; Middle Aged; Military Personnel; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Tertiary Care Centers; Vancomycin

2017
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12

    Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Humans; Iatrogenic Disease; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tazobactam; Thienamycins; Tobramycin

2017
Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Drug Combinations; Gene Expression; Humans; Los Angeles; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins

2017
Reply to MacFadden et al.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 01-18, Volume: 66, Issue:3

    Topics: Bacteremia; Cefepime; Gram-Negative Bacteria; Humans; Meropenem; Piperacillin; Sepsis; Tazobactam

2018
Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2013-2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazoba
    Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins

2018
Skin infection in a renal transplant recipient.
    Medicina clinica, 2018, 06-08, Volume: 150, Issue:11

    Topics: Aged; Amputation, Surgical; Combined Modality Therapy; Debridement; Dermatomycoses; Fatal Outcome; Humans; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Mycophenolic Acid; Piperacillin; Postoperative Complications; Prednisone; Scedosporium; Tacrolimus; Tazobactam

2018
Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2018
A UHPLC-MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluent.
    Journal of pharmaceutical and biomedical analysis, 2018, Jan-30, Volume: 148

    Topics: Calibration; Chromatography, High Pressure Liquid; Critical Illness; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasma; Renal Replacement Therapy; Sensitivity and Specificity; Tandem Mass Spectrometry; Tazobactam; Urine

2018
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study.
    Lung cancer (Amsterdam, Netherlands), 2017, Volume: 113

    Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cost of Illness; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Retrospective Studies; Sepsis; Taxoids; Tazobactam

2017
Case Report:
    The American journal of tropical medicine and hygiene, 2017, Volume: 97, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents, Immunological; Antiparasitic Agents; Bacteremia; Fatal Outcome; Humans; Immunocompromised Host; Ivermectin; Klebsiella pneumoniae; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Penicillanic Acid; Piperacillin; Rituximab; Strongyloides stercoralis; Strongyloidiasis; Tazobactam

2017
Clinical efficacy and safety of cefepime-tazobactam in hospitalized patients in South India.
    Infectious diseases (London, England), 2018, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Hospitalization; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Young Adult

2018
Piperacillin-Tazobactam Plus Vancomycin Equals Acute Kidney Injury: Does It Add Up?
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2017, Volume: 18, Issue:12

    Topics: Acute Kidney Injury; Child; Critical Illness; Humans; Piperacillin; Tazobactam; Vancomycin

2017
Acute generalized exanthematous pustulosis with multisystem manifestations: Pinpoint pustules and purulent lakes.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018, Volume: 120, Issue:1

    Topics: Acute Generalized Exanthematous Pustulosis; Aged; Allergens; Betamethasone Valerate; Bodily Secretions; Diagnosis, Differential; Eosinophils; Erythema; Female; Humans; Methylprednisolone; Neutrophils; Piperacillin; Psoriasis; Tazobactam

2018
Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department.
    BMC infectious diseases, 2018, 01-26, Volume: 18, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Female; Fluoroquinolones; Gentamicins; Germany; Humans; Male; Middle Aged; Odds Ratio; Penicillanic Acid; Piperacillin; Risk Factors; ROC Curve; Tazobactam; Urinary Tract Infections

2018
A rapid, LC-MS/MS assay for quantification of piperacillin and tazobactam in human plasma and pleural fluid; application to a clinical pharmacokinetic study.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2018, Apr-01, Volume: 1081-1082

    Topics: Aged; Aged, 80 and over; Chromatography, Liquid; Empyema, Pleural; Humans; Limit of Detection; Linear Models; Male; Penicillanic Acid; Piperacillin; Pleural Effusion; Reproducibility of Results; Tandem Mass Spectrometry; Tazobactam

2018
Pharmacokinetics of piperacillin in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration.
    The Journal of antimicrobial chemotherapy, 2018, 06-01, Volume: 73, Issue:6

    Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Critical Illness; Female; Filtration; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Prospective Studies; Renal Dialysis; Renal Replacement Therapy; Tazobactam

2018
The Cost of Vancomycin and Piperacillin/Tazobactam Treatment-Reply.
    JAMA pediatrics, 2018, 05-01, Volume: 172, Issue:5

    Topics: Acute Kidney Injury; Child; Child, Hospitalized; Humans; Piperacillin; Tazobactam; Vancomycin

2018
The Cost of Vancomycin and Piperacillin/Tazobactam Treatment.
    JAMA pediatrics, 2018, 05-01, Volume: 172, Issue:5

    Topics: Acute Kidney Injury; Child; Child, Hospitalized; Humans; Piperacillin; Tazobactam; Vancomycin

2018
    BMJ case reports, 2018, Mar-27, Volume: 2018

    Topics: Amoxicillin; Anti-Bacterial Agents; Clavulanic Acid; Clindamycin; Diagnosis, Differential; Female; Humans; Middle Aged; Penicillanic Acid; Penicillin G; Peritonitis; Piperacillin; Streptococcal Infections; Streptococcus pyogenes; Tazobactam; Treatment Outcome

2018
Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens.
    Clinica chimica acta; international journal of clinical chemistry, 2018, Volume: 482

    Topics: Blood Specimen Collection; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Drug Monitoring; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Tazobactam

2018
A rare and dangerous hand infection caused by Francisella tularensis after a mouse bite.
    The Journal of hand surgery, European volume, 2018, Volume: 43, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Bites and Stings; Debridement; Hand; Hospitalization; Humans; Infusions, Intravenous; Male; Mice; Piperacillin; Soft Tissue Infections; Tazobactam; Tularemia; Young Adult

2018
Bilateral nonpitting edema and xerotic skin.
    The Journal of family practice, 2018, Volume: 67, Issue:4

    Topics: Anti-Bacterial Agents; Black or African American; Edema; Elephantiasis; Female; Humans; Middle Aged; Piperacillin; Skin; Tazobactam; Treatment Outcome; United States

2018
The use of broad-spectrum antibiotics reduces the incidence of surgical site infection after pancreatoduodenectomy.
    Surgery today, 2018, Volume: 48, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Cefmetazole; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Incidence; Intraoperative Period; Male; Middle Aged; Pancreaticoduodenectomy; Penicillanic Acid; Piperacillin; Retrospective Studies; Surgical Wound Infection; Tazobactam; Time Factors; Vancomycin

2018
Piperacillin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis.
    The Annals of pharmacotherapy, 2018, Volume: 52, Issue:10

    Topics: Adult; Aged; Anti-Bacterial Agents; Critical Illness; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Renal Dialysis; Renal Replacement Therapy; Tazobactam

2018
Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children with Normal and Augmented Renal Clearance.
    Clinical pharmacokinetics, 2019, Volume: 58, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Bacteria; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Kidney; Male; Microbial Sensitivity Tests; Models, Biological; Piperacillin; Tazobactam

2019
Piperacillin-Tazobactam: Extended Infusion Versus Continuous Infusion.
    Critical care medicine, 2018, Volume: 46, Issue:7

    Topics: Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2018
The authors reply.
    Critical care medicine, 2018, Volume: 46, Issue:7

    Topics: Piperacillin; Tazobactam

2018
Superior mesenteric venous thrombosis complicating acute appendicitis: A case report.
    Medicine, 2018, Volume: 97, Issue:25

    Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Appendectomy; Appendicitis; Diagnostic Errors; Early Medical Intervention; Heparin, Low-Molecular-Weight; Humans; Male; Mesenteric Vascular Occlusion; Mesenteric Veins; Penicillanic Acid; Piperacillin; Tazobactam; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis

2018
Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 2: Stability Evaluation.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:9

    Topics: Anti-Bacterial Agents; Cefepime; Chromatography, Liquid; Drug Stability; Humans; Meropenem; Piperacillin; Tandem Mass Spectrometry; Tazobactam; Temperature

2018
Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 1: Assay Development and Validation.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Chromatography, Liquid; Humans; Meropenem; Piperacillin; Sensitivity and Specificity; Tandem Mass Spectrometry; Tazobactam

2018
Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:9

    Topics: Anti-Bacterial Agents; Cefepime; Critical Illness; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Tazobactam

2018
Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam.
    JAMA internal medicine, 2018, 08-01, Volume: 178, Issue:8

    Topics: Acute Kidney Injury; Febrile Neutropenia; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin

2018
Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam-Reply.
    JAMA internal medicine, 2018, 08-01, Volume: 178, Issue:8

    Topics: Acute Kidney Injury; Febrile Neutropenia; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin

2018
Comparative incidence and excess risk of acute kidney injury in hospitalised patients receiving vancomycin and piperacillin/tazobactam in combination or as monotherapy.
    International journal of antimicrobial agents, 2018, Volume: 52, Issue:5

    Topics: Academic Medical Centers; Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Creatinine; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Hospital Mortality; Humans; Incidence; Length of Stay; Male; Middle Aged; New York; Piperacillin; Retrospective Studies; Risk Assessment; Tazobactam; Vancomycin; Young Adult

2018
Antimicrobial prophylaxis for transurethral resection of bladder tumor: A retrospective comparison of preoperative single-dose administration of piperacillin and tazobactam/piperacillin.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018, Volume: 24, Issue:12

    Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteriuria; Female; Fever; Humans; Male; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Retrospective Studies; Tazobactam; Urinary Bladder Neoplasms

2018
[CME: Fusobacterium nucleatum/naviforme - a Rare but Serious Cause for Pyogenic Liver Abscesses].
    Praxis, 2018, Volume: 107, Issue:19

    Topics: Adult; Chest Pain; Combined Modality Therapy; Diagnosis, Differential; Drainage; Drug Therapy, Combination; Fusobacterium Infections; Fusobacterium nucleatum; Humans; Infusions, Intravenous; Levofloxacin; Liver Abscess; Liver Function Tests; Magnetic Resonance Imaging; Male; Metronidazole; Penicillanic Acid; Piperacillin; Tazobactam; Tomography, X-Ray Computed

2018
Detection of galactomannan content in generic piperacillin-tazobactam products.
    Infectious diseases (London, England), 2019, Volume: 51, Issue:2

    Topics: Antimicrobial Stewardship; Galactose; Mannans; Piperacillin; Tazobactam

2019
Intramedullary Antibiotic Delivery for Emphysematous Osteomyelitis of the Femur.
    Orthopedics, 2019, Jan-01, Volume: 42, Issue:1

    Topics: Anti-Bacterial Agents; Bone Cements; Bone Nails; Emphysema; Escherichia coli; Escherichia coli Infections; Female; Femur; Humans; Middle Aged; Osteomyelitis; Piperacillin; Tazobactam

2019
Factors affecting non-operative management of uncomplicated appendicitis in children: Should laparoscopic appendectomy be immediate, interval, or emergency?
    Asian journal of endoscopic surgery, 2019, Volume: 12, Issue:4

    Topics: Anti-Bacterial Agents; Appendectomy; Appendicitis; Child; Female; Humans; Laparoscopy; Male; Patient Selection; Piperacillin; Prospective Studies; Tazobactam; Time-to-Treatment

2019
Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 10-30, Volume: 69, Issue:10

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Female; Humans; Infusions, Intravenous; Liver Cirrhosis; Male; Middle Aged; Piperacillin; Prospective Studies; Retrospective Studies; Tazobactam; Treatment Outcome

2019
A novel framework to compare the effectiveness of β-lactamase inhibitors against extended-spectrum β-lactamase-producing Enterobacteriaceae.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019, Volume: 25, Issue:9

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Dose-Response Relationship, Drug; Drug Synergism; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Piperacillin; Tazobactam

2019
Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:5

    Topics: Acute Kidney Injury; Aged; Cefepime; Critical Illness; Female; Humans; Incidence; Male; Meropenem; Middle Aged; Multivariate Analysis; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin

2019
By ZEUS! Can We Use Intravenous Fosfomycin for Complicated Urinary Tract Infections?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 11-27, Volume: 69, Issue:12

    Topics: Fosfomycin; Humans; Piperacillin; Pyelonephritis; Tazobactam; Urinary Tract Infections

2019
The Quinazolinone Allosteric Inhibitor of PBP 2a Synergizes with Piperacillin and Tazobactam against Methicillin-Resistant Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:5

    Topics: Anti-Bacterial Agents; Drug Synergism; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Quinazolinones; Tazobactam

2019
Rapidly enlarging, giant hepatic cyst growing pseudomonas.
    BMJ case reports, 2019, Apr-01, Volume: 12, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Cardiac Output, Low; Cysts; Drainage; Dyspnea; Female; Humans; Liver Diseases; Metronidazole; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tomography, X-Ray Computed; Ultrasonography, Interventional

2019
Cefepime challenge after piperacillin/tazobactam-induced thrombocytopenia.
    Journal of thrombosis and thrombolysis, 2019, Volume: 48, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Cefepime; Female; Humans; Immunity, Humoral; Male; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Aspiration; Tazobactam; Thrombocytopenia

2019
Stability Studies of Antipyocyanic Beta-Lactam Antibiotics Used in Continuous Infusion.
    Die Pharmazie, 2019, 06-01, Volume: 74, Issue:6

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Imipenem; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2019
Reduced VRE and MRSA colonisation and infection following sustained reduction in broad spectrum antibiotic use in a large tertiary hospital.
    The Medical journal of Australia, 2019, Volume: 211, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Utilization Review; Humans; Methicillin-Resistant Staphylococcus aureus; New South Wales; Piperacillin; Tazobactam; Vancomycin-Resistant Enterococci

2019
Novel insights into the chemistry of an old medicine: A general degradative pathway for penicillins from a piperacillin/tazobactam stability study.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2019, Aug-01, Volume: 136

    Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2019
In vitro interaction of various antibiotic combinations recommended by Chinese consensus statement against carbapenems-resistant Pseudomonas aeruginosa.
    Letters in applied microbiology, 2019, Volume: 69, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; Carbapenems; Cefoperazone; Ceftazidime; China; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2019
Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen.
    The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Body Weight; Child; Child, Preschool; Female; Fever; Glomerular Filtration Rate; Humans; Infant; Male; Microbial Sensitivity Tests; Neoplasms; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2019
Preanalytical Stability of Piperacillin, Tazobactam, Meropenem, and Ceftazidime in Plasma and Whole Blood Using Liquid Chromatography-Tandem Mass Spectrometry.
    Therapeutic drug monitoring, 2019, Volume: 41, Issue:4

    Topics: Anti-Bacterial Agents; Ceftazidime; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Meropenem; Piperacillin; Plasma; Tandem Mass Spectrometry; Tazobactam

2019
Population Pharmacokinetics and Safety of Piperacillin-Tazobactam Extended Infusions in Infants and Children.
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:11

    Topics: Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2019
    Antimicrobial agents and chemotherapy, 2019, 12-20, Volume: 64, Issue:1

    Topics: Achromobacter; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Boronic Acids; Burkholderia; Cystic Fibrosis; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Stenotrophomonas; Stenotrophomonas maltophilia; Tazobactam

2019
A case of a 22-month-old boy with necrotizing pneumonia presenting with leukaemoid reaction misdiagnosed as leukaemia: a case report and review of the literature.
    Malawi medical journal : the journal of Medical Association of Malawi, 2019, Volume: 31, Issue:3

    Topics: Anti-Bacterial Agents; Diagnostic Errors; Humans; Infant; Leukemoid Reaction; Leukocyte Count; Lung; Male; Piperacillin; Pneumonia, Necrotizing; Tazobactam; Tomography, X-Ray Computed; Treatment Outcome

2019
In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Genome, Bacterial; Genomics; Humans; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Tazobactam; Vancomycin-Resistant Enterococci; Whole Genome Sequencing

2020
Antimicrobial resistance of bacteraemia in the emergency department of a German university hospital (2013-2018): potential carbapenem-sparing empiric treatment options in light of the new EUCAST recommendations.
    BMC infectious diseases, 2019, Dec-30, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Emergency Service, Hospital; Enterobacteriaceae; Germany; Hospitals, University; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus aureus; Tazobactam; Treatment Outcome

2019
Linguistic and cultural adaptation to the Portuguese language of antimicrobial dose adjustment software.
    Einstein (Sao Paulo, Brazil), 2020, Volume: 18

    Topics: Aged; Aged, 80 and over; Anthropometry; Anti-Infective Agents; Brazil; Cross-Cultural Comparison; Delphi Technique; Female; Humans; Intensive Care Units; Linguistics; Male; Middle Aged; Piperacillin; Reference Standards; Reproducibility of Results; Software Design; Statistics, Nonparametric; Surveys and Questionnaires; Tazobactam

2020
First Case of Bacteremia Caused by Coprobacillus catenaformis.
    Annals of laboratory medicine, 2020, Volume: 40, Issue:5

    Topics: Aged; Anti-Bacterial Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Firmicutes; Gram-Positive Bacterial Infections; Humans; Laminectomy; Pedicle Screws; Piperacillin; Spinal Cord; Tazobactam

2020
Intravitreal piperacillin-tazobactam in endophthalmitis caused by
    Indian journal of ophthalmology, 2020, Volume: 68, Issue:7

    Topics: Adult; Anti-Bacterial Agents; Computer Simulation; Endophthalmitis; Female; Humans; Mycobacterium abscessus; Piperacillin; Tazobactam

2020
Acute respiratory distress syndrome during a pandemic-an obvious diagnosis?
    The Lancet. Infectious diseases, 2020, Volume: 20, Issue:7

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Humans; Male; Pandemics; Piperacillin; Psittacosis; Respiratory Distress Syndrome; Tazobactam

2020
Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of bla
    Nature communications, 2020, 10-01, Volume: 11, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Chromosomes, Bacterial; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Amplification; Gene Expression Regulation, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Piperacillin; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 16S; Tazobactam; Whole Genome Sequencing

2020
[Investigation of Pseudomonas aeruginosa Biofilm Formation and Quorum Sensing Genes in Piperacillin/Tazobactam and Ciprofloxacin Sub-minimal Inhibitory Concentrations].
    Mikrobiyoloji bulteni, 2020, Volume: 54, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Ciprofloxacin; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Quorum Sensing; Tazobactam

2020
Comment on "Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples".
    Therapeutic drug monitoring, 2020, Volume: 42, Issue:6

    Topics: Anti-Bacterial Agents; Cefepime; Humans; Meropenem; Piperacillin; Protein Binding; Tazobactam

2020
Comment on "Meropenem, Cefepime, and Piperacillin Protein Binding in Patient Samples".
    Therapeutic drug monitoring, 2020, Volume: 42, Issue:6

    Topics: Anti-Bacterial Agents; Cefepime; Humans; Meropenem; Piperacillin; Protein Binding; Tazobactam

2020
FT-IR/ATR Solid Film Formation: Qualitative and Quantitative Analysis of a Piperacillin-Tazobactam Formulation.
    Molecules (Basel, Switzerland), 2020, Dec-21, Volume: 25, Issue:24

    Topics: Calibration; Chemistry, Pharmaceutical; Evaluation Studies as Topic; Pharmaceutical Preparations; Piperacillin; Spectroscopy, Fourier Transform Infrared; Tazobactam

2020
Imipenem-resistant Pseudomonas aeruginosa treated with piperacillin/tazobactam in a patient with severe pneumonia: a case report and related literature review.
    Annals of palliative medicine, 2021, Volume: 10, Issue:1

    Topics: Aged; Female; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Pseudomonas aeruginosa; Tazobactam

2021
Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2022, Volume: 121, Issue:1 Pt 1

    Topics: Acute Kidney Injury; Humans; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Vancomycin

2022
Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2021, Volume: 92

    Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Diabetic Foot; Drug Resistance; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2021
Impact of a Rapid Blood Culture Diagnostic Panel on Time to Optimal Antimicrobial Therapy at a Veterans Affairs Medical Center.
    Journal of pharmacy practice, 2022, Volume: 35, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Culture; Cohort Studies; Humans; Piperacillin; Retrospective Studies; Tazobactam; Vancomycin; Veterans

2022
A new HPLC-MS/MS analytical method for quantification of tazobactam, piperacillin, and meropenem in human plasma.
    Journal of separation science, 2021, Volume: 44, Issue:14

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Limit of Detection; Meropenem; Piperacillin; Plasma; Reproducibility of Results; Tandem Mass Spectrometry; Tazobactam

2021
Comparison of antibiotic-associated diarrhea caused by cefoperazone/sulbactam or piperacillin/tazobactam in neurosurgery patients.
    The Journal of international medical research, 2021, Volume: 49, Issue:5

    Topics: Anti-Bacterial Agents; Cefoperazone; Diarrhea; Humans; Microbial Sensitivity Tests; Neurosurgery; Penicillanic Acid; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam

2021
Stability and Validation of a High-Throughput LC-MS/MS Method for the Quantification of Cefepime, Meropenem, and Piperacillin and Tazobactam in Serum.
    The journal of applied laboratory medicine, 2021, 09-01, Volume: 6, Issue:5

    Topics: Cefepime; Chromatography, Liquid; Humans; Meropenem; Piperacillin; Reproducibility of Results; Tandem Mass Spectrometry; Tazobactam

2021
Tension pericardial abscess in a patient with tuberculosis: a rare cause of cardiac tamponade.
    Lancet (London, England), 2021, 06-12, Volume: 397, Issue:10291

    Topics: Abscess; Anti-Bacterial Agents; Cardiac Tamponade; Humans; Male; Pericardiocentesis; Pericardium; Piperacillin; Pneumopericardium; Tazobactam; Tuberculosis, Lymph Node; Vancomycin; Young Adult

2021
Population Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation: an ASAP ECMO Study.
    Antimicrobial agents and chemotherapy, 2021, 10-18, Volume: 65, Issue:11

    Topics: Anti-Bacterial Agents; Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Piperacillin; Tazobactam

2021
Development and validation of a liquid chromatography high-resolution mass spectrometry orbitrap method for the sensitive quantification of amoxicillin, piperacillin, tazobactam and meropenem in human faeces.
    Analytica chimica acta, 2021, Sep-08, Volume: 1177

    Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Feces; Humans; Mass Spectrometry; Meropenem; Piperacillin; Research Design; Tazobactam

2021
Time Above All Else: Pharmacodynamic Analysis of β-Lactams in Critically Ill Patients.
    Journal of clinical pharmacology, 2022, Volume: 62, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Critical Illness; Humans; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Piperacillin; Pseudomonas aeruginosa; Tazobactam

2022
Analysis of IV Drugs in the Hospital Workflow by Raman Spectroscopy: The Case of Piperacillin and Tazobactam.
    Molecules (Basel, Switzerland), 2021, Sep-28, Volume: 26, Issue:19

    Topics: Anti-Bacterial Agents; Hospitals; Humans; Piperacillin; Spectrum Analysis, Raman; Tazobactam; Workflow

2021
Effects of piperacillin/tazobactam or cefepime on folinate dose in patients receiving high-dose methotrexate: A retrospective cohort study using Japanese administrative claims data.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:7

    Topics: Cefepime; Drug Therapy, Combination; Humans; Japan; Leucovorin; Methotrexate; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam

2022
Conservative treatment of perforated diverticulitis: following the latest guidelines pays dividends.
    Lancet (London, England), 2021, 10-23, Volume: 398, Issue:10310

    Topics: Abdominal Pain; Administration, Intravenous; Anti-Bacterial Agents; Conservative Treatment; Diverticulitis; Female; Guidelines as Topic; Humans; Middle Aged; Nausea; Piperacillin; Tazobactam; Tomography, X-Ray Computed

2021
Linear IgA bullous dermatosis secondary to piperacillin-tazobactam.
    Dermatologic therapy, 2022, Volume: 35, Issue:2

    Topics: Humans; Immunoglobulin A; Linear IgA Bullous Dermatosis; Piperacillin; Tazobactam

2022
In vitro study of elution kinetics and biological activity of piperacillin/tazobactam and gentamicin in acrylic bone cement.
    Orthopaedics & traumatology, surgery & research : OTSR, 2022, Volume: 108, Issue:8

    Topics: Anti-Bacterial Agents; Bone Cements; Gentamicins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymethyl Methacrylate; Tazobactam

2022
Efficacy of piperacillin-tazobactam and cefotaxime against Escherichia coli hyperproducing TEM-1 in a mouse peritonitis infection model.
    International journal of antimicrobial agents, 2022, Volume: 59, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Antigens, CD; beta-Lactamases; Cefotaxime; Escherichia coli; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; Neoplasm Proteins; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2022
Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 2022, 04-27, Volume: 77, Issue:5

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Ceftazidime; Cephalosporins; Escherichia coli; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Monobactams; Piperacillin; Pseudomonas aeruginosa; Tazobactam

2022
Population pharmacokinetics of piperacillin/tazobactam in critically ill Korean patients and the effects of extracorporeal membrane oxygenation.
    The Journal of antimicrobial chemotherapy, 2022, 04-27, Volume: 77, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Critical Illness; Extracorporeal Membrane Oxygenation; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Republic of Korea; Tazobactam

2022
Comparable Effectiveness of Cefuroxime and Piperacillin-Tazobactam as Empirical Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia.
    Microbiology spectrum, 2022, 06-29, Volume: 10, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefuroxime; Cohort Studies; Humans; Methicillin; Piperacillin; Recurrence; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Treatment Outcome

2022
Sustaining Antimicrobial Stewardship in a High-Antibiotic Resistance Setting.
    JAMA network open, 2022, 05-02, Volume: 5, Issue:5

    Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cohort Studies; Drug Resistance, Microbial; Humans; Piperacillin; Prospective Studies; Tazobactam

2022
Emerging resistance to ceftriaxone treatment owing to different ampD mutations in Enterobacter roggenkampii.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2022, Volume: 102

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Ceftriaxone; Drug Resistance, Bacterial; Enterobacter; Enterobacter cloacae; Humans; Liver Abscess; Microbial Sensitivity Tests; Mutation; Piperacillin; Tazobactam

2022
A case report of a piperacillin/tazobactam-induced acute generalized exanthematous pustulosis.
    Dermatologic therapy, 2022, Volume: 35, Issue:8

    Topics: Acute Generalized Exanthematous Pustulosis; Humans; Piperacillin; Tazobactam

2022
Suppressive effect of therapeutic antibiotic regimen on antipneumococcal Th1/Th17 responses in neonatal mice.
    Pediatric research, 2023, Volume: 93, Issue:4

    Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Cytokines; Humans; Interleukin-17; Mice; Piperacillin; Streptococcus pneumoniae; Tazobactam; Th1 Cells; Th17 Cells

2023
Antibiotic allergy in children with cystic fibrosis: A retrospective case-control study.
    Pediatric pulmonology, 2022, Volume: 57, Issue:11

    Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Case-Control Studies; Ceftazidime; Child; Ciprofloxacin; Cystic Fibrosis; Drug Hypersensitivity; Humans; Levofloxacin; Meropenem; Piperacillin; Retrospective Studies; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination

2022
Epidemiology and antibiotic resistance of prosthetic joint infections according to time of occurrence, a 10-year study.
    The Journal of infection, 2022, Volume: 85, Issue:5

    Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cefotaxime; Coagulase; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Prosthesis-Related Infections; Retrospective Studies; Staphylococcus aureus; Tazobactam; Vancomycin

2022
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique.
    International journal of antimicrobial agents, 2022, Volume: 60, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Gentamicins; Hospitals; Humans; Iron; Mozambique; Piperacillin; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination

2022
Associated microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections.
    Journal of medical virology, 2022, Volume: 94, Issue:12

    Topics: Anti-Bacterial Agents; Antifungal Agents; Bunyaviridae Infections; Coinfection; Humans; Microbiota; Minocycline; Phlebovirus; Piperacillin; Pneumonia; Retrospective Studies; Severe Fever with Thrombocytopenia Syndrome; Tazobactam; Voriconazole

2022
An Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Determination of 4 β-Lactam Antibiotics, Tazobactam, and Linezolid in Human Plasma Samples.
    Therapeutic drug monitoring, 2022, 12-01, Volume: 44, Issue:6

    Topics: Anti-Bacterial Agents; Cefepime; Cefotaxime; Chromatography, High Pressure Liquid; Critical Illness; Drug Monitoring; Humans; Linezolid; Meropenem; Monobactams; Piperacillin; Reproducibility of Results; Tandem Mass Spectrometry; Tazobactam

2022
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-08, Volume: 76, Issue:3

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin

2023
Clearance of Piperacillin-Tazobactam and Vancomycin During Continuous Renal Replacement With Regional Citrate Anticoagulation.
    Therapeutic drug monitoring, 2023, 04-01, Volume: 45, Issue:2

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Anticoagulants; Citrates; Citric Acid; Critical Illness; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Vancomycin

2023
Clinical and microbiological features of intratumor abscess with bloodstream infection caused by Plesiomonas shigelloides, Citrobacter freundii, Streptococcus mitis/oralis, Clostridium perfringens, and Candida albicans in a patient with cholangiocarcinoma
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:12

    Topics: Abscess; Aged; Antifungal Agents; Bacteremia; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Candida albicans; Cholangiocarcinoma; Citrobacter freundii; Clostridium perfringens; Humans; Levofloxacin; Male; Piperacillin; Plesiomonas; RNA, Ribosomal, 16S; Sepsis; Soil; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptococcus mitis; Streptococcus oralis; Tazobactam

2022
Cervical inflammatory mass: a very late complication following neonatal oesophagocoloplasty for oesophageal atresia.
    BMJ case reports, 2022, Sep-20, Volume: 15, Issue:9

    Topics: Anastomosis, Surgical; Colon; Esophageal Atresia; Humans; Infant, Newborn; Male; Piperacillin; Tazobactam

2022
Standardizing the Evaluation and Management of Necrotizing Enterocolitis in a Level IV NICU.
    Pediatrics, 2022, 10-01, Volume: 150, Issue:4

    Topics: Anti-Bacterial Agents; Antifungal Agents; Enterocolitis, Necrotizing; Female; Fetal Diseases; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Piperacillin; Retrospective Studies; Tazobactam

2022
Burn Injury and Augmented Renal Clearance: A Case for Optimized Piperacillin-Tazobactam Dosing.
    Journal of burn care & research : official publication of the American Burn Association, 2023, 01-05, Volume: 44, Issue:1

    Topics: Anti-Bacterial Agents; Burns; Critical Illness; Humans; Microbial Sensitivity Tests; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2023
In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.
    BMC microbiology, 2022, 10-01, Volume: 22, Issue:1

    Topics: Ampicillin; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Klebsiella pneumoniae; Levofloxacin; Meropenem; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Tazobactam; Tigecycline

2022
Prevalence of S. aureus and/or MRSA from seafood products from Indian seafood products.
    BMC microbiology, 2022, 10-01, Volume: 22, Issue:1

    Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Gentamicins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Ofloxacin; Piperacillin; Prevalence; Rifampin; Seafood; Serine; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination; Virulence Factors

2022
PAUSATE Study: Prevalence and appropriateness of the use of antimicrobials in Spanish hospitals.
    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2022, 08-02, Volume: 46, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Cross-Sectional Studies; Hospitals; Humans; Meropenem; Piperacillin; Prevalence; Tazobactam

2022
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China.
    The Journal of infection, 2022, Volume: 85, Issue:5

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefotaxime; Child; Ciprofloxacin; Doxycycline; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Multilocus Sequence Typing; Piperacillin; Pregnancy; Tazobactam; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination

2022
Antibiotic susceptibility and biofilm-forming ability of Veillonella strains.
    Anaerobe, 2022, Volume: 78

    Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Cefoxitin; Clindamycin; Humans; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Piperacillin; Tazobactam; Tetracyclines; Vancomycin; Veillonella

2022
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB.
    Blood advances, 2023, 05-09, Volume: 7, Issue:9

    Topics: Anti-Infective Agents; Carbapenems; Cohort Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Neutropenia; Piperacillin; Retrospective Studies; Tazobactam; Transplantation, Homologous

2023
Relationship between piperacillin concentrations, clinical factors and piperacillin/tazobactam-associated acute kidney injury.
    The Journal of antimicrobial chemotherapy, 2023, 02-01, Volume: 78, Issue:2

    Topics: Acute Kidney Injury; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tazobactam; Vancomycin; Young Adult

2023
The utility of bile juice culture analysis for the management of postoperative infection after pancreaticoduodenectomy.
    Surgery, 2023, Volume: 173, Issue:4

    Topics: Anti-Bacterial Agents; Bile; Cefazolin; Drainage; Humans; Pancreaticoduodenectomy; Piperacillin; Postoperative Complications; Preoperative Care; Retrospective Studies; Surgical Wound Infection; Tazobactam

2023
Piperacillin/Tazobactam Dose Optimization in the Setting of Piperacillin/Tazobactam-susceptible, Carbapenem-resistant Pseudomonas aeruginosa: Time to Reconsider Susceptible Dose Dependent.
    Clinical therapeutics, 2023, Volume: 45, Issue:1

    Topics: Anti-Bacterial Agents; Carbapenems; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Mitomycin; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Tazobactam

2023
Genotypic resistance determined by whole genome sequencing versus phenotypic resistance in 234 Escherichia coli isolates.
    Scientific reports, 2023, 01-09, Volume: 13, Issue:1

    Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Genotype; Gentamicins; Humans; Meropenem; Microbial Sensitivity Tests; Phenotype; Piperacillin; Retrospective Studies; Tazobactam; Tobramycin; Whole Genome Sequencing

2023
Population Pharmacokinetics of Piperacillin/Tazobactam Across the Adult Lifespan.
    Clinical pharmacokinetics, 2023, Volume: 62, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Canada; Creatinine; Frailty; Humans; Longevity; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam

2023
[Relationship of Hypervirulent Capsular Genotypes of Klebsiella pneumoniae with Antibiotic Susceptibility and Beta-Lactamase Genes].
    Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clavulanic Acid; Colistin; Drug Resistance, Bacterial; Genotype; Klebsiella pneumoniae; Microbial Sensitivity Tests; Piperacillin; Tazobactam

2023
Association between emergency department sepsis order set design and delay to second dose piperacillin-tazobactam administration.
    The American journal of emergency medicine, 2023, Volume: 67

    Topics: Adult; Anti-Bacterial Agents; Emergency Service, Hospital; Humans; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Tazobactam

2023
Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis-Reply.
    JAMA, 2023, 02-28, Volume: 329, Issue:8

    Topics: Cefepime; Humans; Piperacillin; Pyelonephritis; Tazobactam; Urinary Tract Infections

2023
Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis.
    JAMA, 2023, 02-28, Volume: 329, Issue:8

    Topics: Anti-Bacterial Agents; Cefepime; Drug Therapy, Combination; Humans; Piperacillin; Pyelonephritis; Tazobactam; Urinary Tract Infections

2023
Characteristics of and antibiotic resistance in urinary tract pathogens isolated from patients with upper urinary tract stones.
    Pakistan journal of pharmaceutical sciences, 2023, Volume: 36, Issue:1

    Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Piperacillin; Sulbactam; Tazobactam; Urinary Calculi; Urinary Tract; Urinary Tract Infections

2023
Prevalence of Multidrug Resistant Pseudomonas aeruginosa Isolated from Clinical Specimens in Tertiary Care Hospital.
    Journal of Nepal Health Research Council, 2023, Mar-07, Volume: 20, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Humans; Microbial Sensitivity Tests; Nepal; Piperacillin; Prevalence; Pseudomonas aeruginosa; Tazobactam; Tertiary Care Centers

2023
EUCAST rapid antimicrobial susceptibility testing (RAST) compared to conventional susceptibility testing: implementation and potential added value in a tertiary hospital in Belgium.
    Acta clinica Belgica, 2023, Volume: 78, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Belgium; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Piperacillin; Tazobactam; Tertiary Care Centers

2023
Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018.
    Antimicrobial resistance and infection control, 2023, 04-18, Volume: 12, Issue:1

    Topics: Adult; Anti-Infective Agents; Canada; Cefazolin; Ceftriaxone; Child; Cross Infection; Hospitals; Humans; Infant, Newborn; Inpatients; Piperacillin; Tazobactam

2023
Geographic patterns of antimicrobial susceptibilities for Bacteroides spp. worldwide: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2007-2020.
    International journal of antimicrobial agents, 2023, Volume: 62, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Clindamycin; Humans; Leadership; Meropenem; Microbial Sensitivity Tests; Piperacillin; Tazobactam; Tigecycline

2023
The Role of MexCD-OprJ and MexEF-OprN Efflux Systems in the Multiple Antibiotic Resistance of Pseudomonas aeruginosa Isolated from Clinical Samples.
    Current microbiology, 2023, May-21, Volume: 80, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Drug Resistance, Microbial; Membrane Transport Proteins; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Tazobactam

2023
Optimal timing for antimicrobial prophylaxis to reduce surgical site infections: a retrospective analysis of 531 patients.
    Scientific reports, 2023, 06-09, Volume: 13, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Cefuroxime; Colorectal Neoplasms; Humans; Metronidazole; Mezlocillin; Piperacillin; Retrospective Studies; Sulbactam; Surgical Wound Infection; Tazobactam

2023
    Antimicrobial agents and chemotherapy, 2023, 07-18, Volume: 67, Issue:7

    Topics: Achromobacter; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin; Tazobactam

2023
In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in the Asia-Pacific region: SMART 2017-2020.
    International journal of antimicrobial agents, 2023, Volume: 62, Issue:3

    Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thailand

2023
Presence of T3SS (exoS, exoT, exoU and exoY), susceptibility pattern and MIC of MDR-Pseudomonas aeruginosa from burn wounds.
    Journal of infection in developing countries, 2023, 08-31, Volume: 17, Issue:8

    Topics: Anti-Bacterial Agents; Colistin; Hospitals, Teaching; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Tazobactam

2023
Microdialysis as a safe and feasible method to study target-site piperacillin-tazobactam disposition in septic piglets and children.
    International journal of antimicrobial agents, 2023, Volume: 62, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Child; Humans; Microdialysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Swine; Tazobactam

2023